Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024139	s-igg3	g/l (g/l)	3070	4169	0.00%
3024139	s-igg3	— (—)	1398	1857	100.00%	Distribution not available
3024139	s-immunoglobuliinig,alaluokka3	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma/COPD (KELA code 203)

1274

2556

3.47

319.31

1.5

1.3

0.38

0.41

g/l

0.76

949

1714

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

310

116

19.95

314.45

1.5

1.2

0.49

0.46

g/l

0.23

214

Asthma, including avohilmo

1525

2746

3.16

310.20

1.5

1.3

0.38

0.42

g/l

2.00

1119

1853

Second line medication for Crohn's disease

922

2392

3.94

309.39

1.6

1.3

0.40

g/l

0.01

651

1677

Asthma (only as main-diagnosis)

1263

945

7.92

307.65

1.5

1.3

0.37

0.41

g/l

1.78

927

592

Asthma-related infections

1136

2104

5.43

307.65

1.5

1.3

0.36

0.42

g/l

4.95

856

1446

Certain disorders involving the immune mechanism

598

699

9.12

307.65

1.9

1.3

0.31

0.41

g/l

6.00

440

481

Chronic lower respiratory diseases

1620

2567

3.41

307.65

1.4

1.3

0.39

0.41

g/l

0.45

1192

1720

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1044

2108

4.53

307.65

1.4

0.43

0.40

g/l

1.39

739

1459

Influenza and pneumonia

1476

2722

3.50

307.65

1.4

1.3

0.39

0.40

g/l

0.39

1072

1853

Acute pancreatitis (for exclusion)

504

685

7.72

307.65

1.6

1.3

0.41

g/l

0.06

225

501

Asthma, excluding more controls

1230

894

7.33

307.65

1.5

1.3

0.37

0.40

g/l

0.77

902

561

Undetermined asthma

304

208

15.28

307.65

1.7

1.2

0.35

0.43

g/l

2.09

223

136

Asthma

1258

945

7.13

307.65

1.5

1.3

0.37

0.41

g/l

1.33

922

592

938

1608

5.97

307.65

1.5

1.3

0.36

0.41

g/l

4.15

712

1110

Systemic connective tissue disorders

703

1245

5.84

307.65

1.7

1.3

0.39

0.42

g/l

1.24

507

858

Asthma-related pneumonia

719

1132

6.55

307.65

1.5

1.3

0.38

0.45

g/l

4.05

543

775

Oral corticosteroids

1992

1896

6.39

307.65

1.5

1.2

0.38

0.42

g/l

1.79

1428

1269

Asthma (only as main-diagnosis), excluding more controls

1243

894

8.14

307.65

1.5

1.3

0.36

0.40

g/l

1.17

914

561

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1310

1789

4.51

307.65

1.4

1.3

0.39

0.43

g/l

1.17

954

1185

Asthma, hospital admission 2, infections

1136

2104

5.43

307.65

1.5

1.3

0.36

0.42

g/l

4.95

856

1446

Asthma, unspecified (mode), excluding more controls

780

820

7.27

307.65

1.4

1.3

0.39

0.40

g/l

0.28

544

521

Asthma, hospital admissions , main diagnosis only

1309

2921

4.03

307.65

1.5

1.3

0.37

0.42

g/l

2.88

966

1998

Chronic sinusitis

775

1496

5.32

307.65

1.5

1.3

0.35

0.44

g/l

5.75

589

997

Fever of other and unknown origin

940

1724

4.96

307.65

1.4

1.3

0.39

0.42

g/l

1.19

670

1216

Asthma, unspecified (mode)

789

863

7.03

307.65

1.4

1.3

0.39

0.42

g/l

0.64

551

547

Abnormal findings on diagnostic imaging of lung

809

1476

5.40

307.65

1.4

0.43

0.41

g/l

0.65

594

1010

Asthma (diagnoses ohter than nonallergic)

1379

2884

4.04

307.65

1.5

1.3

0.37

0.42

g/l

3.22

1013

1981

Pneumonias (Asthma/COPD co-morbidities)

1417

2769

3.49

307.65

1.4

0.40

g/l

0.18

1027

1893

Undetermined asthma, excluding more controls

304

202

15.74

307.65

1.7

1.2

0.35

0.43

g/l

1.84

223

130

ILD medications

1933

1784

6.00

307.65

1.5

1.2

0.38

0.42

g/l

2.82

1379

1192

Inflammatory bowel disease treatment related agents

2011

1986

5.79

307.65

1.5

1.2

0.38

0.41

g/l

1.91

1439

1337

Asthma, hospital admissions 3, pneumonia

720

1134

6.55

307.65

1.5

1.3

0.38

0.45

g/l

4.07

544

776

Immunodeficiency with predominantly antibody defects

285

52.77

307.65

2.1

1.3

0.25

0.39

g/l

2.34

234

Immunodeficiencies

361

146

30.36

307.65

2.0

1.3

0.27

0.40

g/l

3.72

288

103

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1376

2782

3.43

307.65

1.4

0.39

0.40

g/l

0.34

1000

1899

First line medication for Crohn's disease

1794

1766

5.60

307.65

1.5

1.2

0.38

0.42

g/l

3.67

1275

1189

Bronchiectasis

288

156

20.20

307.65

1.4

0.40

0.43

g/l

0.32

216

108

Asthma-related pneumonia or sepsis

720

1134

6.55

307.65

1.5

1.3

0.38

0.45

g/l

4.07

544

776

Acute pancreatitis

504

582

9.10

307.65

1.6

1.3

0.41

g/l

0.04

225

426

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1437

2721

3.71

307.65

1.5

1.3

0.38

0.41

g/l

1.95

1024

1902

All pneumoniae

1424

2777

3.48

307.65

1.4

0.39

0.40

g/l

0.22

1031

1895

Asthma (mode)

1212

950

6.97

307.65

1.5

1.3

0.37

0.41

g/l

1.71

892

595

ILD medications: prednisolone, methylprednisolone, prednisone

1916

1741

6.29

307.65

1.5

1.2

0.38

0.42

g/l

3.42

1374

1162

ILD medications: immunosuppressive drugs

1121

1615

6.61

307.65

1.5

1.2

0.40

0.42

g/l

0.64

796

1082

Pneumonia, organism unspecified

1306

2519

3.70

307.65

1.4

0.39

0.41

g/l

0.46

946

1709

1310

1789

4.51

307.65

1.4

1.3

0.39

0.43

g/l

1.17

954

1185

L04AX Other immunosuppressants

898

2319

3.96

303.34

1.6

1.3

0.40

g/l

0.04

639

1628

Other systemic involvement of connective tissue (FG)

494

791

6.37

289.13

1.8

1.3

0.38

0.41

g/l

0.84

361

539

Other pulmonary diagnosis

865

953

4.60

275.03

1.3

0.39

0.41

g/l

0.85

605

598

Autoimmune diseases related-to ILD

1115

2948

3.28

274.62

1.4

0.39

0.40

g/l

0.48

765

2065

Other systemic involvement of connective tissue

510

914

5.76

270.77

1.8

1.3

0.38

0.40

g/l

0.40

371

632

Excluding asthma or asthma-COPD overlap

856

953

4.55

269.09

1.3

0.39

0.41

g/l

0.70

597

598

ILD differential diagnosis

850

950

4.54

266.06

1.3

0.39

0.41

g/l

0.66

593

595

COPD differential diagnosis

849

951

4.53

265.11

1.3

0.39

0.41

g/l

0.66

593

595

Asthma and opportunity respiratory infection

202

105

21.63

263.73

1.5

1.3

0.38

0.45

g/l

0.76

148

Abnormalities of breathing

1115

1940

3.38

254.93

1.4

1.3

0.40

0.41

g/l

0.15

798

1295

COPD/asthma related infections

1188

1790

3.36

254.85

1.4

1.3

0.39

0.43

g/l

1.78

856

1185

COPD/asthma/ILD related infections

1188

1790

3.36

254.85

1.4

1.3

0.39

0.43

g/l

1.78

856

1185

Cough

609

1248

4.71

254.74

1.4

1.3

0.36

0.41

g/l

2.49

462

842

Other respiratory diseases principally affecting the interstitium

367

516

7.41

247.87

1.4

1.3

0.48

0.42

g/l

1.39

253

359

Disorders of gallbladder, biliary tract and pancreas

1229

2571

3.05

246.22

1.5

1.3

0.43

0.40

g/l

0.66

728

1930

Other and unspecified immunodeficiencies with predominantly antibody defects

146

54.60

245.81

2.2

1.4

0.24

0.33

g/l

1.08

120

ILD, hospital admission 2, with pulmonary infections

232

178

13.73

245.50

1.4

1.3

0.47

g/l

0.01

160

125

Acute sinusitis

770

1892

3.84

244.73

1.5

1.3

0.37

0.41

g/l

2.11

581

1283

Allergic asthma (mode), excluding more controls

346

447

7.74

243.69

1.5

1.3

0.34

0.39

g/l

1.54

282

284

Non-allergic asthma (mode), excluding more controls

296

327

9.20

240.67

1.6

1.2

0.39

0.40

g/l

0.29

223

216

Allergic asthma (mode)

346

455

7.61

240.02

1.5

1.3

0.34

0.40

g/l

2.00

282

292

Other interstitial pulmonary diseases

328

422

8.13

239.69

1.4

1.3

0.50

0.41

g/l

2.68

225

294

Interstitial lung disease

328

424

8.09

238.73

1.4

1.3

0.50

0.40

g/l

2.79

225

295

Interstitial lung disease endpoints

328

424

8.09

238.73

1.4

1.3

0.50

0.40

g/l

2.79

225

295

ILD medications: azathioprine

305

364

8.71

236.82

1.7

1.2

0.44

0.43

g/l

0.17

217

255

ILD, hospital admissions

324

418

8.11

236.24

1.4

1.3

0.50

0.40

g/l

2.51

221

289

Non-allergic asthma (mode)

296

338

8.90

234.55

1.6

1.2

0.39

0.43

g/l

0.76

223

GASTRO-related operations

890

1167

3.87

231.24

1.4

1.2

0.39

0.38

g/l

0.39

587

935

Any gastric operation

890

1167

3.87

231.24

1.4

1.2

0.39

0.38

g/l

0.39

587

935

1291

2278

2.96

230.08

1.4

1.3

0.39

0.43

g/l

2.07

943

1526

Reimbursement for rheumatic diseases

808

2349

3.49

227.38

1.5

1.4

0.44

0.40

g/l

1.06

585

1638

Azathioprine

305

387

8.19

225.18

1.7

1.2

0.44

0.41

g/l

0.48

217

270

Autoimmune diseases excluding thyroid diseases

1255

2361

2.93

224.55

1.4

1.3

0.43

0.39

g/l

1.67

882

1649

Autoimmune diseases excluding thyroid diseases, strict definition

1206

2284

2.92

214.94

1.4

1.3

0.43

0.39

g/l

1.65

854

1605

ILD, hospital admissions 1, main diag only

292

373

8.20

214.80

1.4

1.3

0.51

0.41

g/l

2.63

203

259

Bacterial pneumonia (organism specified)

611

1363

4.14

214.42

1.4

0.39

0.43

g/l

1.56

440

933

Bacterial pneumoniae

558

1123

4.47

213.75

1.4

0.39

0.44

g/l

1.60

406

754

Obesity related asthma

519

1162

4.57

212.49

1.4

1.3

0.39

0.43

g/l

0.65

371

782

General symptoms and signs

1218

2112

2.92

210.00

1.5

1.3

0.38

0.42

g/l

1.66

859

1456

ILD, hospital admissions 3, with pneumonia sepsis

206

171

12.72

207.91

1.2

1.4

0.48

0.44

g/l

0.36

142

119

Chronic rhinitis, nasopharyngitis and pharyngitis

493

1089

4.63

205.22

1.4

0.36

0.41

g/l

2.61

397

739

Bacterial pneumonia, not elsewhere classified

521

1042

4.49

200.82

1.3

1.4

0.39

0.44

g/l

1.36

378

702

Bronchitis

1229

2967

2.64

189.90

1.4

1.3

0.38

0.42

g/l

2.29

897

2025

Other acute lower respiratory infections

721

2087

3.35

188.40

1.5

1.4

0.38

0.41

g/l

0.90

533

1441

Chronic pancreatitis

253

335

7.88

180.40

1.9

1.2

0.42

0.40

g/l

0.28

129

247

Nonhereditary hypogammaglobulinemia

107

52.09

179.92

2.3

1.4

0.22

0.34

g/l

1.56

Bacterial infection, other or unspecified

657

1660

3.49

178.86

1.3

1.4

0.40

0.42

g/l

0.74

470

1141

Dyspnoea

1046

2882

2.71

178.40

1.4

0.41

0.40

g/l

0.24

745

2020

Symptoms and signs involving the circulatory and respiratory systems

1085

1947

2.82

176.45

1.4

1.3

0.37

0.41

g/l

2.16

771

1296

Bacterial infection, other or unspecified

699

1808

3.32

174.86

1.3

1.4

0.40

0.41

g/l

0.14

504

1248

Acute upper respiratory infections

1144

2711

2.63

174.45

1.4

1.3

0.38

0.42

g/l

2.86

842

1840

Other bacterial diseases

1073

2767

2.64

168.82

1.4

0.41

0.40

g/l

0.08

758

1923

Other diseases of pleura

555

1323

3.74

167.88

1.5

1.4

0.40

0.43

g/l

1.00

384

907

Cholangitis (primary sclerosing, PSC)

163

137

12.63

163.39

1.8

1.2

0.44

0.40

g/l

0.45

104

Other diseases of biliary tract

186

190

10.26

163.03

2.1

1.3

0.46

0.42

g/l

0.36

102

141

Examination and observation for other reasons

692

1177

3.44

162.68

1.5

1.3

0.40

0.42

g/l

0.56

582

686

Kela reimbursement Agammaglobulinemia (D80-84)

64.82

161.90

2.2

1.5

0.24

0.38

g/l

1.00

Acute bronchitis

548

1518

3.60

161.67

1.4

0.38

0.42

g/l

1.14

405

1054

Other bacterial diseases

1126

2849

2.53

161.34

1.4

0.41

0.40

g/l

0.30

805

1970

Selective deficiency of immunoglobulin G [IgG] subclasses

67.68

161.33

2.5

1.2

0.21

0.45

g/l

2.11

Autoimmune diseases

1176

2373

2.54

159.01

1.4

1.3

0.42

0.39

g/l

1.48

822

1657

Used for control exclusion in common control thyroid runs

1108

2156

2.62

158.35

1.4

1.3

0.41

0.39

g/l

0.82

753

1527

Asthma and allergy, excluding more controls

209

257

8.23

155.42

1.5

1.4

0.34

0.38

g/l

0.83

173

170

Pain in joint

658

1264

3.36

154.42

1.4

0.37

0.43

g/l

3.09

483

853

Asthma and allergy

209

260

8.14

153.92

1.5

1.4

0.34

0.38

g/l

0.96

173

168

Anaemias

350

416

5.61

153.65

1.4

1.3

0.38

0.41

g/l

0.48

247

304

Diseases of the respiratory system

597

794

3.80

152.28

1.4

1.3

0.39

0.42

g/l

0.87

419

495

Enlarged lymph nodes

276

486

5.85

149.44

1.5

1.2

0.42

g/l

0.06

198

346

Tramadol

859

1914

2.79

146.44

1.4

0.40

0.41

g/l

0.21

615

1318

Acute upper respiratory infections of multiple and unspecified sites

840

2298

2.74

146.27

1.4

1.3

0.37

0.42

g/l

2.91

618

1563

Suggestive for eosinophilic asthma

198

252

8.23

146.21

1.8

1.3

0.31

0.41

g/l

3.30

154

169

Early onset COPD, excluding more controls

222

328

6.89

142.57

1.6

1.2

0.40

0.44

g/l

0.52

158

215

Other specified/unspecified systemic involvement of connective tissue

160

161

10.60

142.27

2.4

1.4

0.40

0.39

g/l

0.07

129

112

Other necrotizing vasculopathies

168

182

9.75

141.27

1.4

0.34

0.40

g/l

0.92

120

134

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

172

192

9.40

141.20

1.6

1.4

0.48

0.41

g/l

0.85

112

131

Abnormal findings on examination of blood, without diagnosis

565

1623

3.25

139.60

1.6

1.4

0.44

0.42

g/l

0.50

388

1119

Septicaemia

491

1323

3.53

138.89

1.4

0.42

0.43

g/l

0.13

342

918

Diseases of oesophagus, stomach and duodenum

1121

2857

2.37

137.36

1.3

1.4

0.41

0.40

g/l

0.10

797

1985

Bacterial Sepsis

534

1386

3.34

135.72

1.4

0.42

0.44

g/l

0.34

377

951

Any reimbursement code in KELA

608

894

3.44

135.63

1.4

1.3

0.37

0.39

g/l

0.32

423

623

Ethmoidectomy

262

485

5.61

134.91

1.7

1.3

0.36

0.41

g/l

1.12

191

337

FESS (DNB20)

257

472

5.66

133.51

1.7

1.4

0.36

0.41

g/l

1.03

187

326

Diseases of liver

454

1299

3.56

132.39

1.3

1.4

0.51

0.40

g/l

1.93

294

916

Other diseases of upper respiratory tract

1079

2359

2.40

131.29

1.4

1.3

0.38

0.43

g/l

2.56

785

1572

Pain in throat and chest

828

1868

2.69

131.28

1.4

1.3

0.38

0.41

g/l

1.33

606

1237

Other necrotizing vasculopathies (FG)

144

140

10.87

130.98

1.4

1.3

0.35

0.43

g/l

0.98

102

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

574

1856

3.04

129.38

1.4

1.3

0.37

0.43

g/l

3.19

397

1236

Finngen Rheumatological endpoints

1002

2364

2.43

128.31

1.4

1.3

0.39

0.40

g/l

0.20

714

1612

Headache

680

1952

2.81

126.99

1.5

1.3

0.38

0.42

g/l

0.84

500

1360

Explicit Sepsis

513

1502

3.24

126.82

1.4

0.41

0.43

g/l

0.26

360

1039

Gastrointestinal diseases

578

872

3.35

124.20

1.4

1.3

0.39

0.40

g/l

0.16

393

656

Other septicaemia

427

1178

3.54

122.56

1.4

1.3

0.42

g/l

0.05

302

814

Vasomotor and allergic rhinitis

446

1334

3.33

117.04

1.4

1.3

0.35

0.41

g/l

2.76

354

884

Implicit bacterial Sepsis

448

1196

3.37

116.62

1.4

0.42

0.43

g/l

0.18

318

823

Infections, IBD-co-morbidities

207

217

6.94

115.43

1.6

1.2

0.38

0.41

g/l

0.45

144

148

Other diseases of pancreas

153

190

8.39

115.28

1.6

1.2

0.42

0.38

g/l

0.37

140

Polyarthropathies

725

1812

2.64

114.03

1.4

0.41

g/l

0.13

532

1252

Medical observation and evaluation for suspected diseases and conditions

659

1179

2.89

112.75

1.5

1.3

0.38

0.42

g/l

1.67

504

688

Opioids

965

2147

2.35

112.28

1.4

0.38

0.41

g/l

1.25

669

1482

Certain infectious and parasitic diseases

945

1997

2.39

112.26

1.4

1.3

0.38

0.42

g/l

2.22

653

1363

Other immunodeficiencies

28.07

110.46

2.3

1.3

0.31

0.38

g/l

0.68

Symptoms and signs involving the digestive system and abdomen

962

2071

2.35

109.95

1.4

1.3

0.39

0.41

g/l

0.72

651

1465

Implicit bacterial Sepsis

470

1305

3.15

109.28

1.4

0.42

0.43

g/l

0.25

336

894

L04AA Selective immunosuppressants

343

929

3.78

108.94

1.5

1.3

0.39

0.40

g/l

0.19

249

639

Other soft tissue disorders, not elsewhere classified

949

2440

2.30

108.58

1.4

1.3

0.38

0.40

g/l

1.21

689

1673

Mixed connective tissue disease

149

195

8.05

107.71

1.9

1.5

0.39

0.38

g/l

0.15

118

132

Codeine

905

2104

2.36

107.05

1.4

0.37

0.41

g/l

2.33

625

1454

Other specific joint derangements/joint disorders

777

2049

2.47

107.00

1.4

0.38

0.40

g/l

0.96

558

1410

Other and unspecified dermatitis

578

2163

2.71

105.67

1.5

1.4

0.40

0.41

g/l

0.26

414

1527

Dermatitis

661

2631

2.53

105.57

1.5

1.4

0.40

0.41

g/l

0.26

472

1852

Gastro-oesophageal reflux disease

699

2460

2.48

103.52

1.4

0.38

0.41

g/l

1.29

484

1714

Implicit viral Sepsis

349

990

3.59

103.13

1.4

0.41

0.43

g/l

0.29

249

695

Malaise and fatigue

497

1364

2.96

102.47

1.4

1.3

0.36

0.43

g/l

3.86

350

958

Abdominal and pelvic pain

939

2071

2.29

102.43

1.4

1.3

0.39

0.41

g/l

1.03

630

1465

Primary_lymphoid and hematopoietic malignant neoplasms

310

819

3.87

101.95

1.4

0.33

0.43

g/l

4.71

218

572

Implicit Sepsis

743

2340

2.42

101.39

1.4

0.40

0.41

g/l

0.05

516

1627

Sicca syndrome [Sjögren]

163

254

6.68

100.31

1.5

1.4

0.40

g/l

0.02

106

184

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

312

342

4.62

100.31

1.3

0.36

0.41

g/l

1.11

218

226

Idiopathic pulmonary fibrosis

128

156

8.52

97.89

1.4

1.2

0.55

0.40

g/l

2.60

111

Other diseases of intestines

1044

2834

2.11

96.75

1.4

1.3

0.38

0.40

g/l

0.90

740

1968

Vocal cord dysfunction

176

263

6.12

96.72

1.6

1.2

0.35

0.42

g/l

1.80

117

174

Viral Sepsis

269

670

4.10

96.09

1.4

1.3

0.39

0.42

g/l

0.34

191

478

Implicit viral Sepsis

268

667

4.10

95.84

1.4

1.3

0.39

0.42

g/l

0.38

190

476

Haemorrhage from respiratory passages

335

871

3.51

93.80

1.4

1.3

0.44

g/l

0.06

236

569

Low back pain

745

2312

2.33

93.06

1.4

1.3

0.39

0.41

g/l

0.74

529

1570

Other diseases of blood and blood-forming organs, wide

308

864

3.65

92.91

1.4

0.41

g/l

0.10

206

606

Noninfective enteritis and colitis

537

2066

2.63

92.73

1.3

1.4

0.38

0.40

g/l

0.63

359

1467

Liquid cancers, helper endpoint

422

1254

2.98

89.26

1.4

0.38

0.42

g/l

0.71

301

880

Adrenocortical insufficiency

104

111

10.04

88.76

1.7

1.4

0.41

0.39

g/l

0.09

Parasetamol

697

1457

2.44

87.30

1.4

1.3

0.39

0.40

g/l

0.26

487

972

Nasal polyp

240

591

4.14

87.11

1.6

1.3

0.34

0.44

g/l

4.16

196

395

Other disorders of adrenal gland

116

146

8.42

86.82

1.6

1.3

0.41

0.39

g/l

0.12

104

Budesonide

170

317

5.48

86.57

1.4

1.2

0.44

0.42

g/l

0.19

114

214

Oedema, not elsewhere classified

320

946

3.38

86.52

1.6

1.3

0.38

0.44

g/l

2.32

236

664

Other special examinations and investigations of persons without complaint or reported diagnosis

603

1179

2.61

86.15

1.3

0.40

0.42

g/l

0.72

435

688

Exclusions for E4_PCOS_BROAD

269

726

3.80

85.95

1.5

1.4

0.37

0.39

g/l

0.37

130

534

Codeine or tramadol medication

1056

2888

2.01

85.86

1.4

0.37

0.42

g/l

3.89

730

2000

All influenza

286

806

3.61

85.44

1.5

1.3

0.37

0.43

g/l

2.13

209

560

Diagnoses used for exclusion with ILD

310

922

3.42

85.33

1.4

1.3

0.38

0.43

g/l

1.47

208

662

Cholelithiasis, broad definition with cholecystitis

766

2328

2.23

85.09

1.4

0.44

0.40

g/l

0.78

489

1742

Respiratory disorders in diseases classified elsewhere

20.20

84.14

1.8

1.3

0.35

0.38

g/l

0.17

Drug-induced adrenocortical insufficiency

16.62

83.99

1.9

1.4

0.36

0.32

g/l

0.28

Other disorders involving the immune mechanism, not elsewhere classified

11.37

83.80

2.6

1.3

0.40

0.39

g/l

0.05

Other diseases of the respiratory system

248

646

3.91

83.29

1.5

1.4

0.35

0.43

g/l

2.80

175

457

Other respiratory disorders and diseases

248

646

3.91

83.29

1.5

1.4

0.35

0.43

g/l

2.80

175

457

Other disorders of white blood cells

116

154

7.90

82.82

1.4

0.42

0.38

g/l

0.44

108

Implicit Sepsis

767

2588

2.18

82.41

1.4

0.41

0.40

g/l

0.17

526

1816

General examination and investigation of persons without complaint and reported diagnosis

579

1179

2.58

81.96

1.4

1.3

0.36

0.42

g/l

3.57

480

688

Heart failure, not strict

696

2086

2.29

81.92

1.5

1.4

0.45

0.40

g/l

1.03

492

1439

Disorders of lacrimal system

463

1759

2.66

81.90

1.5

1.4

0.39

0.41

g/l

0.61

322

1221

Cardiovascular diseases

637

1410

2.45

81.76

1.4

1.3

0.37

0.39

g/l

0.53

429

1018

Unspecified acute lower respiratory infection

216

518

4.27

81.36

1.5

1.3

0.38

0.41

g/l

0.82

161

359

Disorders of other endocrine glands

491

1897

2.58

81.31

1.5

1.3

0.37

0.40

g/l

1.19

280

1359

Nausea and vomiting

293

846

3.44

81.26

1.4

1.3

0.38

0.42

g/l

0.97

216

622

Dermatitis and eczema

1035

3295

1.96

80.56

1.4

1.3

0.39

0.41

g/l

0.37

734

2285

Osteoporosis

279

745

3.56

80.27

1.5

1.3

0.36

0.42

g/l

1.60

193

513

Pain in limb

760

2353

2.18

79.50

1.4

1.3

0.41

0.40

g/l

0.05

555

1613

Other disorders of lacrimal gland

393

1400

2.85

79.30

1.6

1.3

0.39

0.41

g/l

0.42

272

970

Cardiovascular diseases (excluding rheumatic etc)

661

1650

2.32

77.32

1.4

1.3

0.37

0.38

g/l

0.27

442

1177

Cholangitis (primary sclerosing, PSC), with reimbursement 202

13.90

77.18

1.9

1.3

0.47

0.35

g/l

0.92

Provisional assignment of new diseases of uncertain etiology

551

2341

2.38

76.86

1.5

1.3

0.42

0.40

g/l

0.30

407

1621

Other heart diseases

502

1274

2.60

76.83

1.5

1.3

0.39

0.38

g/l

0.07

356

908

Codes for special purposes

551

2343

2.37

76.71

1.5

1.3

0.42

0.40

g/l

0.30

407

1623

Wegener granulomatosis

19.20

76.70

1.7

1.3

0.35

g/l

0.02

Sulfasalazine

255

719

3.59

76.10

1.4

1.2

0.40

0.43

g/l

0.63

177

478

Pneumonia due to other infectious organisms, not elsewhere classified

11.60

76.04

1.4

1.3

0.42

0.39

g/l

0.20

Cholelithiasis

716

2278

2.18

75.96

1.4

0.44

0.40

g/l

0.71

452

1705

Pain, not elsewhere classified

288

880

3.32

75.84

1.7

1.3

0.35

0.41

g/l

2.70

226

619

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

11.42

75.72

2.7

1.3

0.40

0.41

g/l

0.06

COPD (mode)

214

398

4.27

75.52

1.3

1.2

0.50

0.44

g/l

1.00

155

254

Irritable bowel syndrome

323

1062

3.09

75.33

1.5

1.4

0.34

0.40

g/l

2.51

227

730

Other inflammatory liver diseases

121

187

6.73

75.11

1.3

1.5

0.53

0.34

g/l

3.70

130

Oxycodone

368

1163

2.90

75.07

1.5

1.4

0.39

0.44

g/l

1.38

255

805

Dorsalgia

903

2394

2.03

75.07

1.5

1.3

0.38

0.41

g/l

1.60

634

1624

Covid-19 confirmed case

389

1420

2.78

74.90

1.5

1.3

0.40

0.41

g/l

0.13

261

974

Dental caries

294

882

3.25

74.16

1.5

1.3

0.40

0.42

g/l

0.42

219

595

Eosinophilic disease (BM)

21.98

73.95

1.5

1.2

0.47

0.55

g/l

0.32

Biological medicines for asthma

13.42

73.76

1.3

0.30

0.33

g/l

0.30

Viral pneumonia

171

369

4.74

73.67

1.3

0.38

0.41

g/l

0.23

121

260

COPD

367

1049

2.89

72.90

1.4

1.3

0.47

0.44

g/l

0.63

264

698

Aplastic and other anaemias

426

1528

2.63

72.73

1.4

0.43

g/l

0.01

269

1078

Other arthritis (FG)

327

1105

3.00

72.65

1.4

1.3

0.42

0.41

g/l

0.04

238

748

Diseases of the skin and subcutaneous tissue

898

2241

2.02

72.31

1.4

1.3

0.40

g/l

0.10

624

1529

Neurological diseases

803

1928

2.11

71.87

1.4

0.38

0.41

g/l

1.52

554

1362

Neurological diseases, wide definition

294

407

3.66

71.83

1.4

1.2

0.39

0.38

g/l

0.17

204

284

Pleural effusion

176

397

4.52

71.73

1.5

1.4

0.45

0.44

g/l

0.12

114

281

15.68

71.38

1.5

1.3

0.45

0.41

g/l

0.19

Pain (limb, back, neck, head abdominally)

617

1326

2.35

71.02

1.4

0.38

0.43

g/l

1.69

432

898

Osteopathies and chondropathies

545

2222

2.31

70.32

1.5

1.4

0.37

0.41

g/l

2.11

376

1565

Implicit fungal Sepsis

111

169

6.80

69.85

1.4

0.40

g/l

0.01

120

Disorders of thyroid, IBD co-morbidities

170

241

5.02

69.45

1.4

1.2

0.34

0.42

g/l

2.08

122

163

Other chronic obstructive pulmonary disease

350

1011

2.88

69.39

1.4

1.3

0.47

0.44

g/l

0.63

251

667

Lower back pain or/and sciatica

953

3290

1.90

69.11

1.4

1.3

0.40

g/l

0.09

681

2266

Hernia of abdominal wall, postoperative

161

348

4.69

69.04

1.5

1.3

0.48

0.40

g/l

0.90

110

290

Condition for Implicit Sepsis (Organ dysfunction codes)

766

2667

2.04

68.88

1.3

1.4

0.41

g/l

0.08

525

1877

Simple and mucopurulent chronic bronchitis

10.28

68.77

1.3

0.37

0.46

g/l

0.74

Certain infectious and parasitic diseases

636

1406

2.28

68.76

1.3

0.38

0.42

g/l

1.34

457

949

Caries of dentine

260

770

3.34

68.55

1.5

1.3

0.39

0.42

g/l

0.58

194

519

Other and unspecified anaemias

390

1418

2.65

68.12

1.4

0.43

g/l

0.03

249

997

5-aminosalicylic acid

210

563

3.78

67.65

1.4

1.2

0.40

0.41

g/l

0.07

129

372

Condition for Implicit Sepsis (Organ dysfunction codes)

805

2801

2.00

67.62

1.3

1.4

0.41

0.40

g/l

0.18

556

1955

Other anaemias

391

1429

2.63

67.22

1.4

0.43

g/l

0.04

250

1004

Complications of surgical and medical care, not elsewhere classified

894

3211

1.92

67.12

1.4

0.41

0.40

g/l

0.05

647

2222

Other heart diseases, wide

865

2720

1.96

67.05

1.4

0.42

0.38

g/l

0.92

600

1904

Intestinal infectious diseases

869

3453

1.92

66.95

1.4

1.3

0.37

0.41

g/l

3.19

614

2403

Disorders of eyelid, lacrimal system and orbit

773

2977

1.99

65.44

1.5

1.3

0.37

0.42

g/l

2.74

547

2090

Respiratory insufficiency

8.95

65.09

1.3

0.39

0.50

g/l

1.27

Allergic rhinitis

370

1400

2.65

64.90

1.4

1.3

0.34

0.39

g/l

2.73

301

962

Symptoms and signs involving the skin and subcutaneous tissue

660

3168

2.06

64.39

1.5

1.3

0.37

0.41

g/l

2.19

502

2210

ILD-related respiratory insufficiency

10.57

64.27

1.2

0.42

g/l

0.00

Diseases of salivary glands

354

1341

2.68

63.57

1.6

1.3

0.39

0.40

g/l

0.13

250

924

Other specified/unspecified arthritis

288

978

2.99

63.53

1.4

0.42

g/l

0.08

206

673

L04AD Calcineurin inhibitors

179

451

4.09

63.39

1.3

1.4

0.45

0.39

g/l

1.03

123

321

Other noninfective gastroenteritis and colitis

287

974

2.99

63.34

1.4

1.3

0.36

0.40

g/l

1.22

201

700

Fibrosis and cirrhosis of liver

119

216

5.69

62.74

1.2

1.4

0.73

0.39

g/l

2.14

150

Hypothyroidism and >3 levothyroxin purchases

256

414

3.53

62.48

1.4

1.3

0.37

0.41

g/l

0.77

170

297

Hypothyroidism, levothyroxine purchases

256

414

3.53

62.48

1.4

1.3

0.37

0.41

g/l

0.77

170

297

Rheumatoid arthritis

316

1008

2.85

62.42

1.5

1.4

0.40

0.42

g/l

0.32

237

695

Other headache syndromes

418

1730

2.44

62.08

1.4

0.38

0.41

g/l

0.98

299

1219

Other joint disorders

787

2095

1.99

61.93

1.4

0.37

0.40

g/l

1.38

563

1438

Sarcoidosis

181

467

3.97

61.89

1.4

0.38

0.42

g/l

0.83

118

335

Candidiasis

320

1174

2.77

61.23

1.4

1.3

0.39

g/l

0.05

236

811

Diarrhoea and gastroenteritis of presumed infectious origin

660

2954

2.03

61.22

1.4

0.37

0.41

g/l

2.24

467

2058

Hypothyroidism (congenital or acquired)

254

416

3.48

60.80

1.4

1.3

0.37

0.41

g/l

0.81

167

299

Spondylopathies

673

1953

2.07

60.71

1.4

1.3

0.39

0.41

g/l

1.05

466

1315

Infection due to other mycobacteria

18.08

60.60

1.5

1.4

0.45

0.43

g/l

0.06

Childhood asthma (age<16), excluding more controls

138

215

5.13

60.39

1.3

1.2

0.37

g/l

0.01

100

132

Diseases of the eye and adnexa

736

1826

2.03

60.11

1.4

1.3

0.37

0.41

g/l

2.02

523

1247

Soft tissue disorders

901

2475

1.89

60.07

1.4

1.3

0.38

0.40

g/l

1.47

632

1697

Episodal and paroxysmal disorders

963

2676

1.84

59.61

1.4

0.39

0.41

g/l

1.05

656

1897

Childhood asthma (age<16)

138

219

5.03

59.23

1.3

1.2

0.37

g/l

0.02

100

134

All kidney diseases

874

3243

1.85

59.09

1.4

0.42

0.40

g/l

0.84

594

2294

Chronic laryngitis and laryngotracheitis

161

395

4.16

58.91

1.4

1.3

0.35

0.44

g/l

2.24

118

263

Other dorsopathies, not elsewhere classified

867

2417

1.89

58.34

1.4

1.3

0.39

0.41

g/l

1.10

610

1643

Coagulation defects, purpura and other haemorrhagic conditions

237

757

3.19

58.33

1.5

1.3

0.38

0.40

g/l

0.36

179

528

Other functional intestinal disorders

419

1649

2.38

58.18

1.5

1.3

0.36

0.41

g/l

2.13

298

1156

Eosinophilia

13.63

57.99

1.5

1.3

0.47

0.43

g/l

0.14

Colitis, primary sclerosing

12.63

57.85

1.4

1.2

0.49

0.33

g/l

1.48

Dorsopathies

893

2443

1.87

57.79

1.4

1.3

0.38

0.41

g/l

1.39

623

1666

Migraine

485

1766

2.25

57.34

1.4

1.3

0.36

0.40

g/l

1.86

352

1272

Diarrhoea and gastroenteritis of presumed infectious origin

890

3235

1.82

56.85

1.4

0.37

0.41

g/l

2.88

632

2243

Symptoms and signs concerning food and fluid intake

131

281

4.76

56.80

1.5

1.3

0.43

0.40

g/l

0.21

211

Methotrexate

139

313

4.51

56.80

1.6

1.2

0.38

0.43

g/l

0.73

100

219

Fibromyalgia

130

279

4.78

56.55

1.6

1.4

0.35

0.39

g/l

0.61

194

Persons encountering health services for examination and investigation

529

1179

2.26

56.45

1.4

1.3

0.40

0.42

g/l

0.53

398

688

Diseases of the digestive system

417

1796

2.33

56.10

1.5

1.4

0.43

0.42

g/l

0.02

282

1246

Arthropathies

795

2108

1.92

55.93

1.4

0.38

0.40

g/l

0.89

576

1451

Other intervertebral disc disorders

702

2156

1.97

55.58

1.4

1.3

0.41

g/l

0.04

497

1457

COPD, hospital admission 2, with asthma infections

285

875

2.82

55.06

1.4

0.43

g/l

0.15

205

601

Other general symptoms and signs

143

6.52

54.89

1.6

1.3

0.35

0.39

g/l

0.43

108

Abnormalities of heart beat

292

1059

2.73

54.63

1.3

1.4

0.40

0.42

g/l

0.13

200

709

Intestinal infectious diseases

987

3217

1.76

54.53

1.4

0.37

0.41

g/l

3.31

701

2225

All chronic kidney diseases

477

1782

2.21

54.21

1.5

1.4

0.45

0.42

g/l

0.82

328

1239

Pneumocystosis

12.15

54.21

1.6

1.4

0.41

0.42

g/l

0.06

Sleep disorders (combined)

962

2847

1.78

54.19

1.3

1.4

0.37

0.41

g/l

3.34

648

1999

Voice disturbances

282

1035

2.76

54.01

1.4

0.39

0.41

g/l

0.29

204

718

Endocrine, nutritional and metabolic diseases

723

1877

1.96

53.99

1.4

1.3

0.39

0.40

g/l

0.16

475

1362

Purpura and other haemorrhagic conditions

176

490

3.67

53.96

1.5

1.4

0.42

0.40

g/l

0.20

131

347

Fungal Sepsis

8.04

53.88

1.4

1.3

0.40

0.38

g/l

0.17

Complications of medical and surgical care

645

3070

1.95

53.51

1.4

0.38

0.41

g/l

1.29

467

2144

Hypertensive diseases (excluding secondary)

482

1248

2.26

53.50

1.5

1.3

0.38

0.39

g/l

0.27

317

885

Diseases of the musculoskeletal system and connective tissue

465

1008

2.33

52.88

1.4

1.3

0.38

0.39

g/l

0.31

323

693

Inflammatory bowel disease

340

1386

2.48

52.53

1.3

0.38

0.39

g/l

0.16

221

962

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

120

7.01

52.41

1.5

1.4

0.49

0.39

g/l

0.50

Protozoal diseases

8.50

52.12

1.5

1.4

0.43

g/l

0.02

Persons encountering health services for specific procedures and health care

939

3222

1.76

51.97

1.3

1.4

0.40

g/l

0.09

668

2238

Persons encountering health services in other circumstances, wide

990

2931

1.75

51.96

1.4

0.38

0.41

g/l

2.38

718

2013

Other diseases of pericardium

103

7.55

51.94

1.4

1.3

0.39

0.40

g/l

0.10

Implicit fungal Sepsis

8.21

51.86

1.5

1.3

0.41

0.36

g/l

0.30

Functional dyspepsia

264

956

2.80

51.85

1.4

0.36

0.41

g/l

1.63

194

657

Sleep apnoea

802

2852

1.83

51.76

1.3

1.4

0.39

0.41

g/l

0.24

528

2008

Complications of procedures, not elsewhere classified

700

3099

1.88

51.60

1.4

0.42

0.41

g/l

0.19

516

2145

Mycoses

286

1085

2.67

51.36

1.5

1.3

0.42

0.41

g/l

0.05

193

753

Other disorders of fluid, electrolyte and acid-base balance

289

1044

2.67

51.27

1.3

0.42

0.45

g/l

0.46

192

717

Osteoporosis with pathological fracture (FG)

142

6.29

51.14

1.6

1.2

0.32

0.45

g/l

2.27

104

Viral infections characterized by skin and mucous membrane lesions

411

1840

2.26

51.09

1.5

1.4

0.34

0.40

g/l

3.17

301

1283

COPD, hospital admissions 3, with asthma pneumonia sepsis

241

701

2.97

51.03

1.5

1.4

0.43

g/l

0.06

179

488

Primary biliary cholangitis (PBC)

13.29

50.73

1.2

1.02

0.29

g/l

2.07

Cholecystectomy

607

2695

1.96

50.68

1.4

0.41

g/l

0.03

380

1921

Viral infections characterized by skin and mucous membrane lesions

757

3575

1.82

50.66

1.4

0.38

0.41

g/l

0.91

542

2492

Dysphagia

222

741

3.03

50.59

1.4

1.3

0.36

0.45

g/l

3.01

153

528

Renal failure

380

1448

2.34

50.48

1.4

0.51

0.42

g/l

1.82

243

1004

Cardiac arrhythmias

551

1745

2.07

50.47

1.3

1.4

0.44

0.38

g/l

1.11

373

1253

Rheumatoid arthritis, including avohilmo

361

1546

2.36

49.97

1.4

0.41

g/l

0.00

266

1057

Depression medications

266

443

3.04

49.94

1.4

1.3

0.38

0.41

g/l

0.60

181

319

Urticaria and erythema

375

1634

2.32

49.86

1.4

0.35

0.40

g/l

2.35

278

1144

Other diseases of liver

209

683

3.11

49.57

1.3

0.42

0.38

g/l

0.67

135

486

Hypopituitarism

124

286

4.48

49.49

1.5

1.3

0.44

0.38

g/l

0.69

215

Rheumatism, unspecified

157

432

3.70

48.96

1.8

1.4

0.51

0.41

g/l

0.52

115

301

Atypical mycobacterium lung infection

20.73

48.90

1.4

1.3

0.43

0.45

g/l

0.06

Drug-induced osteoporosis with pathological fracture

14.27

48.17

1.9

1.3

0.37

0.41

g/l

0.20

Chronic kidney disease

261

960

2.70

47.69

1.4

0.48

0.43

g/l

0.81

170

679

Antihypertensive medication - note that there are other indications

571

1498

2.03

47.68

1.4

1.3

0.34

0.40

g/l

3.56

390

1070

Symptoms and signs involving speech and voice

320

1327

2.44

47.68

1.4

0.38

0.41

g/l

0.65

232

919

Sleep apnoea, including avohilmo

834

2943

1.77

47.30

1.4

0.39

0.41

g/l

0.40

552

2065

Ulcerative colitis, NAS

178

544

3.34

47.27

1.3

1.4

0.40

0.39

g/l

0.08

119

385

Intestinal malabsorption

124

6.52

47.20

1.4

1.3

0.42

0.35

g/l

0.50

Anxiety disorders, excluding more controls

724

2582

1.84

47.17

1.5

1.4

0.37

0.42

g/l

2.94

535

1778

Other pleural conditions

108

231

4.77

47.16

1.5

1.4

0.46

0.44

g/l

0.11

166

Chronic hepatitis, not elsewhere classified

7.84

47.00

1.4

1.3

0.50

0.28

g/l

3.30

Persons encountering health services in other circumstances

382

1711

2.24

46.92

1.4

1.3

0.34

0.41

g/l

4.23

229

1169

Abnormal findings on diagnostic imaging of other body structures

151

417

3.69

46.87

1.5

1.3

0.44

0.40

g/l

0.38

293

Explicit bacterial Sepsis

125

303

4.21

46.58

1.4

0.41

0.40

g/l

0.08

220

Myalgia

239

871

2.78

46.44

1.5

1.3

0.34

0.40

g/l

2.35

173

592

Pulmonary heart disease, diseases of pulmonary circulation

284

1129

2.54

46.30

1.4

0.38

0.43

g/l

1.76

210

783

Ulcerative colitis

264

1015

2.64

46.21

1.3

0.41

0.40

g/l

0.14

171

708

Disorders of conjunctiva

728

3277

1.79

45.94

1.5

1.3

0.35

0.41

g/l

4.05

543

2272

Neoplasms

680

1924

1.88

45.79

1.4

0.38

0.40

g/l

0.46

446

1366

Renal tubulo-interstitial diseases

728

3030

1.80

45.79

1.4

0.43

0.40

g/l

1.15

491

2134

Constipation

742

2876

1.80

45.70

1.4

0.39

0.41

g/l

0.27

510

2044

Nutritional anaemias

424

1934

2.13

45.66

1.5

1.4

0.39

0.42

g/l

1.02

310

1348

Bleeding

683

2658

1.84

45.64

1.4

0.42

0.40

g/l

0.79

481

1845

Seropositive rheumatoid arthritis

223

789

2.85

45.43

1.5

1.3

0.40

0.41

g/l

0.16

169

536

Polymyalgia rheumatica

126

313

4.09

45.41

1.5

1.3

0.41

0.42

g/l

0.16

223

Erysipelas

555

2183

1.95

45.18

1.5

1.4

0.41

0.40

g/l

0.25

399

1500

Other chronic obstructive pulmonary disease, including avohilmo

425

1653

2.14

45.06

1.4

0.45

0.42

g/l

0.82

303

1140

Other disorders of skin and subcutaneous tissue

575

2700

1.91

44.70

1.4

0.40

0.42

g/l

0.75

420

1882

Biological medication for rheuma

215

758

2.89

44.63

1.3

1.4

0.39

g/l

0.00

146

517

Sciatica+with lumbago

430

1895

2.10

44.47

1.4

0.41

g/l

0.05

311

1288

Lumbar disc prolapse

526

2054

1.98

44.40

1.4

0.42

0.41

g/l

0.17

368

1385

Early onset COPD

222

798

2.82

44.36

1.6

1.4

0.40

g/l

0.12

158

543

Streptococcal septicaemia

104

230

4.62

43.66

1.5

1.4

0.42

0.40

g/l

0.10

172

Colitis, primary sclerosing, strict definition

11.94

43.40

1.4

1.2

0.45

0.29

g/l

1.85

Other and unspecified iron deficiency

305

1292

2.38

43.28

1.4

1.3

0.38

0.42

g/l

1.10

219

900

Symptoms and signs involving the nervous and musculoskeletal systems

498

2553

1.96

43.27

1.6

1.4

0.38

0.41

g/l

1.18

362

1799

Benign neoplasm of colon, rectum, anus and anal canal

503

2229

1.97

43.23

1.4

0.42

g/l

0.03

377

1522

Iron deficiency anaemia

370

1677

2.19

43.07

1.5

1.4

0.39

0.42

g/l

1.23

268

1172

Later onset COPD, excluding more controls

121

220

4.29

42.99

1.1

1.2

0.58

0.45

g/l

1.57

143

Metabolic disorders

787

2767

1.74

42.86

1.5

1.4

0.39

0.41

g/l

0.49

549

1933

Multiple myeloma and malignant plasma cell neoplasms

108

6.60

42.38

1.4

1.3

0.25

0.47

g/l

3.30

Nerve, nerve root and plexus disorders

866

3151

1.69

42.31

1.4

0.39

0.41

g/l

0.56

596

2189

Pneumonia due to Streptococcus pneumoniae

6.89

42.20

1.4

1.2

0.35

0.40

g/l

0.53

Non-Hodgkin lymphoma, all, including Hilmo

147

430

3.48

41.88

1.5

1.4

0.31

0.42

g/l

3.34

103

305

Hypermobility syndrome

172

5.22

41.87

1.6

1.4

0.30

0.39

g/l

1.40

123

Unspecified jaundice

6.88

41.69

1.9

1.2

0.44

0.42

g/l

0.12

Anxiety disorders

775

3151

1.72

41.56

1.5

1.3

0.36

0.40

g/l

2.30

573

2161

Aspergillosis

16.04

41.48

1.4

1.2

0.38

0.35

g/l

0.20

Other symptoms and signs involving the nervous and musculoskeletal systems

384

1824

2.12

41.32

1.6

1.3

0.37

0.41

g/l

1.26

276

1268

Persons encountering health services for other counselling and medical advice, not elsewhere classified

899

2931

1.67

41.25

1.4

0.38

0.41

g/l

0.84

683

2013

Atrial fibrillation and flutter

268

678

2.59

40.98

1.3

0.44

0.41

g/l

0.52

192

471

COPD, hospital admissions

349

1337

2.23

40.93

1.4

0.47

0.42

g/l

1.41

250

906

Neurotic, stress-related and somatoform disorders

765

3128

1.72

40.82

1.5

1.3

0.36

0.40

g/l

2.32

567

2143

Other antidepressants

843

2545

1.71

40.73

1.4

0.36

0.42

g/l

3.85

572

1770

Benign neoplasm: Colon

428

2025

2.03

40.73

1.5

1.4

0.42

g/l

0.02

320

1394

COPD, early/later onset

350

1342

2.22

40.63

1.4

0.47

0.42

g/l

1.45

251

911

Acute renal failure

200

714

2.84

40.51

1.4

1.3

0.53

0.43

g/l

1.13

119

502

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

384

1117

2.19

40.45

1.5

1.3

0.40

g/l

0.01

253

788

Polyarthrosis

185

583

2.98

40.36

1.6

1.5

0.41

0.42

g/l

0.16

123

408

Pulmonary embolism

256

1035

2.50

40.36

1.4

0.36

0.43

g/l

2.24

184

722

Diverticular disease of intestine

542

1822

1.91

39.94

1.6

1.4

0.39

0.42

g/l

1.08

405

1259

IBD (strict) with PSC

13.48

39.89

1.3

0.52

0.32

g/l

1.39

Inflammatory diseases of the central nervous system

111

278

4.09

39.73

1.5

1.4

0.34

0.37

g/l

0.46

192

Abnormal results of function studies

110

274

4.11

39.65

1.4

1.3

0.44

0.41

g/l

0.30

193

Pulmonary heart disease

256

1044

2.48

39.63

1.4

0.36

0.43

g/l

2.32

184

730

Abnormal serum enzyme levels

257

1022

2.48

39.55

1.5

1.4

0.43

g/l

0.07

187

702

Chronic diseases of tonsils and adenoids

596

2052

1.85

39.46

1.3

0.38

0.42

g/l

1.37

448

1363

Other gastritis (incl. Duodenitis)

200

725

2.79

39.35

1.5

1.4

0.43

g/l

0.02

148

492

Multiple myeloma, including Hilmo

110

6.30

39.30

1.4

0.23

0.39

g/l

2.59

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

804

3130

1.68

38.91

1.4

0.39

0.40

g/l

0.64

551

2243

Ulcerative colitis (strict) with PSC

15.70

38.84

1.3

0.49

0.28

g/l

1.35

Conjunctivitis

651

3111

1.76

38.74

1.5

1.3

0.35

0.41

g/l

4.61

495

2152

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

500

2636

1.88

38.42

1.3

1.4

0.39

0.41

g/l

0.62

365

1829

Giant cell arteritis

7.01

38.35

1.2

1.5

0.33

0.40

g/l

0.59

Drug-induced cataract

8.19

38.22

1.5

1.3

0.35

g/l

0.06

Benign neoplasms

801

2630

1.69

37.93

1.4

1.3

0.37

0.41

g/l

2.63

551

1817

Other specified/unspecified necrotizing vasculopathies

13.23

37.92

1.4

0.42

0.36

g/l

0.23

Spondyloarthritis

173

594

2.95

37.66

1.4

1.3

0.38

0.40

g/l

0.31

119

420

Dialysis, with operation codes

144

449

3.27

37.13

1.4

0.45

0.39

g/l

0.68

315

Mood disorders, excluding more controls

761

2698

1.69

37.12

1.4

0.37

0.42

g/l

2.60

537

1857

Depression or dysthymia

562

1678

1.86

36.91

1.4

0.38

0.42

g/l

1.99

389

1163

Syncope and collapse

317

1236

2.21

36.85

1.4

1.3

0.40

0.44

g/l

0.56

217

864

Heart failure,strict

382

1302

2.08

36.73

1.4

0.50

0.42

g/l

1.13

260

878

Pneumonia derived septicemia

6.95

36.70

1.4

0.42

g/l

0.01

Infections of the skin and subcutaneous tissue

506

2729

1.85

36.63

1.4

1.3

0.42

0.40

g/l

0.43

376

1882

Nephropathy related operations

140

434

3.29

36.47

1.4

1.3

0.46

0.40

g/l

0.64

306

Erysipelas

407

1816

2.00

36.41

1.5

1.4

0.43

0.41

g/l

0.47

293

1241

Collagenous colitis

110

292

3.85

36.33

1.4

0.36

0.39

g/l

0.46

203

Noninfectious colitis NAS

153

501

3.10

36.32

1.5

1.3

0.36

0.40

g/l

1.13

114

362

IBD patients in KELA-register

237

973

2.47

36.29

1.2

1.3

0.41

0.39

g/l

0.19

143

684

Diseases of arteries, arterioles and capillaries (FINNGEN)

201

503

2.79

36.27

1.3

1.4

0.48

0.41

g/l

1.26

143

343

Non-invasive ventilation

193

632

2.75

36.20

1.3

1.4

0.33

0.40

g/l

1.90

436

Transplanted organ and tissue status

124

358

3.54

36.17

1.5

1.4

0.46

0.41

g/l

0.54

273

Urticaria

297

1346

2.23

36.16

1.5

1.4

0.34

0.39

g/l

2.22

221

947

Mycoses

699

3625

1.69

36.09

1.4

0.39

0.41

g/l

0.69

490

2521

Benign neoplasm of other and ill-defined parts of digestive system

177

632

2.84

35.96

1.5

1.3

0.38

0.40

g/l

0.42

128

436

Spondylopathies (FG)

146

468

3.17

35.91

1.5

1.3

0.37

0.40

g/l

0.54

102

312

Migraine with aura

233

954

2.47

35.83

1.4

0.37

0.39

g/l

0.53

173

682

SLE (Finngen)

7.16

35.78

1.6

1.4

0.47

0.34

g/l

1.26

All influenza (not pneumonia)

147

474

3.14

35.77

1.4

0.36

0.42

g/l

1.41

327

Diaphragmatic hernia

298

1358

2.21

35.76

1.4

0.38

0.42

g/l

0.81

223

942

Heart failure and antihypertensive medication

218

539

2.67

35.65

1.5

1.3

0.51

0.41

g/l

0.68

152

382

Hypertensive diseases

659

2142

1.75

35.51

1.4

0.39

g/l

0.02

445

1508

Hypertension, essential

633

2042

1.76

35.36

1.4

0.38

0.39

g/l

0.05

425

1428

Depression

787

3262

1.64

35.26

1.4

0.37

0.41

g/l

2.01

557

2253

Hypertension

657

2139

1.74

35.19

1.4

0.38

0.39

g/l

0.06

443

1506

Candidiasis

149

493

3.07

34.77

1.5

1.3

0.40

0.41

g/l

0.17

103

349

Hypothyroidism, strict autoimmune

506

1798

1.86

34.77

1.3

0.41

0.40

g/l

0.11

348

1276

Migraine without aura

201

779

2.61

34.75

1.4

0.35

0.39

g/l

1.15

148

567

Recurrent or chronic depression

358

1212

2.09

34.75

1.3

1.4

0.33

0.42

g/l

5.42

253

846

Care involving use of rehabilitation procedures

532

2740

1.80

34.72

1.4

0.41

g/l

0.07

371

1920

Other and unspecified disorders of white blood cells

107

5.99

34.62

1.3

0.37

0.39

g/l

0.09

Crohn disease

153

516

3.02

34.54

1.2

1.3

0.37

0.39

g/l

0.25

101

366

Diseases of middle ear and mastoid

502

2250

1.84

34.52

1.4

0.39

g/l

0.09

350

1551

COPD related to multimorbidity

289

1100

2.24

34.46

1.4

0.45

0.42

g/l

0.66

204

742

Disorders of sclera, cornea, iris and ciliary body

461

2489

1.87

34.43

1.4

0.38

0.40

g/l

0.52

318

1745

Diseases of the ear and mastoid process

936

2970

1.59

34.42

1.4

1.3

0.39

0.41

g/l

0.54

657

2086

Other bacterial intestinal infections

173

627

2.80

34.16

1.4

1.3

0.37

0.43

g/l

1.37

126

435

Glomerular diseases

181

672

2.73

34.16

1.6

1.3

0.43

0.41

g/l

0.27

119

470

Temporomandibular joint disorders, including avohilmo

396

2012

1.96

34.03

1.5

1.3

0.37

0.39

g/l

0.58

274

1418

Enterocolitis due to Clostridium difficile

104

278

3.80

33.96

1.5

1.4

0.38

0.40

g/l

0.19

199

Pericarditis

6.96

33.67

1.2

1.3

0.42

0.40

g/l

0.12

Spondylosis

402

1684

1.96

33.62

1.4

1.3

0.36

0.42

g/l

3.39

258

1140

Mood disorders

827

3348

1.61

33.54

1.4

0.37

0.41

g/l

2.40

580

2323

Pulmonary eosinophilia, not elsewhere classified

13.73

33.50

1.8

1.3

0.35

0.39

g/l

0.18

Acute suppurative otitis media

272

1144

2.24

33.18

1.4

1.3

0.39

0.38

g/l

0.19

198

792

Mood [affective] disorders

824

3348

1.60

33.16

1.4

0.37

0.41

g/l

2.35

578

2322

Migraine with aura and triptan purchases

175

649

2.74

33.12

1.4

0.36

0.38

g/l

0.43

132

451

DVT of lower extremities and pulmonary embolism

322

1552

2.08

33.07

1.4

0.37

0.44

g/l

2.83

227

1080

Inflammatory bowel disease, strict (require KELA)

237

1016

2.36

33.01

1.2

1.3

0.41

0.39

g/l

0.24

143

713

Nonsuppurative otitis media

231

837

2.41

32.90

1.5

1.3

0.38

0.39

g/l

0.07

168

589

Thrombocytopenia, unspecified

214

4.21

32.85

1.6

1.3

0.47

0.40

g/l

0.70

144

Tumor necrosis factor alpha inhibitors

182

692

2.67

32.83

1.3

1.4

0.40

0.39

g/l

0.17

121

468

Venous thromboembolism

410

2087

1.91

32.83

1.5

1.4

0.37

0.43

g/l

1.77

287

1450

Bacterial intestinal infections, IBD co-morbidities

172

635

2.74

32.81

1.4

1.3

0.37

0.40

g/l

0.76

126

443

Unspecified chronic bronchitis

7.74

32.79

1.3

1.4

0.32

0.42

g/l

0.83

Pollen allergy

213

863

2.47

32.64

1.4

1.3

0.34

0.37

g/l

0.84

180

607

Gout

198

682

2.58

32.61

1.4

1.5

0.42

0.44

g/l

0.24

133

465

Herpesviral [herpes simplex] infections

133

428

3.16

32.60

1.4

0.37

0.42

g/l

0.65

305

Alcohol-induced acute pancreatitis

110

5.76

32.59

1.4

1.3

0.44

0.39

g/l

0.52

Cholecystitis

120

364

3.34

32.32

1.9

1.2

0.49

0.42

g/l

0.98

259

Visual disturbances and blindness

424

2276

1.88

32.25

1.5

1.4

0.36

0.41

g/l

3.06

318

1581

Hypothyroidism, drug reimbursement

124

255

3.47

32.17

1.7

1.3

0.38

0.43

g/l

0.60

188

Polypectomy (DHB20)

207

4.21

31.70

2.0

1.3

0.35

0.40

g/l

0.67

140

Other symptoms and signs involving the digestive system and abdomen

142

482

2.98

31.64

1.4

1.3

0.39

0.42

g/l

0.34

355

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

305

1478

2.08

31.35

1.6

1.3

0.34

0.40

g/l

2.16

170

1045

Atopic dermatitis, strict definition with reimbursement

281

1275

2.15

31.09

1.4

1.3

0.35

0.39

g/l

1.22

214

892

Suppurative and unspecified otitis media

339

1506

2.01

31.04

1.4

1.3

0.39

0.38

g/l

0.11

243

1047

Zoster [herpes zoster]

385

1996

1.91

31.03

1.4

0.37

0.42

g/l

1.60

283

1378

Other disorders of urethra and urinary system

540

2240

1.75

30.97

1.4

1.3

0.38

0.42

g/l

0.93

376

1577

Other ulcerative colitis

194

4.28

30.90

1.3

0.40

0.37

g/l

0.28

131

Other reaction to severe stress, and adjustment disorders

330

1656

2.01

30.78

1.5

1.3

0.36

0.40

g/l

1.34

239

1142

Mucosal proctocolitis

143

497

2.92

30.64

1.3

0.43

0.38

g/l

0.75

353

Hypo-osmolality and hyponatraemia

153

548

2.81

30.58

1.3

0.40

0.43

g/l

0.57

376

Ischemic heart diseases

637

2286

1.68

30.58

1.5

1.4

0.43

0.39

g/l

0.75

445

1589

Other bacterial intestinal infections

203

841

2.44

30.55

1.3

0.39

0.42

g/l

0.40

150

580

COPD, hospital admissions 1, only main diagnosis

251

963

2.25

30.51

1.3

1.4

0.47

0.43

g/l

0.75

182

658

Visual disturbances

398

2135

1.88

30.44

1.6

1.4

0.36

0.41

g/l

2.68

298

1478

Spinal stenosis

355

1368

1.98

30.42

1.4

0.41

0.44

g/l

0.72

259

920

Polyarteritis nodosa and related conditions

10.61

30.34

1.6

1.3

0.38

0.32

g/l

0.45

Disorders of lens

503

1769

1.78

29.99

1.3

1.4

0.41

0.42

g/l

0.02

346

1249

Other specified/unspecified inflammatory spondylopathies

138

4.91

29.81

1.6

1.4

0.38

0.41

g/l

0.28

Viral pneumonia (unknown virus, not influenza)

208

4.08

29.78

1.2

1.3

0.40

0.39

g/l

0.04

148

Percutaneous Coronary Intervention

599

2177

1.70

29.75

1.4

0.44

0.40

g/l

0.83

439

1512

Congenital malformations of the respiratory system

6.91

29.67

1.5

1.4

0.34

0.38

g/l

0.39

Pneumococcal septicemia

5.89

29.60

1.4

1.3

0.42

0.41

g/l

0.04

Corticotropin deficiency

12.70

29.59

2.1

1.3

0.54

0.33

g/l

0.96

Systemic lupus erythematosus

5.81

29.27

1.6

1.4

0.47

0.34

g/l

1.27

Disturbances of skin sensation

255

1186

2.17

29.23

1.3

0.36

0.39

g/l

1.15

185

808

Other/unspecified dorsalgia

293

1422

2.06

29.23

1.3

1.4

0.35

0.41

g/l

2.45

203

974

Coronary revascularization (ANGIO or CABG)

597

2177

1.69

29.16

1.4

0.44

0.40

g/l

0.85

437

1512

Polyneuropathies and other disorders of the peripheral nervous system

188

769

2.47

29.14

1.4

1.3

0.42

0.43

g/l

0.18

142

536

Heart failure, strict

404

1526

1.88

29.12

1.4

0.50

0.42

g/l

1.06

276

1046

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

454

2495

1.78

29.08

1.6

1.3

0.34

0.40

g/l

3.67

350

1735

Continuous positive airway pressure

153

467

2.79

29.08

1.3

0.33

0.41

g/l

2.64

135

329

Other and unspecified tonsillitis

279

1118

2.11

28.99

1.4

0.37

0.39

g/l

0.57

200

736

Hypoparathyroidism

5.97

28.98

2.4

1.3

0.38

0.37

g/l

0.05

Zoster [herpes zoster]

161

613

2.66

28.97

1.5

1.3

0.32

0.41

g/l

2.78

124

425

Shoulder lesions

554

1961

1.72

28.94

1.4

1.3

0.40

0.41

g/l

0.34

399

1332

Weight loss

105

315

3.39

28.92

1.4

0.41

g/l

0.00

226

Abnormal weight loss

277

3.57

28.85

1.4

0.42

0.41

g/l

0.11

198

Other encephalitis

6.60

28.80

1.3

0.34

0.40

g/l

0.36

Other and unspecified polyneuropathies, also in other diseases

166

645

2.61

28.68

1.4

1.3

0.41

0.42

g/l

0.22

126

450

Atrial fibrillation and flutter with reimbursement

194

490

2.54

28.68

1.4

0.46

0.42

g/l

0.56

133

335

Unknown and unspecified causes of morbidity

175

4.30

28.64

1.3

0.36

0.41

g/l

0.70

130

Benzodiazepine use

779

3447

1.56

28.62

1.3

1.4

0.37

0.41

g/l

1.93

536

2401

Intracranial trauma

431

1667

1.83

28.51

1.5

1.4

0.39

0.41

g/l

0.51

299

1171

Emergency coronary revascularization (for ACS)

630

2327

1.65

28.51

1.4

0.44

0.40

g/l

0.76

461

1604

Other Crohn's disease

248

3.71

28.28

1.2

1.3

0.39

g/l

0.03

170

Seropositive rheumatoid arthritis, wide

223

998

2.26

28.14

1.5

1.4

0.40

0.41

g/l

0.10

169

689

Any mental disorder

851

2766

1.55

28.03

1.4

0.37

0.42

g/l

2.74

603

1908

Encephalitis

6.12

27.94

1.3

0.34

0.38

g/l

0.26

All-cause Heart Failure

393

1495

1.87

27.83

1.4

0.50

0.42

g/l

1.04

270

1024

Other nutritional deficiencies

533

3003

1.68

27.71

1.4

0.40

g/l

0.09

375

2126

COPD-related respiratory insufficiency

100

299

3.39

27.66

1.4

0.35

0.41

g/l

1.17

216

Congenital malformations of the respiratory system

6.87

27.58

1.5

1.4

0.35

0.39

g/l

0.30

Concussion

376

1650

1.87

27.56

1.5

1.4

0.38

0.41

g/l

0.90

262

1161

Other complications of surgical and medical care, not elsewhere classified

105

325

3.29

27.53

1.4

0.42

0.41

g/l

0.02

232

Non-follicular lymphoma

286

3.45

27.48

1.4

0.31

0.40

g/l

1.87

200

Anxiety (asthma-related co-morbidities)

506

2296

1.71

27.43

1.4

0.38

0.39

g/l

0.24

385

1595

Agranulocytosis

116

382

3.09

27.42

1.3

1.4

0.41

0.40

g/l

0.12

262

Alcohol-induced chronic pancreatitis

213

3.90

27.26

1.2

0.44

0.40

g/l

0.27

149

Other diseases of lip and oral mucosa

332

1743

1.92

27.23

1.4

0.44

0.40

g/l

0.93

243

1203

Cerebrovascular diseases (FINNGEN)

235

750

2.23

27.02

1.3

0.44

0.41

g/l

0.20

173

519

Other skin changes

160

629

2.57

27.02

1.7

1.3

0.39

0.42

g/l

0.44

117

440

Disorders of orbit

126

4.89

27.01

1.6

1.4

0.33

0.37

g/l

0.38

Hard cardiovascular diseases

635

2336

1.63

27.00

1.4

0.43

0.39

g/l

0.82

463

1607

Vasculitis limited to skin, not elsewhere classified

7.08

26.89

1.4

1.2

0.32

0.46

g/l

0.87

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

440

2524

1.75

26.86

1.4

0.37

0.41

g/l

1.63

320

1754

Follow-up examination after treatment for conditions other than malignant neoplasms

296

965

2.04

26.79

1.4

1.3

0.37

0.44

g/l

2.32

224

570

Valvular heart disease excluding rheumatic fever

335

1256

1.94

26.69

1.4

0.44

0.40

g/l

0.74

228

863

Cystitis

641

2364

1.62

26.64

1.4

1.3

0.40

0.42

g/l

0.64

464

1667

Lung cancer and mesothelioma

247

3.42

26.59

1.2

1.3

0.51

0.46

g/l

0.44

160

Non-rheumatic valve diseases

332

1242

1.94

26.56

1.4

0.44

0.41

g/l

0.72

226

851

Symptoms and signs involving cognition, perception, emotional state and behaviour

738

3251

1.55

26.49

1.4

0.40

g/l

0.04

524

2269

Hypokalaemia

114

379

3.05

26.49

1.3

0.45

0.42

g/l

0.26

261

Multiple myeloma

7.14

26.45

1.3

0.20

0.37

g/l

1.96

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

7.14

26.45

1.3

0.20

0.37

g/l

1.96

Disorders of oesophagus in diseases classified elsewhere

9.02

26.45

1.5

1.1

0.55

0.38

g/l

1.06

All anxiety disorders

514

2420

1.69

26.43

1.4

1.3

0.38

0.39

g/l

0.28

390

1666

Congenital malformations, deformations and chromosomal abnormalities

529

2946

1.66

26.41

1.4

1.3

0.40

0.39

g/l

0.35

362

2058

Insulin, combination of fast acting with intermediate-acting or long-acting

461

2454

1.73

26.39

1.5

1.4

0.41

g/l

0.07

295

1718

Disorders of skin appendages

398

2231

1.79

26.36

1.3

1.4

0.38

0.40

g/l

0.34

287

1547

Suppurative and necrotic conditions of lower respiratory tract

149

4.46

26.27

1.4

1.3

0.33

0.42

g/l

1.30

101

Personal history of allergy to drugs, medicaments and biological substances

9.50

26.25

1.6

1.1

0.32

0.40

g/l

0.50

Adalimumab

115

387

3.03

26.22

1.3

0.41

0.39

g/l

0.24

267

Cirrhosis of liver, NAS

146

4.49

26.04

1.2

1.3

0.52

0.39

g/l

1.32

Dentofacial anomalies [including malocclusion]

569

2809

1.64

26.01

1.4

0.37

0.40

g/l

0.94

389

1976

Allergic conjunctivitis

470

2701

1.71

25.99

1.6

1.3

0.34

0.40

g/l

3.36

364

1877

Asthma mixed form (mode), excluding more controls

6.09

25.93

1.7

1.3

0.35

0.40

g/l

0.46

Deviated nasal septum

241

1148

2.11

25.92

1.3

0.41

0.43

g/l

0.25

161

746

Other/unspecified seropositive rheumatoid arthritis

216

988

2.21

25.89

1.5

1.4

0.40

0.41

g/l

0.11

165

683

Presence of other functional implants

412

1598

1.80

25.86

1.4

0.38

0.43

g/l

1.26

223

1146

Papulosquamous disorders

315

1656

1.92

25.76

1.4

0.37

0.41

g/l

1.07

230

1141

Pain in thoracic spine

136

506

2.72

25.67

1.4

1.3

0.40

0.44

g/l

0.57

106

345

Other and unspecified vasculitis limited to skin

7.11

25.63

1.4

1.2

0.32

0.46

g/l

0.80

Lymphoid leukaemia

144

4.48

25.56

1.4

1.2

0.34

0.43

g/l

0.89

100

Thyroiditis, ILD-related definition

114

388

2.98

25.44

1.5

1.3

0.37

0.41

g/l

0.57

274

Gout, FINNGEN

198

878

2.27

25.38

1.4

0.42

0.45

g/l

0.44

133

603

Congenital malformations, deformations and chromosomal abnormalities

484

2755

1.68

25.37

1.5

1.4

0.40

0.39

g/l

0.47

332

1923

Iridocyclitis

202

909

2.25

25.24

1.5

1.3

0.37

0.40

g/l

0.59

142

635

Temporal arteritis

6.11

25.23

1.2

1.5

0.32

0.40

g/l

0.63

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

213

980

2.19

25.18

1.5

1.4

0.40

0.41

g/l

0.18

162

680

Paralytic ileus and intestinal obstruction

190

833

2.30

25.17

1.4

1.3

0.41

0.44

g/l

0.39

125

570

Other (seronegative) rheumatoid arthritis, wide

162

664

2.47

25.08

1.5

1.4

0.36

0.42

g/l

1.23

122

457

Use of hypnotics and sedatives

809

3078

1.51

25.06

1.3

1.4

0.37

0.41

g/l

1.82

580

2129

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

136

513

2.69

25.04

1.3

1.4

0.50

0.41

g/l

1.58

359

Glomerulonephritis

105

345

3.10

24.97

1.7

1.4

0.44

0.41

g/l

0.37

243

Other diseases of urinary system

748

2741

1.54

24.88

1.4

0.41

g/l

0.09

522

1933

Factors influencing health status and contact with health services

201

423

2.40

24.77

1.3

0.38

0.44

g/l

1.01

142

267

Major coronary heart disease event

609

2297

1.61

24.70

1.4

0.44

0.40

g/l

0.81

444

1583

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

164

682

2.44

24.64

1.2

1.4

0.39

0.38

g/l

0.09

478

Giant cell arteritis with polymyalgia rheumatica

5.95

24.57

1.2

1.4

0.32

0.44

g/l

0.97

Ulcerative colitis (strict definition, require KELA)

169

714

2.40

24.52

1.2

1.4

0.39

g/l

0.01

101

499

Diseases of spleen

8.21

24.46

1.7

1.2

0.47

0.42

g/l

0.23

Cervicobrachial syndrome

181

788

2.32

24.45

1.6

1.3

0.40

0.41

g/l

0.15

144

526

Insulin medication

461

2300

1.69

24.42

1.5

1.3

0.41

0.40

g/l

0.27

295

1618

Other overlap syndromes

9.19

24.34

1.6

1.3

0.34

0.35

g/l

0.04

Non-selective monoamine reuptake inhibitors

287

1434

1.94

24.33

1.4

0.35

0.42

g/l

3.35

201

1002

GI-bleeding

229

1098

2.10

24.31

1.4

1.3

0.44

0.43

g/l

0.07

158

764

Secondary hypertension

205

3.72

24.10

1.3

1.2

0.49

0.42

g/l

0.55

141

Rotator cuff syndrome

427

1773

1.74

24.03

1.4

1.3

0.45

0.41

g/l

0.46

315

1198

Other viral diseases

330

1793

1.84

23.78

1.5

1.3

0.38

0.39

g/l

0.14

237

1263

Sequelae with surgical and medical care as external cause

175

762

2.32

23.69

1.4

0.39

0.41

g/l

0.27

129

515

Somatoform disorder

154

634

2.46

23.66

1.4

1.3

0.31

0.41

g/l

3.25

108

430

Disorders of parathyroid gland

159

655

2.42

23.65

1.7

1.3

0.36

0.41

g/l

1.14

111

450

Drug-induced osteoporosis

9.32

23.54

2.1

1.4

0.28

0.38

g/l

0.57

Cervical disc disorders

262

1336

1.97

23.49

1.4

0.36

0.43

g/l

2.59

179

909

Emphysema

137

4.37

23.42

1.2

1.3

0.47

0.42

g/l

0.45

Asthma mixed form (mode)

5.50

23.37

1.7

1.3

0.35

0.42

g/l

0.78

Secondary right heart disease

5.41

23.32

1.3

0.43

0.44

g/l

0.06

Other symptoms and signs involving the circulatory and respiratory systems

155

4.13

23.20

1.4

1.3

0.42

0.44

g/l

0.12

108

Systemic sclerosis (FG)

6.90

23.09

1.3

0.44

0.33

g/l

0.90

Paroxysmal tachycardia

173

625

2.33

23.01

1.4

1.3

0.48

0.40

g/l

0.39

117

425

Pain and other conditions associated with female genital organs and menstrual cycle

178

724

2.28

22.81

1.4

0.41

0.40

g/l

0.05

126

505

Herpesviral [herpes simplex] infections

221

1073

2.08

22.79

1.4

1.3

0.42

0.39

g/l

0.29

162

733

Disorders of synovium and tendon

387

1958

1.74

22.77

1.5

1.3

0.39

0.41

g/l

0.64

269

1342

Migraine without aura and triptan purchases

160

683

2.37

22.71

1.3

1.4

0.35

0.38

g/l

0.78

119

480

Psychiatric diseases

749

2485

1.51

22.64

1.3

1.4

0.38

0.42

g/l

1.96

515

1720

Acute and subacute iridocyclitis

172

759

2.29

22.60

1.4

1.3

0.38

0.40

g/l

0.38

115

535

Cutaneous abscess, furuncle and carbuncle

224

1097

2.06

22.57

1.3

0.41

0.40

g/l

0.17

164

767

Arthrosis

487

1607

1.67

22.55

1.3

1.4

0.41

g/l

0.01

345

1100

Hypogonadotropic hypogonadism

5.07

22.43

1.2

0.33

0.36

g/l

0.46

130

507

2.60

22.43

1.6

1.3

0.38

0.40

g/l

0.24

337

Other or unspecified ileus, impaction or obstruction

140

565

2.50

22.42

1.3

1.4

0.44

0.42

g/l

0.18

387

Sequelae of external causes of morbidity and mortality

210

1007

2.10

22.39

1.5

1.4

0.39

0.41

g/l

0.39

154

688

Other pulmonary heart/vessel disease

102

4.91

22.30

1.4

1.3

0.42

0.46

g/l

0.31

Diseases of arteries, arterioles and capillaries

448

1985

1.67

22.29

1.3

1.4

0.48

0.41

g/l

2.26

312

1370

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

173

770

2.27

22.29

1.2

1.4

0.38

0.39

g/l

0.08

104

536

Other diseases of the digestive system

225

1108

2.04

22.29

1.3

1.4

0.44

0.43

g/l

0.12

158

773

Idiopathic thrombocytopenic purpura

5.41

22.15

1.4

1.3

0.43

0.42

g/l

0.08

Atopic dermatitis

452

2242

1.66

22.14

1.3

0.37

0.39

g/l

0.50

339

1579

Recurrent aphthous stomatitis , including avohilmo

135

542

2.52

21.95

1.4

0.37

0.40

g/l

0.51

109

377

Other specified/unspecified soft tissue disorders

104

4.80

21.78

1.5

1.4

0.43

0.40

g/l

0.18

Gastroduodenal ulcer

172

769

2.25

21.70

1.3

0.48

0.43

g/l

0.64

113

519

Heart failure and coronary heart disease

270

991

1.94

21.69

1.4

1.3

0.51

0.43

g/l

0.83

193

651

Disorders of the thyroid gland

692

2999

1.51

21.64

1.5

1.3

0.38

0.41

g/l

1.12

458

2135

Triptan medication for migraine, min. 3 purchases

458

2132

1.65

21.54

1.4

1.3

0.33

0.40

g/l

5.19

340

1491

Other abnormal immunological findings in serum

6.79

21.44

1.7

1.2

0.58

0.38

g/l

1.34

Anterior Iridocyclitis

178

816

2.20

21.35

1.4

1.3

0.37

0.40

g/l

0.50

120

566

Triptan medication for migraine, single purchase ok

606

2668

1.54

21.33

1.4

0.38

0.39

g/l

0.18

426

1860

Migraine, single triptan purchase ok & required. ICD-code if available is included

606

2668

1.54

21.33

1.4

0.38

0.39

g/l

0.18

426

1860

Other anxiety disorders

373

1884

1.73

21.28

1.3

0.38

0.39

g/l

0.47

287

1289

Extracorporeal dialysis

184

3.72

21.26

1.5

1.3

0.52

0.39

g/l

0.70

129

Ascites

170

3.82

21.25

1.3

1.2

0.57

0.40

g/l

1.49

125

Lung diseases due to external agents

107

389

2.78

21.20

1.2

1.4

0.40

0.41

g/l

0.11

284

Obesity and other hyperalimentation

485

2931

1.60

21.14

1.4

0.40

g/l

0.06

344

2072

Otitis media, unspecified

115

398

2.70

21.02

1.3

0.37

g/l

0.05

294

Other inflammation of eyelid

122

477

2.59

20.98

1.6

1.4

0.35

0.41

g/l

1.35

332

Volume depletion

244

3.28

20.85

1.4

1.3

0.35

0.42

g/l

1.16

161

Hypothyroidism, other/unspecified

645

2807

1.52

20.80

1.4

1.3

0.40

0.41

g/l

0.57

426

2003

Nonalcoholic fatty liver disease

106

390

2.76

20.63

1.3

1.4

0.39

0.38

g/l

0.08

271

Other viral diseases, not elsewhere classified

176

813

2.18

20.58

1.4

0.37

0.39

g/l

0.24

131

579

Other arthrosis

352

1395

1.76

20.58

1.3

1.4

0.40

0.42

g/l

0.44

252

962

Exposure to unspecified factor

745

3674

1.46

20.54

1.4

0.38

0.41

g/l

1.00

475

2613

Hypothyreosis and Thyroxine purchase for inclusion criteria

668

2930

1.50

20.51

1.4

0.39

0.41

g/l

0.62

444

2092

Total colectomy

118

4.43

20.45

1.6

1.4

0.38

g/l

0.02

Total colectomy operation

118

4.43

20.45

1.6

1.4

0.38

g/l

0.02

Obesity

481

2929

1.59

20.45

1.4

0.40

g/l

0.04

340

2072

Deforming dorsopathies

211

1050

2.02

20.38

1.5

1.4

0.47

0.42

g/l

0.32

161

717

Seronegative rheumatoid arthritis

326

2.92

20.36

1.4

1.3

0.35

0.42

g/l

1.06

216

Bronchitis, not specified as acute or chronic

223

3.36

20.33

1.5

1.3

0.40

0.41

g/l

0.10

151

Viral pneumonia (known virus, not influenza)

5.69

20.20

1.5

1.3

0.36

0.41

g/l

0.36

Non-Hodgkin lymphoma, all

4.84

20.16

1.5

1.2

0.28

0.41

g/l

1.33

Nonorganic sleeping disorders, excluding more controls

163

739

2.23

20.11

1.3

0.35

0.40

g/l

1.30

111

499

Acute laryngitis and tracheitis

108

399

2.69

20.06

1.3

0.37

0.38

g/l

0.12

262

Dermatitis due to substances taken internally

150

3.94

20.04

1.5

0.38

0.40

g/l

0.17

107

Stomatitis and related lesions

175

819

2.16

19.97

1.3

0.39

0.40

g/l

0.16

138

572

Dizziness and giddiness

539

2764

1.55

19.96

1.4

0.43

0.41

g/l

0.21

385

1928

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.81

19.95

1.4

1.3

0.38

0.40

g/l

0.13

Acute tubulo-interstitial nephritis

439

2345

1.62

19.89

1.4

0.39

0.40

g/l

0.21

314

1656

Glomerular disorders in diseases classified elsewhere

104

386

2.73

19.88

1.4

0.42

0.39

g/l

0.28

273

Behavioural syndromes associated with physiological disturbances and physical factors

691

3330

1.48

19.87

1.3

1.4

0.37

0.41

g/l

1.29

483

2327

Chronic gastritis

180

853

2.13

19.83

1.3

1.4

0.44

g/l

0.01

146

585

Congenital malformations of the musculoskeletal system, not elsewhere classified

6.09

19.81

1.4

1.2

0.34

0.36

g/l

0.08

Other infectious diseases

273

3.08

19.78

1.4

1.3

0.44

0.42

g/l

0.12

189

Myocarditis

117

4.35

19.71

1.4

1.2

0.35

0.39

g/l

0.30

Other viral diseases, not elsewhere classified

236

1231

1.92

19.60

1.4

0.38

0.39

g/l

0.22

177

869

Other and unspecified urticaria

178

845

2.13

19.59

1.4

1.3

0.32

0.40

g/l

3.05

127

584

Systemic sclerosis

5.82

19.58

1.3

0.44

0.35

g/l

0.61

Endocarditis

5.18

19.37

1.4

1.2

0.38

0.40

g/l

0.11

Convulsions, not elsewhere classified

165

753

2.18

19.34

1.5

1.3

0.39

0.41

g/l

0.29

115

520

Ehlers-Danlos syndrome

7.57

19.27

1.4

1.3

0.27

0.34

g/l

0.63

Other diseases of hard tissues of teeth

408

1260

1.68

19.26

1.4

1.3

0.41

0.44

g/l

0.63

277

857

Heart failure and bmi 25plus

218

736

2.01

19.26

1.4

1.3

0.51

0.40

g/l

0.80

138

459

Insulin, fast-acting

275

1524

1.82

19.16

1.5

1.3

0.41

g/l

0.05

181

1075

Other metabolic disorders

122

499

2.47

19.13

1.7

1.3

0.34

0.40

g/l

1.23

339

Non-ischemic cardiomyopathy

206

826

2.02

19.09

1.3

0.53

0.41

g/l

0.84

142

560

Other viral diseases

258

1401

1.85

19.07

1.5

1.3

0.38

g/l

0.01

185

991

6-mercaptopurine

5.32

18.96

2.1

1.2

0.49

0.35

g/l

0.72

Care involving dialysis

270

3.05

18.91

1.4

1.3

0.51

0.40

g/l

0.75

190

Other diseases of intestine

113

451

2.53

18.66

1.4

1.3

0.39

0.42

g/l

0.47

308

Persons with potential health hazards related to communicable diseases

320

1855

1.72

18.53

1.4

1.3

0.31

0.39

g/l

5.36

196

1328

Psoriatic and enteropathic arthropathies

101

383

2.67

18.53

1.3

0.42

g/l

0.05

260

Adverse effects, not elsewhere classified

175

845

2.09

18.45

1.6

1.3

0.33

0.40

g/l

2.83

125

595

Cervicalgia

151

688

2.21

18.44

1.8

1.3

0.39

0.44

g/l

0.91

110

466

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

301

2.90

18.40

1.5

1.3

0.34

0.39

g/l

0.84

213

Other arrhythmias

447

2128

1.59

18.36

1.4

0.44

0.39

g/l

0.60

297

1488

Other enthesopathies

215

1119

1.93

18.31

1.6

1.3

0.35

0.41

g/l

2.13

156

766

Chronic iridocyclitis

151

3.79

18.29

1.5

1.3

0.33

0.39

g/l

0.86

106

Sleep disorders

654

3234

1.47

18.27

1.3

1.4

0.37

0.41

g/l

2.23

457

2248

Intestinal stricture

221

1162

1.92

18.26

1.3

1.4

0.42

g/l

0.09

149

806

Benign neoplasm: Transverse colon

336

2.78

18.19

1.5

1.4

0.39

0.43

g/l

0.44

236

Selective serotonin reuptake inhibitors

715

2572

1.46

18.12

1.3

1.4

0.38

0.41

g/l

2.01

495

1794

Senile cataract

411

1548

1.63

18.07

1.3

1.4

0.41

0.42

g/l

0.07

282

1098

Hernia

674

3113

1.46

17.94

1.4

0.39

0.41

g/l

0.32

469

2150

Misadventures to patients during surgical and medical care

120

504

2.41

17.79

1.3

0.41

g/l

0.10

356

Malignant neoplasm of pancreas, including Hilmo

217

3.22

17.76

1.6

1.4

0.41

g/l

0.01

158

Other disorders of ear

658

2961

1.46

17.70

1.5

1.3

0.39

0.41

g/l

0.56

465

2089

Diseases of tongue

159

3.64

17.69

1.5

1.3

0.40

0.45

g/l

0.46

110

Other medical care

318

1685

1.71

17.66

1.3

1.4

0.42

0.43

g/l

0.08

221

1166

Diabetes mellitus

753

3093

1.43

17.61

1.5

1.4

0.41

0.40

g/l

0.52

498

2203

Other cataract

296

1286

1.75

17.53

1.5

1.3

0.40

0.41

g/l

0.11

203

910

Internal derangement of knee

256

1422

1.80

17.47

1.5

1.4

0.35

0.41

g/l

1.97

178

983

Gonarthrosis [arthrosis of knee](FG)

454

1674

1.58

17.38

1.3

0.40

0.41

g/l

0.12

328

1148

Radiculopathy

115

479

2.42

17.35

1.4

1.3

0.52

0.46

g/l

0.17

335

Viral infections of the central nervous system

273

2.94

17.34

1.3

1.4

0.33

0.39

g/l

0.89

185

Insulin, intermediate and long-acting

379

2288

1.62

17.33

1.4

0.39

0.41

g/l

0.44

246

1607

Type 2 diabetes

706

2874

1.44

17.30

1.5

1.4

0.41

0.40

g/l

0.41

470

2035

Fissure and fistula of anal and rectal regions

174

859

2.04

17.28

1.2

1.3

0.52

0.42

g/l

0.48

116

573

L04AC Interleukin inhibitors

206

3.27

17.26

1.4

1.3

0.35

0.36

g/l

0.09

138

Pyothorax

108

4.25

17.25

1.4

1.3

0.30

0.43

g/l

1.59

Insulin, fast-acting or short human

276

1581

1.76

17.25

1.5

1.3

0.41

g/l

0.01

182

1102

SLE, strict definition

117

4.13

17.21

1.6

1.4

0.44

0.34

g/l

0.85

SLE, ICD10

117

4.13

17.21

1.6

1.4

0.44

0.34

g/l

0.85

Heartburn

312

2.79

17.21

1.3

1.2

0.32

0.40

g/l

1.97

216

Dermatographic urticaria

232

3.11

17.20

1.8

1.4

0.36

0.38

g/l

0.21

159

Haemorrhoids and perianal venous thrombosis

210

1106

1.91

17.15

1.2

1.4

0.41

0.43

g/l

0.27

141

756

Other infectious diseases

222

3.15

17.13

1.4

1.3

0.45

0.41

g/l

0.23

155

Invasive ventilation

217

3.18

17.13

1.3

0.33

0.40

g/l

1.00

155

Diabetes, varying definitions

747

3090

1.42

17.12

1.5

1.4

0.41

0.40

g/l

0.51

491

2202

Hepatic failure, not elsewhere classified

4.65

17.11

1.4

1.3

0.49

0.33

g/l

1.58

Ocular pain

298

2.83

16.99

1.5

0.33

0.41

g/l

1.84

207

Panhypopituitarism

6.27

16.98

1.7

1.3

0.41

0.39

g/l

—

Insomnia

635

3196

1.45

16.97

1.3

1.4

0.37

0.41

g/l

2.31

451

2218

Coxibs

198

517

2.03

16.87

1.3

0.37

0.44

g/l

1.58

139

351

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

682

3049

1.44

16.84

1.4

0.40

0.41

g/l

0.07

462

2140

Vascular disorders of the intestines

137

3.77

16.71

1.2

1.3

0.47

0.45

g/l

0.16

Ulcerative enterocolitis

4.56

16.67

1.4

1.3

0.35

g/l

0.03

Crohn's disease of small intestine

242

3.02

16.62

1.3

1.4

0.35

0.37

g/l

0.17

168

Other disorders of eye and adnexa

126

558

2.28

16.58

1.4

0.32

0.41

g/l

3.29

387

Gastric ulcer

114

484

2.37

16.49

1.3

0.50

0.43

g/l

0.61

334

Chorioretinal inflammation

5.06

16.49

1.4

1.3

0.36

0.30

g/l

0.73

Systemic sclerosis, icd10

4.96

16.49

1.3

0.44

0.37

g/l

0.49

Conjunctivitis (acute, non atopic)

221

1198

1.85

16.48

1.4

1.3

0.35

0.39

g/l

1.52

165

836

Keratitis

265

1523

1.75

16.44

1.4

0.39

0.40

g/l

0.09

178

1045

Other and unspecified effects of external causes

226

1242

1.83

16.34

1.5

1.3

0.35

0.39

g/l

1.41

160

861

Symptoms and signs involving the urinary system

527

2699

1.49

16.33

1.5

1.4

0.43

0.41

g/l

0.27

372

1873

Gout, idiopatic and unspecified

163

804

2.04

16.27

1.4

1.3

0.43

0.45

g/l

0.31

109

564

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.81

16.18

1.4

1.2

0.36

0.35

g/l

0.02

Other and unspecified types of non-Hodgkin lymphoma, hilmo

105

4.18

16.13

1.7

1.3

0.35

0.39

g/l

0.25

Secondary and unspecified malignant neoplasm of lymph nodes

257

2.92

16.12

1.4

0.40

0.39

g/l

0.11

183

Unspecified kidney failure

246

2.96

16.11

1.3

1.4

0.48

0.43

g/l

0.37

173

Localized swelling, mass and lump of skin and subcutaneous tissue

229

1269

1.82

16.10

1.6

1.3

0.37

0.41

g/l

1.01

189

865

Type 2 diabetes, wide definition

496

2101

1.52

16.07

1.4

1.3

0.42

0.41

g/l

0.28

361

1541

Viral infections of the central nervous system

247

2.96

16.04

1.4

0.29

0.39

g/l

2.59

164

Benign neoplasm: Colon, unspecified

171

863

2.00

16.02

1.5

1.4

0.39

0.44

g/l

0.83

120

598

Seropositive rheumatoid arthritis, strict definition

121

535

2.29

16.00

1.4

1.3

0.45

0.41

g/l

0.36

363

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

314

2.71

15.94

1.3

1.4

0.47

0.40

g/l

0.43

226

Chronic apical periodontitis

806

3321

1.39

15.92

1.4

0.40

0.41

g/l

0.21

540

2336

Postviral fatigue syndrome

12.65

15.88

2.0

1.4

0.36

0.40

g/l

0.18

Chronic ulcer of skin, not elsewhere classified

167

3.40

15.74

1.9

1.3

0.45

0.44

g/l

0.06

119

Excessive, frequent and irregular menstruation

284

894

1.75

15.74

1.4

0.38

0.40

g/l

0.24

197

614

Psoriasis

215

1178

1.84

15.72

1.3

1.4

0.41

0.40

g/l

0.06

153

811

Algoneurodystrophy

103

4.18

15.70

1.4

1.3

0.31

0.34

g/l

0.31

Soft tissue disorders related to use, overuse and pressure

185

966

1.93

15.69

1.4

1.3

0.43

0.42

g/l

0.06

141

653

Coronary atherosclerosis

407

1640

1.58

15.66

1.4

0.45

0.40

g/l

1.94

286

1119

Other diseases of stomach and duodenum

158

3.47

15.64

1.3

0.44

0.41

g/l

0.18

110

Crohn's disease NAS

224

3.04

15.64

1.1

1.3

0.38

g/l

0.03

155

Congenital malformations and deformations of the musculoskeletal system

386

2.51

15.55

1.6

1.3

0.37

0.38

g/l

0.16

288

Disorders of ocular muscles, binocular movement, accommodation and refraction

353

2199

1.60

15.53

1.5

1.4

0.40

0.39

g/l

0.15

259

1546

Rare circulating lymphoid malignancy, including Hilmo

4.67

15.47

1.9

1.2

0.41

0.39

g/l

0.16

Pneumothorax

169

3.36

15.46

1.3

1.2

0.38

0.41

g/l

0.26

121

Other CVD (FINNGEN)

218

2.83

15.44

1.3

0.35

0.40

g/l

0.64

143

Dental operations

406

1319

1.59

15.39

1.4

1.3

0.40

0.43

g/l

0.79

277

925

Cluster headache, strict

4.25

15.36

1.3

0.34

0.37

g/l

0.24

Abnormal findings on diagnostic imaging of central nervous system

151

3.51

15.28

1.6

1.3

0.33

0.39

g/l

0.91

109

Chronic nephritic syndrome

114

3.95

15.27

1.9

1.3

0.51

0.38

g/l

1.26

Obesity due to excess calories

350

2208

1.59

15.19

1.3

1.4

0.42

0.40

g/l

0.14

243

1540

Pruritus

357

2.55

15.16

1.6

1.4

0.44

0.43

g/l

0.07

256

Genitourinary diseases

434

1402

1.56

15.14

1.3

0.38

0.40

g/l

0.62

301

967

Missing teeth due to accident, extraction or parodontitis

394

2403

1.55

15.12

1.5

1.4

0.38

0.42

g/l

1.38

271

1665

Congenital malformations and deformations of the musculoskeletal system

112

489

2.31

15.09

1.5

1.4

0.36

0.37

g/l

0.22

367

Panniculitis, unspecified

15.87

15.07

1.5

1.4

0.35

0.29

g/l

0.31

Atopic dermatitis, strict definition

249

1412

1.74

15.06

1.4

0.36

0.38

g/l

0.60

192

992

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.92

15.01

1.5

1.3

0.48

0.40

g/l

0.31

Haemolytic anaemias

4.18

14.97

1.6

1.3

0.40

0.39

g/l

0.04

Other/unspecified rheumatoid arthritis

377

2.49

14.97

1.5

1.4

0.37

0.42

g/l

0.51

255

Spondylolisthesis/Spondylolysis

128

596

2.16

14.92

1.7

1.3

0.49

0.45

g/l

0.16

410

Cluster headache, wide

103

4.06

14.82

1.3

0.33

0.37

g/l

0.28

Cerebral cysts

174

3.27

14.79

1.8

1.3

0.43

0.39

g/l

0.30

123

Acute pharyngitis

116

518

2.24

14.67

1.3

0.33

0.39

g/l

1.42

348

Exclusions for E4_PCOS_CONSORTIUM

538

2311

1.46

14.65

1.4

0.39

0.40

g/l

0.13

329

1670

Subjective visual disturbances

189

1018

1.87

14.64

1.4

1.3

0.33

0.40

g/l

3.72

139

686

Pyogenic arthritis

170

3.28

14.63

1.3

0.41

0.45

g/l

0.34

116

Other peripheral vascular diseases

249

2.85

14.63

1.3

1.4

0.45

0.39

g/l

0.72

176

Other disorders of bone

157

797

1.99

14.53

1.5

1.3

0.31

0.40

g/l

3.84

116

559

Diseases of oral cavity, salivary glands and jaws

387

1263

1.58

14.51

1.4

1.3

0.40

0.44

g/l

0.85

271

860

Acute lymphadenitis

208

3.03

14.42

1.9

1.3

0.40

0.36

g/l

0.44

149

Meniscus derangement

347

1468

1.60

14.39

1.3

1.4

0.38

0.41

g/l

0.97

220

1003

Ulcerative ileocolitis

133

3.61

14.39

1.2

1.3

0.41

0.35

g/l

0.42

Personality disorders, excluding more controls

188

1017

1.86

14.34

1.3

0.37

0.40

g/l

0.66

129

686

Disorders of mineral metabolism

263

2.77

14.33

1.3

1.4

0.49

0.41

g/l

0.26

180

Brachial plexus disorders

356

2.50

14.27

1.5

1.4

0.34

0.37

g/l

0.48

247

Gout, unspecified

133

640

2.09

14.26

1.4

1.3

0.43

0.44

g/l

0.10

451

Other meningitis

5.85

14.23

1.6

1.3

0.30

0.39

g/l

0.48

Disorders of optic nerve and visual pathways

345

2.52

14.20

1.5

1.4

0.37

0.40

g/l

0.40

241

Polyarthritis, unspecified

4.24

14.18

1.8

1.4

0.31

0.43

g/l

1.22

Rash and other nonspecific skin eruption

328

2.56

14.14

1.4

0.39

0.40

g/l

0.11

237

Postprocedural disorders of nervous system

254

2.80

14.12

1.5

1.4

0.36

0.38

g/l

0.21

180

Enthesopathies of lower limb, excluding foot

156

801

1.96

13.98

1.5

1.3

0.39

0.42

g/l

0.77

116

538

Coeliac disease

101

439

2.33

13.97

1.7

1.4

0.44

0.40

g/l

0.44

307

Cardiac murmurs and other cardiac sounds

263

2.73

13.96

1.2

1.3

0.36

0.40

g/l

0.42

193

Nephrotic syndrome

4.04

13.96

1.9

1.3

0.36

0.35

g/l

0.07

Acetic acid derivatives and related substances

187

506

1.93

13.93

1.5

1.3

0.37

0.44

g/l

1.74

131

343

Other disorders of skin and subcutaneous tissue, not elsewhere classified

107

477

2.26

13.93

1.7

1.3

0.38

0.41

g/l

0.50

335

Small fibre neuropathy

4.38

13.91

1.5

1.3

0.43

0.42

g/l

0.04

Demyelinating diseases of the central nervous system

331

2.54

13.90

1.4

0.31

0.38

g/l

1.47

229

Crohn's disease of large intestine

176

3.18

13.88

1.3

0.35

0.38

g/l

0.22

124

Exposure to other specified factors

540

3480

1.43

13.83

1.5

1.4

0.37

0.41

g/l

1.02

385

2425

Other abnormalities of plasma proteins

6.69

13.74

1.8

1.4

0.43

0.38

g/l

0.07

Reactive arthropathies, FINNGEN

215

2.92

13.60

1.4

1.3

0.43

0.41

g/l

0.19

148

Persons encountering health services for specific procedures, not carried out

288

2.64

13.56

1.3

1.4

0.41

0.38

g/l

0.31

200

Carpal tunnel syndrome

410

2415

1.50

13.51

1.4

0.40

0.41

g/l

0.36

296

1687

Postprocedural endocrine and metabolic disorders, not elsewhere classified

102

452

2.28

13.50

1.8

1.3

0.34

0.40

g/l

1.08

308

Diseases of the myoneural junction and muscle

396

2.37

13.50

1.5

1.4

0.32

0.41

g/l

2.10

285

Hypersensitivity pneumonitis due to organic dust

6.26

13.48

1.1

1.4

0.49

0.36

g/l

0.52

Abscess of lung

5.76

13.47

1.4

0.42

0.37

g/l

0.28

Lichen simplex chronicus and prurigo

169

3.18

13.44

1.1

1.5

0.46

0.40

g/l

0.47

121

Postmenopausal osteoporosis with pathological fracture

139

3.43

13.44

1.3

1.4

0.26

0.41

g/l

2.54

Ovarian cyst

253

855

1.72

13.34

1.3

1.4

0.36

0.40

g/l

1.10

177

583

Disorders of calcium metabolism

181

3.08

13.24

1.3

1.4

0.56

0.42

g/l

0.40

121

Ankylosing spondylitis

286

2.62

13.21

1.3

0.39

0.41

g/l

0.27

199

Benign neoplasm: Stomach

310

2.55

13.17

1.8

1.4

0.36

0.41

g/l

0.66

214

Inflammatory diseases of female pelvic organs

425

2103

1.49

13.16

1.4

0.37

0.40

g/l

0.75

306

1488

Gonarthrosis

387

1441

1.53

13.10

1.3

1.4

0.41

g/l

0.10

280

993

Tonsillectomy and adenotomy

441

2080

1.48

13.09

1.4

1.3

0.37

0.38

g/l

0.11

330

1439

Oxicams

157

451

1.99

13.09

1.3

0.46

0.45

g/l

0.05

117

306

Ischaemic heart disease, wide definition

498

2132

1.45

13.07

1.5

1.4

0.44

0.40

g/l

1.32

344

1477

Other and unspecified drugs and medicaments

282

2.62

13.07

1.4

0.36

0.39

g/l

0.42

191

Diabetes medication

733

3207

1.36

13.05

1.4

0.41

0.40

g/l

0.34

487

2276

Ulcerative colitis (strict definition, all Crohn cases excluded)

122

589

2.09

13.04

1.2

1.4

0.42

0.38

g/l

0.49

419

Disease of hard tissues of teeth, NOS

366

1233

1.56

13.02

1.4

1.3

0.38

0.44

g/l

1.78

245

836

Other diseases of oesophagus

248

2.73

13.01

1.2

1.3

0.35

0.40

g/l

0.39

175

Pleural plaque

204

2.92

13.00

1.4

1.2

0.50

0.44

g/l

0.41

146

Type 2 diabetes, definitions combined

645

2738

1.39

13.00

1.4

0.41

0.40

g/l

0.28

428

1946

Substance abuse, excluding more controls

371

2085

1.52

13.00

1.3

1.4

0.40

0.42

g/l

0.54

247

1417

Cardiomyopathy

115

544

2.13

12.94

1.4

1.3

0.47

0.41

g/l

0.80

376

Chronic tubulo-interstitial nephritis

4.02

12.93

1.3

1.5

0.45

0.36

g/l

0.69

Benign neoplasm: Pancreas

4.54

12.91

1.5

1.3

0.34

0.38

g/l

0.19

Marginal zone B-cell lymphoma, including Hilmo

5.52

12.87

1.5

1.3

0.30

0.33

g/l

0.13

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

654

2864

1.38

12.84

1.4

0.41

0.40

g/l

0.34

432

2038

Viral and other specified intestinal infections

212

1186

1.73

12.80

1.5

1.3

0.40

0.39

g/l

0.05

144

826

Crohn disease (strict definition, require KELA, min 2 HDR)

234

2.78

12.78

1.2

1.3

0.43

0.38

g/l

0.36

161

Other neurological diseases

467

2538

1.45

12.74

1.4

0.39

0.41

g/l

0.60

324

1760

Viral and other specified intestinal infections

162

849

1.87

12.69

1.6

1.3

0.39

0.40

g/l

0.09

106

595

Obesity, other/unspecified

254

1552

1.65

12.68

1.5

1.4

0.43

0.39

g/l

0.32

198

1078

Meningitis

160

3.18

12.65

1.6

1.3

0.31

0.37

g/l

0.94

112

Covid-19 suspected case

175

967

1.82

12.57

1.3

0.49

0.40

g/l

1.15

153

659

Retention of urine

209

990

1.74

12.51

1.5

1.4

0.43

0.44

g/l

0.09

145

675

Crohn disease (strict definition, require KELA)

237

2.74

12.48

1.2

1.3

0.43

0.39

g/l

0.33

164

Acquired haemolytic anaemia

4.53

12.45

1.6

1.4

0.37

0.39

g/l

0.11

Hyperkinetic disorders, excluding more controls

103

453

2.20

12.41

1.3

0.34

0.38

g/l

0.95

311

Disorders of muscles

319

2.47

12.40

1.3

0.42

g/l

0.02

218

Substance use, excluding alcohol

158

850

1.87

12.38

1.3

0.39

g/l

0.01

111

588

Otalgia

284

2.57

12.38

1.7

1.3

0.33

0.41

g/l

1.57

205

Adenocarcinoma and ductal carcinoma of pancreas

4.16

12.35

1.1

1.4

0.55

0.38

g/l

0.82

Other disorders of conjunctiva

101

463

2.20

12.35

1.5

1.3

0.40

0.41

g/l

0.07

319

Panic disorder

124

615

2.03

12.34

1.3

0.39

0.40

g/l

0.05

418

Other coagulation defects

256

2.65

12.29

1.5

1.4

0.28

0.39

g/l

2.84

174

Other bursopathies

413

2.27

12.28

1.5

1.3

0.35

0.42

g/l

1.37

280

Diffuse large B-cell lymphoma, including Hilmo

123

3.47

12.24

1.4

0.34

0.37

g/l

0.24

Diffuse large B-cell lymphoma, helper endpoint

123

3.47

12.24

1.4

0.34

0.37

g/l

0.24

Diffuse large B-cell lymphoma

123

3.47

12.24

1.4

0.34

0.37

g/l

0.24

Other demyelinating diseases of the central nervous system

138

3.33

12.23

1.4

0.31

0.39

g/l

1.19

Hyperlipidaemia, other/unspecified

234

1297

1.67

12.22

1.4

0.43

0.44

g/l

0.15

171

886

Injuries to the abdomen, lower back, lumbar spine and pelvis

260

1595

1.62

12.21

1.2

1.4

0.43

0.42

g/l

0.29

187

1097

Chronic lymphocytic leukaemia, helper endpoint

4.45

12.21

1.3

1.2

0.31

0.40

g/l

0.58

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.45

12.21

1.3

1.2

0.31

0.40

g/l

0.58

Chronic lymphocytic leukaemia

4.45

12.21

1.3

1.2

0.31

0.40

g/l

0.58

Sacroiliitis, not elsewhere classified

138

3.31

12.20

1.4

1.5

0.41

0.38

g/l

0.23

Fentanyl

239

2.70

12.20

1.7

1.2

0.41

0.44

g/l

0.19

172

ILD medications: pirfenidone

18.89

12.17

1.2

1.0

0.61

0.37

g/l

—

391

2394

1.48

12.14

1.3

1.4

0.43

0.40

g/l

0.61

233

1663

Other external causes of accidental injury

601

2166

1.39

12.13

1.4

1.3

0.38

0.41

g/l

0.93

418

1531

Psoriatic arthropathies

341

2.40

12.11

1.3

0.42

0.44

g/l

0.20

231

Type 2 diabetes, strict (exclude DM1)

645

2772

1.37

12.11

1.4

0.41

0.40

g/l

0.33

428

1961

Faecal incontinence

218

2.78

12.10

1.4

1.2

0.28

0.42

g/l

3.20

148

Extreme obesity with alveolar hypoventilation

110

3.61

12.04

1.4

1.3

0.33

0.36

g/l

0.25

Psoriasis vulgaris

139

725

1.93

11.99

1.2

1.3

0.41

g/l

0.02

100

502

Colectomy operation

115

561

2.07

11.99

1.4

1.3

0.47

0.40

g/l

0.81

386

Alcohol use disorder, Swedish definition

367

2258

1.50

11.98

1.3

1.4

0.43

0.40

g/l

0.58

218

1571

Hypothyroidism, strict autoimmune, 3 medication purchases required

559

2716

1.39

11.96

1.3

0.40

0.41

g/l

0.29

389

1940

Vitamin deficiency

135

3.31

11.93

1.2

1.3

0.38

0.39

g/l

0.08

Vitamin deficiency, wide

135

3.31

11.93

1.2

1.3

0.38

0.39

g/l

0.08

Coxarthrosis [arthrosis of hip](FG)

295

1317

1.58

11.92

1.3

0.45

0.43

g/l

0.42

230

895

Nonorganic sleeping disorders

163

897

1.83

11.91

1.3

1.4

0.35

0.39

g/l

1.00

111

617

Erythema nodosum

4.14

11.90

1.6

1.4

0.38

0.35

g/l

0.19

Trochanteric bursitis

438

2.21

11.89

1.5

1.4

0.45

0.41

g/l

0.47

304

Tongue abnormality

177

2.98

11.85

1.6

1.5

0.37

0.38

g/l

0.13

124

Cluster headache, strict, including avohilmo

167

3.04

11.79

1.3

0.33

0.38

g/l

0.43

112

Injuries to the knee and lower leg

827

3496

1.32

11.78

1.4

0.38

0.41

g/l

1.23

589

2426

Acute generalized exanthematous pustulosis

142

3.23

11.68

1.4

1.3

0.37

0.40

g/l

0.13

Rosacea

442

2.19

11.66

1.3

1.4

0.42

g/l

0.04

304

Generalized skin eruption due to drugs and medicaments

118

3.45

11.56

1.5

1.3

0.40

0.38

g/l

0.08

Haemorrhage, not elsewhere classified

4.23

11.55

1.4

1.3

0.40

0.48

g/l

0.48

Abnormal findings on examination of urine, without diagnosis

123

3.39

11.53

1.3

0.38

0.39

g/l

0.05

Secondary uncertain malignant neoplasm

412

2.23

11.50

1.4

0.44

0.41

g/l

0.30

290

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

164

3.03

11.50

1.6

1.4

0.46

0.41

g/l

0.34

123

Synovial cyst of popliteal space [Baker]

180

2.92

11.49

1.3

0.32

0.42

g/l

1.49

125

408

2482

1.45

11.46

1.3

1.4

0.43

0.40

g/l

0.75

245

1725

Diseases of pulp and periapical tissues, including avohilmo

735

2858

1.34

11.46

1.4

0.40

0.41

g/l

0.25

507

2002

Hodgkin lymphoma, hilmo

4.11

11.45

1.6

1.3

0.41

0.35

g/l

0.39

STROKE

353

1598

1.51

11.44

1.3

1.4

0.43

0.39

g/l

0.45

257

1094

Other diseases of anus and rectum

180

1030

1.75

11.42

1.2

1.4

0.47

0.43

g/l

0.21

136

711

Cluster headache, wide,, including avohilmo

176

2.94

11.37

1.3

0.33

0.39

g/l

0.67

119

Other and unspecified visual disturbances

345

2.34

11.36

1.7

1.3

0.33

0.41

g/l

1.73

237

Oter anti-inflammatory and antirheumatic agents, non-steroids

143

406

1.95

11.36

1.2

1.3

0.37

0.45

g/l

1.77

106

277

Cytomegalovirus infection, IBD co-morbidity

4.42

11.30

1.4

1.2

0.49

0.31

g/l

0.90

Carrier of infectious disease

4.07

11.27

1.6

1.3

0.33

0.38

g/l

0.31

Vitamin D deficiency

4.69

11.26

1.2

1.3

0.34

0.37

g/l

0.14

Raynaud syndrome

310

2.42

11.23

1.4

1.5

0.40

g/l

0.07

218

Hyperhidrosis

4.50

11.22

1.4

1.2

0.44

0.46

g/l

0.08

Dental caries, including avohilmo

493

1780

1.42

11.21

1.4

1.3

0.40

0.43

g/l

0.67

333

1253

External causes of morbidity and mortality

475

1668

1.43

11.18

1.4

1.3

0.38

0.41

g/l

1.13

330

1178

Other diseases of arteries and capillaries

251

2.58

11.16

1.6

1.4

0.41

0.39

g/l

0.16

178

Cardiomyopathy, other and unspecified

211

2.73

11.14

1.4

1.3

0.47

0.39

g/l

0.86

151

Type 2 diabetes, definitions combined, including avohilmo

642

2772

1.35

11.14

1.4

0.42

0.40

g/l

0.59

429

1958

Malignant neoplasm of pancreas

162

3.00

11.11

1.2

1.4

0.45

0.39

g/l

0.37

117

Falls/tendency to fall

781

2974

1.32

11.08

1.3

1.4

0.39

0.40

g/l

0.14

549

2072

Ulcerative rectosigmoiditis

294

2.44

11.06

1.3

0.33

0.38

g/l

0.70

204

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

172

872

1.77

11.01

1.3

0.36

0.38

g/l

0.38

125

614

Autonomic disorders

4.73

11.00

1.4

0.24

0.35

g/l

1.01

Disorders of vestibular function (Vertigo)

297

1921

1.53

10.86

1.3

1.4

0.38

0.41

g/l

0.48

200

1340

Oesophagitis

128

3.24

10.83

1.3

1.2

0.39

0.38

g/l

0.08

Hernia of abdominal wall

294

1932

1.53

10.83

1.5

1.4

0.43

0.41

g/l

0.45

210

1343

Benign neoplasm: Caecum

334

2.33

10.82

1.6

1.4

0.37

0.41

g/l

0.40

236

Systemic lupus erythematosus, unspecified

3.62

10.81

1.4

0.50

0.33

g/l

1.21

Reactive arthropathies

285

2.45

10.81

1.4

0.43

0.45

g/l

0.15

189

Erythema multiforme

4.51

10.79

1.3

0.37

0.38

g/l

0.03

Phlebitis and thrombophlebitis (not including DVT)

154

860

1.80

10.76

1.4

0.29

0.41

g/l

7.62

105

613

Gout, strict definition

111

557

2.01

10.76

1.4

1.3

0.42

0.45

g/l

0.33

393

Viral warts

360

2.27

10.75

1.5

1.4

0.34

0.40

g/l

1.21

246

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

256

2.53

10.75

1.2

1.4

0.43

0.39

g/l

0.32

178

Iron deficiency anaemia secondary to blood loss (chronic)

103

503

2.06

10.75

1.5

1.3

0.41

0.42

g/l

0.12

345

Aortic aneurysm

131

682

1.89

10.72

1.4

1.3

0.47

0.44

g/l

0.31

476

Hyperparathyroidism

111

551

2.00

10.71

1.4

1.3

0.33

0.41

g/l

1.81

378

Complications of internal orthopaedic prosthetic devices, implants and grafts

136

732

1.87

10.70

1.3

1.4

0.38

0.43

g/l

0.91

497

Cytomegaloviral disease

4.22

10.68

1.4

1.3

0.49

0.33

g/l

0.73

Hepatomegaly and splenomegaly, not elsewhere classified

9.61

10.65

1.3

1.2

0.45

0.30

g/l

1.01

Cerebral palsy and other paralytic syndromes

413

2.18

10.63

1.5

1.4

0.32

0.40

g/l

2.12

291

Other or ill-defined heart diseases

145

3.07

10.62

1.4

1.2

0.42

0.38

g/l

0.32

Other CVD

114

580

1.98

10.61

1.4

1.3

0.38

0.44

g/l

1.07

407

Accidents

589

2166

1.37

10.60

1.4

1.3

0.38

0.41

g/l

0.95

413

1531

Bullous disorders

156

2.99

10.59

1.4

0.52

0.41

g/l

0.75

108

conjunctival haemorrhage

212

2.67

10.51

1.6

1.3

0.36

0.42

g/l

0.59

149

Subacute thyroiditis

101

3.53

10.48

1.5

1.4

0.28

0.38

g/l

1.36

Etanercept

242

2.56

10.44

1.4

1.3

0.45

0.37

g/l

0.96

171

Scleritis and episcleritis

213

2.67

10.43

1.4

1.5

0.39

g/l

0.04

153

Menorrhagia

233

793

1.64

10.41

1.4

0.37

0.40

g/l

0.73

161

543

Neuromuscular dysfunction of bladder

278

2.43

10.41

1.3

0.36

0.40

g/l

0.23

192

Failure and rejection of transplanted organs and tissues

5.07

10.35

1.3

1.4

0.38

0.35

g/l

0.14

Other obstetric conditions, not elsewhere classified

242

962

1.61

10.34

1.3

1.4

0.38

0.36

g/l

0.32

176

689

Myelodysplastic syndrome, including Hilmo

4.34

10.34

1.3

1.5

0.62

0.40

g/l

1.32

Other and unspecified rosacea

316

2.34

10.33

1.3

1.4

0.41

g/l

0.03

220

Hyperkalaemia

132

3.14

10.31

1.6

1.3

0.41

0.47

g/l

0.38

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

236

932

1.62

10.28

1.3

1.4

0.38

0.36

g/l

0.33

171

668

Dystonia

181

2.80

10.25

1.4

1.5

0.36

g/l

0.02

123

Other noninfective disorders of lymphatic vessels and lymph nodes

3.61

10.23

1.4

0.80

0.34

g/l

0.54

Neuralgia and neuritis, unspecified

138

3.08

10.22

1.4

1.3

0.34

0.38

g/l

0.43

Chronic suppurative otitis media, including avohilmo

275

2.43

10.18

1.7

1.4

0.33

0.40

g/l

1.50

195

Procreative management

255

1366

1.56

10.17

1.5

1.4

0.36

0.37

g/l

0.32

171

945

Special screening examination for other diseases and disorders

299

2.36

10.17

1.3

0.34

0.42

g/l

1.26

166

Benign neoplasm: Small intestine

113

3.33

10.16

1.2

1.5

0.46

0.41

g/l

0.29

Achalasia of cardia

5.39

10.16

1.3

1.4

0.26

0.29

g/l

—

Coxarthrosis

276

1181

1.55

10.15

1.3

1.4

0.46

0.43

g/l

0.48

215

821

Diabetes, insulin treatment (Kela reimbursement)

675

3094

1.32

10.14

1.4

0.42

0.40

g/l

0.47

448

2185

Irregular menses

332

1782

1.48

10.07

1.5

1.4

0.34

0.41

g/l

2.35

239

1283

Other localized connective tissue disorders

4.90

10.06

1.5

1.2

0.32

0.35

g/l

0.21

Viral meningitis

114

3.30

10.03

1.4

1.3

0.28

0.39

g/l

1.90

Special screening examination for infectious and parasitic diseases

148

606

1.81

9.97

1.4

1.3

0.33

0.39

g/l

1.66

112

350

Chronic hepatitis NAS

5.31

9.92

1.2

0.48

0.37

g/l

—

Cellulitis

151

861

1.76

9.88

1.4

1.3

0.39

0.41

g/l

0.24

118

600

Adhesive capsulitis of shoulder

107

547

1.97

9.88

1.3

0.39

0.43

g/l

0.51

378

Allergic urticaria

279

2.39

9.87

1.3

1.4

0.34

0.39

g/l

0.70

191

Tuberculosis, IBD comorbidity

157

2.89

9.85

2.1

1.4

0.49

0.42

g/l

0.54

112

Fall on same level

798

3387

1.29

9.85

1.3

1.4

0.41

0.40

g/l

0.38

562

2362

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

183

1096

1.67

9.84

1.2

1.3

0.34

0.40

g/l

1.93

123

753

Injury, poisoning and certain other consequences of external causes

384

1330

1.45

9.83

1.5

1.3

0.39

0.41

g/l

0.42

273

907

Any death

377

1885

1.44

9.79

1.2

1.4

0.47

0.41

g/l

1.28

264

1281

Hypotension

461

2.05

9.74

1.3

0.39

0.44

g/l

0.57

323

Disorders of refraction and accommodation

200

1230

1.63

9.72

1.3

0.39

0.38

g/l

0.09

153

860

Conductive and sensorineural hearing loss

492

2425

1.37

9.72

1.5

1.3

0.41

0.42

g/l

0.11

334

1699

Isolated proteinuria

3.55

9.67

1.3

0.42

0.37

g/l

0.37

Other follicular disorders

276

2.38

9.64

1.4

0.39

g/l

0.09

189

Cutaneous lupus erythematosus

4.37

9.63

1.2

0.52

0.38

g/l

0.51

Benign neoplasm: salivary glands, exclude unknown (D119)

270

2.40

9.62

1.6

1.4

0.35

0.40

g/l

0.49

188

Thyroiditis

252

2.45

9.61

1.5

0.29

0.43

g/l

3.59

176

Other retinal disorders

382

2095

1.42

9.61

1.4

0.39

0.42

g/l

0.97

254

1458

Caries of dentine, including avohilmo

523

1960

1.37

9.57

1.4

0.40

0.43

g/l

0.87

352

1393

Disorders of continuity of bone

353

2.20

9.54

1.4

1.3

0.39

g/l

0.00

242

Fenamates

320

2.07

9.53

1.5

1.3

0.36

0.46

g/l

2.08

223

Optic neuritis

155

2.89

9.52

1.6

1.4

0.34

0.41

g/l

0.85

109

Combined immunodeficiencies

8.36

9.45

1.4

1.2

0.33

g/l

0.03

Primary adrenocortical insufficiency

5.33

9.45

1.8

1.2

0.41

0.39

g/l

0.10

Nummular dermatitis

236

2.48

9.44

1.4

0.34

0.42

g/l

1.40

171

Anaemia in chronic diseases classified elsewhere

4.30

9.42

1.5

1.2

0.38

0.39

g/l

0.03

Other congenital malformations

355

2.19

9.40

1.3

1.4

0.42

0.37

g/l

0.84

256

Seborrhoeic keratosis

137

771

1.79

9.40

1.5

1.4

0.41

0.42

g/l

0.05

108

537

Disorders of vitreous body and globe

311

2045

1.47

9.39

1.4

0.36

0.42

g/l

1.93

232

1421

Other bullous disorders

3.81

9.37

1.2

1.4

0.46

0.39

g/l

0.35

Lesion of ulnar nerve

103

530

1.96

9.37

1.5

1.3

0.37

0.42

g/l

0.82

371

Diplopia

455

2.04

9.36

1.8

1.3

0.39

0.41

g/l

0.25

320

Benign neoplasm of major salivary glands

305

2.28

9.34

1.5

1.4

0.35

0.40

g/l

0.59

216

Unspecified/other endometriosis

350

2.19

9.32

1.4

0.30

0.40

g/l

2.27

239

Acute bronchiolitis

223

2.45

9.30

1.4

1.3

0.37

0.36

g/l

0.14

176

Vasomotor rhinitis (mode)

220

2.53

9.29

1.7

1.4

0.34

0.37

g/l

0.29

151

Umbilical hernia

177

1073

1.66

9.28

1.6

1.4

0.46

0.40

g/l

0.83

124

748

Endometriosis

226

834

1.60

9.28

1.3

1.4

0.41

0.40

g/l

0.10

167

568

Operations 2 for CAVS

151

849

1.73

9.27

1.4

0.46

0.44

g/l

0.24

109

598

Calcific aortic valvular stenosis, diagnosis (helper)

151

849

1.73

9.27

1.4

0.46

0.44

g/l

0.24

109

598

Mouth breathing

274

1837

1.50

9.21

1.4

0.42

0.40

g/l

0.13

186

1289

Adenocarcinoma of pancreas

4.21

9.21

1.1

1.3

0.58

0.40

g/l

0.70

Unspecified misadventure during surgical and medical care

158

2.82

9.19

1.3

1.4

0.46

0.38

g/l

0.75

108

Ulcer of lower limb, not elsewhere classified

431

2.06

9.19

1.3

0.40

0.41

g/l

0.11

304

Other abnormal findings of blood chemistry

131

3.02

9.18

1.6

1.3

0.33

0.38

g/l

0.54

Calcific aortic valvular stenosis, including rheumatic fever

151

851

1.73

9.17

1.4

0.46

0.44

g/l

0.24

109

598

Childhood allergy (age < 16)

117

516

1.88

9.16

1.4

1.3

0.37

g/l

0.07

366

Disorders of vitreous body

302

1998

1.47

9.12

1.4

0.37

0.41

g/l

1.56

223

1391

Disorders of choroid and retina

501

2641

1.35

9.10

1.4

0.39

0.41

g/l

0.81

339

1840

Calcific aortic valvular stenosis

151

854

1.72

9.09

1.4

0.46

0.45

g/l

0.21

109

603

Calcific aortic valvular stenosis, operated

151

854

1.72

9.09

1.4

0.46

0.45

g/l

0.21

109

603

Diseases of inner ear

336

2274

1.43

9.05

1.3

1.4

0.39

0.41

g/l

0.62

223

1591

Viral encephalitis, not elsewhere classified/unspecified

4.17

9.03

1.3

0.29

0.38

g/l

0.79

Disorders of lipoprotein metabolism and other lipidaemias

500

2291

1.35

9.02

1.4

0.40

0.42

g/l

0.45

360

1586

Injuries to the ankle and foot

488

3225

1.35

9.02

1.4

1.3

0.40

g/l

0.05

359

2233

Other enthesopathy of foot (+metatarsalgia)

316

2.23

9.02

1.6

1.3

0.29

0.42

g/l

3.91

215

Fibroblastic disorders

131

737

1.79

9.01

1.4

1.3

0.44

g/l

0.04

512

Allergic purpura

3.60

8.98

1.3

0.37

0.36

g/l

0.09

Colonic or urogenital fistula

179

1098

1.64

8.98

1.2

1.4

0.51

0.41

g/l

0.53

120

758

Postprocedural disorders of digestive system, not elsewhere classified

3.59

8.98

2.1

1.3

0.30

0.37

g/l

0.65

Nonspecific lymphadenitis

212

2.53

8.97

1.5

1.3

0.50

0.35

g/l

0.79

152

Episcleritis

172

2.71

8.92

1.5

1.4

0.40

0.37

g/l

0.26

124

Sensorineural hearing loss

457

2274

1.37

8.90

1.5

1.3

0.41

g/l

0.04

304

1596

Other/unspecified reactive arthropathies

231

2.45

8.89

1.4

0.44

0.37

g/l

0.61

162

Unspecified haematuria

248

1356

1.52

8.84

1.6

1.4

0.40

0.42

g/l

0.53

184

926

Benign neoplasm: Duodenum

3.85

8.83

1.3

0.51

0.48

g/l

0.13

Other specified/unspecified bacterial intestinal infections

196

2.58

8.82

1.2

1.4

0.31

0.37

g/l

0.91

136

Paracetamol or NSAID medication

108

276

1.98

8.81

1.4

1.3

0.38

0.43

g/l

0.60

202

Hypertensive heart and/or renal disease

145

623

1.74

8.78

1.4

0.56

0.43

g/l

0.64

106

406

Other and unspecified nerve root and plexus disorders, also in other diseases

136

781

1.75

8.75

1.5

1.3

0.38

0.41

g/l

0.45

537

Other symptoms and signs involving cognitive functions and awareness

266

1630

1.49

8.73

1.4

0.39

0.43

g/l

0.67

187

1116

Diseases of external ear

221

1437

1.55

8.67

1.4

0.38

0.41

g/l

0.66

162

991

Gingivitis and periodontal diseases

690

2761

1.29

8.67

1.4

0.40

0.41

g/l

0.17

501

1900

Stenosis and insufficiency of lacrimal passages

277

2.29

8.66

1.3

0.36

0.43

g/l

0.70

195

Osteonecrosis

175

2.66

8.63

1.4

1.3

0.40

0.38

g/l

0.09

119

Olecranon bursitis

175

2.66

8.62

1.4

1.2

0.40

0.43

g/l

0.23

118

Dipeptidyl peptidase 4 (DPP-4) inhibitors

328

1839

1.43

8.61

1.3

1.4

0.46

0.41

g/l

0.96

231

1284

Post-traumatic stress disorder

297

2.24

8.59

1.3

0.33

0.41

g/l

1.38

199

Supplementary factors related to causes of morbidity and mortality classified elsewhere

212

1369

1.56

8.59

1.7

1.3

0.38

0.40

g/l

0.62

154

938

Fracture of lumbar spine and pelvis

127

718

1.78

8.57

1.3

0.43

0.41

g/l

0.26

503

Ankylosing spondylitis, ICD10

331

2.17

8.49

1.3

0.39

0.38

g/l

0.02

228

Atherosclerosis, excluding cerebral and coronary sclerosis

209

1059

1.57

8.49

1.4

0.49

0.43

g/l

0.87

151

728

Tuberculosis, wide

171

2.65

8.45

2.1

1.4

0.49

0.43

g/l

0.38

122

Cervicocranial syndrome

312

2.20

8.44

1.5

1.3

0.31

0.45

g/l

4.13

222

Amyloidosis

4.53

8.40

1.5

1.4

0.23

0.35

g/l

1.00

Other/unspecified cytomegaloviral diseases

4.07

8.39

1.4

1.2

0.48

0.31

g/l

0.77

Perforation of tympanic membrane

313

2.19

8.39

1.3

1.4

0.39

0.41

g/l

0.14

220

Benign neoplasm: Ascending colon

440

1.99

8.37

1.4

1.3

0.51

0.42

g/l

0.25

306

Superficial injury of lower leg

166

1019

1.64

8.34

1.3

0.37

0.40

g/l

0.78

128

698

Injuries to the thorax

274

1878

1.46

8.31

1.5

1.4

0.41

0.42

g/l

0.14

204

1287

Arthropathic psoriasis

421

2.01

8.30

1.3

1.4

0.44

0.39

g/l

0.58

295

Other hearing loss

152

893

1.67

8.29

1.5

1.3

0.38

0.44

g/l

1.55

616

Symptoms and signs involving emotional state

3.25

8.25

1.1

1.3

0.30

0.38

g/l

0.83

Other diseases of gallbladder

3.37

8.22

1.4

1.3

0.30

0.40

g/l

1.38

Metatarsalgia

290

2.23

8.21

1.6

1.3

0.29

0.42

g/l

3.29

198

Other and unspecified disorders of vitreous body

252

1682

1.48

8.18

1.4

0.36

0.41

g/l

1.73

192

1168

Fracture of rib(s), sternum and thoracic spine

179

1126

1.60

8.15

1.5

1.3

0.44

0.42

g/l

0.11

134

769

Other noninflammatory disorders of vulva and perineum

330

2.14

8.15

1.4

1.3

0.38

0.40

g/l

0.15

223

Other/unspecified synovitis and tenosynovitis

363

2.08

8.14

1.6

1.3

0.33

0.42

g/l

1.87

250

Artrosis, including avohilmo

546

2270

1.32

8.12

1.3

1.4

0.40

g/l

0.00

392

1549

Cramp and spasm

152

2.74

8.11

1.4

0.37

0.41

g/l

0.25

105

Later onset COPD

129

588

1.75

8.11

1.1

1.4

0.58

0.44

g/l

2.34

415

Non-allergic asthma

285

2.23

8.11

1.9

1.5

0.48

0.39

g/l

0.84

200

Juvenile arthritis (FINNGEN)

158

2.69

8.08

1.3

1.4

0.39

0.36

g/l

0.21

113

Acute nasopharyngitis (common cold)

395

2.03

8.07

1.3

0.40

0.39

g/l

0.08

251

Benign neoplasm: Descending colon

205

2.47

8.07

1.3

1.4

0.44

0.40

g/l

0.31

141

Polycystic ovarian syndrome, consortium definition

466

2058

1.34

8.02

1.4

0.35

0.41

g/l

2.56

329

1463

Chronic suppurative otitis media

200

2.47

7.98

1.8

1.3

0.34

0.39

g/l

0.77

140

Ulcer of oesophagus

165

2.63

7.94

1.3

1.2

0.48

0.41

g/l

0.44

115

Smoking dependency

314

2.16

7.94

1.3

1.4

0.39

g/l

0.01

215

Endometriosis of pelvic peritoneum

115

617

1.79

7.91

1.4

0.46

0.40

g/l

0.39

429

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

110

3.03

7.90

1.4

1.2

0.50

0.42

g/l

0.42

Anogenital herpesviral [herpes simplex] infection

422

1.98

7.90

1.4

1.5

0.38

g/l

0.03

292

Idiopathic gout

263

2.26

7.89

1.3

0.45

0.43

g/l

0.17

180

Peritonsillar abscess

120

686

1.76

7.88

1.3

1.4

0.40

g/l

0.03

445

Glaucoma

318

1942

1.41

7.86

1.3

1.4

0.40

0.43

g/l

0.18

209

1362

Appendectomy

431

3080

1.34

7.85

1.3

1.4

0.41

0.40

g/l

0.13

293

2149

Type of accident

195

1263

1.55

7.84

1.7

1.3

0.39

0.40

g/l

0.30

142

870

Prurigo nodularis

4.11

7.83

1.1

1.4

0.50

0.37

g/l

0.61

Peripheral artery disease

223

1175

1.52

7.83

1.3

1.4

0.49

0.43

g/l

1.07

165

807

Restless leg syndrome

486

1.91

7.83

1.7

1.3

0.36

0.42

g/l

1.07

335

Mental and behavioural disorders due to tobacco

316

2.14

7.82

1.3

1.4

0.39

g/l

0.00

217

Duodenal ulcer

258

2.26

7.78

1.2

1.3

0.55

0.43

g/l

0.82

183

Other and unspecified coagulation defects

173

2.58

7.77

1.5

1.4

0.27

0.39

g/l

2.82

115

Other and unspecified follicular disorders

122

2.91

7.77

1.6

1.3

0.35

0.38

g/l

0.24

Dental pulpitis, including avohilmo

626

3176

1.28

7.77

1.4

0.38

0.41

g/l

1.18

415

2226

Benign paroxysmal vertigo

177

1124

1.58

7.77

1.3

1.4

0.37

0.41

g/l

0.53

117

780

Hordeolum and other deep inflammation of eyelid

191

2.49

7.75

1.6

1.3

0.31

0.40

g/l

1.52

133

CR(E)ST syndrome

4.43

7.73

1.4

1.3

0.31

0.37

g/l

0.31

Oral lichen planus

3.59

7.73

1.8

1.3

0.29

0.36

g/l

0.62

Disorders of plasma-protein metabolism, not elsewhere classified

8.44

7.72

1.3

1.4

0.34

0.33

g/l

—

Other and unspecified iridocyclitis

128

2.85

7.71

1.7

1.3

0.34

0.38

g/l

0.32

Other endocrine disorders

212

2.38

7.70

1.3

0.37

g/l

0.01

167

Hallux valgus (acquired)

189

868

1.57

7.68

1.4

0.41

0.44

g/l

0.50

142

609

Disturbance of activity and attention

100

535

1.85

7.67

1.3

1.4

0.33

0.38

g/l

1.06

373

Vascular diseases of the intestine

3.37

7.67

1.1

1.3

0.49

0.42

g/l

0.28

Other aneurysm

134

2.79

7.65

1.5

1.2

0.61

0.41

g/l

1.60

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

248

2.28

7.63

1.5

1.4

0.39

0.40

g/l

0.02

173

Other obstructive and reflux uropathy

118

2.92

7.60

1.2

1.3

0.49

0.39

g/l

0.32

Other juvenile arthritis

146

2.71

7.60

1.3

1.4

0.40

0.38

g/l

0.10

100

Arthropathies in other diseases classified elsewhere

3.20

7.56

1.3

0.34

0.42

g/l

0.73

Ulcerative proctitis

212

2.38

7.53

1.4

1.3

0.32

0.37

g/l

0.88

150

Kidney transplant status

188

2.48

7.51

1.7

1.3

0.46

0.38

g/l

0.68

132

Other disorders of eyelid

244

1589

1.47

7.50

1.5

1.3

0.36

0.43

g/l

2.09

181

1116

Other bacterial agents as the cause of diseases classified to other chapters

6.65

7.48

1.2

1.3

0.37

0.35

g/l

0.06

Open wound of lower leg

101

558

1.82

7.48

1.5

1.3

0.33

0.41

g/l

2.42

387

Adult respiratory distress syndrome

6.63

7.48

1.1

1.2

0.22

0.34

g/l

—

Other disorders of kidney and ureter

445

1.92

7.45

1.4

0.46

0.40

g/l

0.38

316

Substance abuse

371

2569

1.36

7.44

1.3

1.4

0.40

g/l

0.11

247

1771

Malignant neoplasm, wide definition for exclusion

581

2650

1.29

7.40

1.3

1.4

0.41

0.40

g/l

0.39

383

1880

Lichen planus

433

1.93

7.36

1.8

1.3

0.32

0.41

g/l

1.70

305

Other diseases of blood and blood-forming organs

202

2.40

7.35

1.3

1.4

0.34

0.38

g/l

0.43

138

Other congenital malformations

540

1.83

7.32

1.3

1.4

0.40

0.39

g/l

0.17

387

Inflammation of lacrimal passages (acute and unspecified)

4.22

7.31

1.7

1.2

0.32

0.34

g/l

0.18

Other autoimmune haemolytic anaemias

6.42

7.31

1.8

1.2

0.36

0.48

g/l

0.39

Hypertensive Heart Disease

125

573

1.72

7.29

1.5

1.4

0.55

0.42

g/l

0.57

380

Other keratitis

428

1.93

7.27

1.4

0.33

0.40

g/l

1.16

300

Presence of cardiac and vascular implants and grafts

228

1144

1.49

7.24

1.4

0.45

0.44

g/l

0.09

174

803

Pure hypercholesterolaemia

427

2090

1.34

7.23

1.4

0.40

0.42

g/l

0.42

308

1445

Abnormal involuntary movements

478

1.88

7.23

1.3

0.34

0.41

g/l

1.05

335

Superficial injury of abdomen, lower back and pelvis

102

572

1.79

7.21

1.2

1.4

0.46

0.40

g/l

0.66

404

Other contact dermatitis

261

2.20

7.18

1.5

0.30

0.41

g/l

1.88

189

Polyuria

135

819

1.66

7.18

1.3

0.38

0.43

g/l

0.58

566

Conduction disorders

160

814

1.60

7.18

1.3

0.43

0.40

g/l

0.50

109

563

Mental and behavioural disorders due to psychoactive substance use

381

2627

1.35

7.17

1.3

1.4

0.40

g/l

0.05

250

1810

Myeloid leukaemia

3.60

7.17

1.5

1.3

0.36

0.43

g/l

0.43

Other embolism and thrombosis

437

1.91

7.17

1.7

1.3

0.37

0.40

g/l

0.46

308

Cardiomyopathies, Primary/intrinsic

368

2.00

7.15

1.4

1.3

0.48

0.42

g/l

0.71

257

Oesophageal varices

106

2.96

7.14

1.6

1.3

0.54

0.38

g/l

0.85

Injuries to the wrist and hand

664

3666

1.26

7.13

1.3

1.4

0.38

0.40

g/l

1.03

472

2550

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

303

2.10

7.12

1.3

1.4

0.37

0.38

g/l

0.05

228

Atypical facial pain

157

2.58

7.11

1.7

1.4

0.35

0.38

g/l

0.23

113

Other sleep disorders

356

2.01

7.06

1.4

0.38

0.41

g/l

0.25

255

Diseases of pulp and periapical tissues and dental caries

419

1601

1.34

7.05

1.4

1.3

0.39

0.42

g/l

0.90

279

1127

Ganglion

128

770

1.67

7.04

1.5

1.3

0.39

0.40

g/l

0.17

528

Psoriatic arthropathies, ICD10

419

1.93

7.04

1.3

1.4

0.42

0.39

g/l

0.41

294

Disorders resulting from impaired renal tubular function

107

2.94

7.03

1.3

0.60

0.41

g/l

0.50

Decubitus ulcer and pressure area

129

2.74

7.02

1.5

1.2

0.49

0.47

g/l

0.06

Abnormal blood-pressure reading, without diagnosis

107

2.93

7.02

1.7

1.4

0.29

0.42

g/l

2.09

Intestinal adhesions without obstruction

219

2.30

7.01

1.7

1.3

0.37

0.44

g/l

0.70

151

Lesion of lateral popliteal nerve

141

2.65

6.98

1.5

1.3

0.38

0.40

g/l

0.09

Excessive vomiting in pregnancy

324

2.06

6.98

1.4

1.5

0.37

0.39

g/l

0.14

223

MS-disease / Multiple Sclerosis

278

2.14

6.95

1.4

0.30

0.38

g/l

1.46

195

Cardiodefibrillation

189

1248

1.52

6.93

1.3

1.4

0.44

g/l

0.03

113

861

Corneal ulcer

124

746

1.67

6.84

1.5

1.3

0.40

g/l

0.03

522

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

202

1344

1.49

6.83

1.4

0.38

g/l

0.02

157

948

Other disorders of optic [2nd] nerve and visual pathways

203

2.34

6.83

1.6

1.3

0.38

g/l

0.03

144

Nail disorders

287

2.11

6.80

1.2

1.4

0.39

0.40

g/l

0.14

200

Other extrapyramidal and movement disorders in other diseases

144

901

1.61

6.80

1.5

1.4

0.38

0.42

g/l

0.81

107

622

Hyperkinetic disorders

105

593

1.75

6.75

1.3

1.4

0.34

0.38

g/l

1.13

417

Other epidermal thickening

121

2.76

6.72

1.4

1.2

0.34

0.40

g/l

0.47

Nonischemic cardiomyopathy

275

2.12

6.70

1.3

0.49

0.38

g/l

1.15

194

Trigeminal neuralgia

180

2.41

6.70

1.8

1.4

0.36

0.38

g/l

0.15

126

Cardiomyopathy (excluding other)

377

1.95

6.70

1.4

1.3

0.48

0.42

g/l

0.63

261

Acute peritonitis

180

2.41

6.70

1.5

1.3

0.46

0.41

g/l

0.28

127

Superficial injury of hip and thigh

455

1.86

6.66

1.3

0.41

g/l

0.03

313

Viral warts

146

922

1.59

6.65

1.5

1.3

0.37

0.40

g/l

0.55

103

642

Drug-induced neutropenia

231

2.23

6.64

1.4

1.5

0.41

0.37

g/l

0.23

159

Phobic anxiety disorders

542

1.78

6.64

1.5

1.3

0.38

0.39

g/l

0.18

369

Lateral epicondylitis

457

1.85

6.59

1.5

1.3

0.37

0.41

g/l

0.90

315

Myocardial infarction

252

1242

1.43

6.58

1.3

1.4

0.45

0.41

g/l

0.73

181

825

Vulvovaginal ulceration/inflammation in other diseases

220

2.25

6.52

1.5

1.4

0.41

0.38

g/l

0.25

155

Exophthalmic conditions

5.87

6.52

1.6

1.2

0.26

0.32

g/l

0.40

Other specified and unspecified retinal disorders

3.04

6.52

1.6

1.3

0.29

0.37

g/l

1.00

Other and unspecified glaucoma

170

2.43

6.52

1.5

1.3

0.30

0.47

g/l

3.00

118

Glaucoma suspect

202

1375

1.47

6.50

1.4

0.44

0.43

g/l

0.05

133

963

Elevated blood glucose level

261

2.12

6.39

2.1

1.3

0.36

0.40

g/l

0.37

174

Urethritis and urethral syndrome

3.78

6.39

1.4

1.3

0.34

0.39

g/l

0.25

Other and unspecified psoriasis

203

2.29

6.38

1.2

1.5

0.46

0.41

g/l

0.38

142

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

280

2.08

6.37

1.1

1.4

0.45

0.46

g/l

0.05

201

Viral hepatitis, IBD co-morbidity

102

2.86

6.36

1.0

1.2

0.49

0.43

g/l

0.37

Personality disorders

188

1268

1.49

6.36

1.3

0.37

0.39

g/l

0.28

129

873

Barrett oesophagus

119

2.72

6.35

1.5

1.3

0.52

0.38

g/l

0.40

Desensitization to allergens

223

2.22

6.33

1.3

1.4

0.32

0.37

g/l

0.86

154

Other and unspecified diseases of blood and blood-forming organs

3.39

6.30

1.4

1.3

0.34

0.39

g/l

0.28

Disorders of adult personality and behaviour

199

1360

1.47

6.30

1.3

1.4

0.36

0.38

g/l

0.43

140

941

Unspecified fall

308

2237

1.36

6.29

1.5

1.4

0.39

0.41

g/l

0.44

204

1574

Myocardial infarction, strict

233

1157

1.44

6.28

1.3

1.4

0.45

0.41

g/l

0.46

169

767

Other (not insulin) diabetes medications

611

2900

1.25

6.27

1.3

1.4

0.42

0.40

g/l

0.32

409

2043

Hypercalcemia

120

2.70

6.26

1.2

1.4

0.69

0.39

g/l

0.55

Pleural plaque with presence of asbestos

180

2.35

6.23

1.3

1.2

0.58

0.48

g/l

0.59

129

Neovascular glaucoma

2.89

6.22

1.4

1.2

0.39

g/l

0.01

Lichen simplex chronicus

3.09

6.21

1.2

1.3

0.43

0.41

g/l

0.11

Pneumonitis due to solids and liquids

199

2.28

6.21

1.3

1.2

0.37

0.43

g/l

0.40

141

Unspecific neurodegenerative disorder

954

0.56

6.20

1.2

1.4

0.39

0.45

g/l

0.76

657

Otitis externa

147

946

1.56

6.20

1.3

0.37

0.40

g/l

0.51

118

661

Dislocation, sprain and strain of joints and ligaments of knee

393

2770

1.31

6.18

1.4

1.3

0.36

0.40

g/l

1.95

273

1912

Infective dermatitis

403

1.87

6.15

1.4

1.3

0.49

0.42

g/l

0.77

289

Acne

403

1.87

6.12

1.3

0.42

0.40

g/l

0.24

277

Glaucoma secondary to other eye disorders

2.86

6.11

1.4

1.3

0.39

0.44

g/l

0.20

Eustachian salpingitis and obstruction

334

1.96

6.11

1.6

1.3

0.33

0.41

g/l

1.11

234

Anogenital herpesviral [herpes simplex] infection

233

2.17

6.10

1.5

1.4

0.35

0.37

g/l

0.11

160

Other psoriatic arthropathies

405

1.87

6.07

1.3

1.4

0.41

0.39

g/l

0.35

283

Diabetes insipidus

5.73

6.07

1.9

1.3

0.28

0.32

g/l

—

Hidradenitis suppurativa

134

2.57

6.06

1.3

1.4

0.42

0.36

g/l

0.54

Autoimmune hyperthyroidism

170

2.37

6.05

1.4

0.32

0.41

g/l

1.59

120

Speech and linguistic disorders, excluding more controls

282

2.02

6.03

1.2

1.3

0.39

0.36

g/l

0.25

198

Tuberculosis

134

2.56

6.03

1.9

1.3

0.47

0.43

g/l

0.32

Crohn disease (strict definition, all UC cases excluded)

183

2.32

6.03

1.1

1.3

0.36

g/l

0.03

126

Pacemaker

156

980

1.53

6.02

1.2

1.4

0.45

0.44

g/l

0.18

105

695

Excessive attrition of teeth

363

2763

1.32

6.01

1.5

1.4

0.38

0.40

g/l

0.41

252

1940

Thoracic aortic aneurysm

457

1.81

6.00

1.5

1.3

0.45

0.42

g/l

0.16

320

Injuries to the head

724

3651

1.22

5.94

1.5

1.3

0.37

0.41

g/l

2.02

504

2555

Other and unspecified acquired haemolytic anaemias

6.58

5.92

1.9

1.2

0.41

0.31

g/l

—

Allergic colitis

101

2.82

5.92

1.3

1.4

0.34

0.41

g/l

0.64

Dialysis

130

2.57

5.89

1.4

1.3

0.54

0.39

g/l

0.44

Appendicitis, broad definition

473

3374

1.27

5.88

1.4

0.41

0.40

g/l

0.03

313

2357

Diseases of appendix

476

3387

1.27

5.86

1.4

0.40

g/l

0.01

316

2369

Infections with a predominantly sexual mode of transmission

262

1773

1.38

5.86

1.3

0.38

g/l

0.03

188

1212

Oral lichen planus, including avohilmo , including avohilmo

224

2.16

5.86

1.5

0.33

0.39

g/l

0.99

155

Familial hypercholesterolemia

468

1.78

5.84

1.6

1.4

0.39

0.45

g/l

0.84

321

Noninflammatory disorders of female genital tract

254

906

1.41

5.83

1.4

0.41

0.40

g/l

0.18

177

624

Alcoholic liver disease

320

1.95

5.77

1.3

0.45

0.37

g/l

1.10

225

Adjustment and management of implanted device

559

1.71

5.76

1.1

1.4

0.40

0.45

g/l

0.66

397

Morphin

4.94

5.76

1.6

1.3

0.76

0.51

g/l

0.67

Impingement syndrome of shoulder

132

844

1.57

5.76

1.4

1.3

0.36

0.43

g/l

2.13

101

588

Abnormality of white blood cells, not elsewhere classified

5.78

5.76

1.3

1.2

0.23

0.34

g/l

—

Dermatophytosis

449

1.79

5.74

1.6

1.4

0.49

0.40

g/l

0.98

313

Sleep disorders, other/unspecified

120

2.62

5.74

1.2

1.4

0.32

0.38

g/l

0.70

Spondylopathies in diseases classified elsewhere

5.71

5.73

1.2

1.3

0.44

0.48

g/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

0.35

0.40

g/l

0.36

106

Spasmodic torticollis

103

2.76

5.72

1.6

1.4

0.41

0.34

g/l

0.34

Right bundle-branch block

2.99

5.70

1.1

0.46

0.39

g/l

0.36

Paralytic ileus

2.99

5.70

1.3

1.2

0.47

g/l

0.01

Impetigo

163

2.36

5.67

1.4

1.2

0.56

0.39

g/l

0.43

120

Diabetic maculopathy, excluding more controls

350

1.90

5.67

1.5

1.3

0.43

0.39

g/l

0.32

244

Angina pectoris

294

1447

1.36

5.66

1.5

1.4

0.44

0.40

g/l

0.88

196

975

Other/unspecified enthesopathies, not elsewhere classified

247

2.08

5.66

1.8

1.3

0.36

0.41

g/l

0.49

175

Benign neoplasm: Rectum

103

624

1.66

5.62

1.5

1.3

0.36

0.42

g/l

1.20

432

Use of pramipexole

128

818

1.57

5.61

1.4

0.36

0.40

g/l

0.86

568

Type 1 diabetes

162

1088

1.49

5.61

1.5

1.3

0.43

0.39

g/l

0.41

111

766

Papilloedema, unspecified

3.33

5.61

1.4

0.30

0.39

g/l

0.85

Other specified and unspecified disorders of eyelid

5.12

5.60

1.9

1.3

0.20

0.40

g/l

—

Acute appendicitis, no complications

359

2745

1.31

5.58

1.4

0.38

0.40

g/l

0.64

236

1919

Other and unspecified myopathies

242

2.08

5.56

1.4

1.3

0.36

0.42

g/l

0.62

166

Diseases of peritoneum

332

1.91

5.53

1.5

1.4

0.70

0.41

g/l

0.68

229

Sudden idiopathic hearing loss

318

1.93

5.53

1.8

1.3

0.38

0.40

g/l

0.16

228

Bell's palsy

418

1.81

5.52

1.3

0.33

0.42

g/l

2.49

291

Spontaneous rupture of synovium and tendon

223

2.12

5.51

1.8

1.3

0.39

0.42

g/l

0.24

157

Testicular hypofunction

117

2.60

5.49

1.3

1.2

0.37

0.40

g/l

0.09

Heterophoria

305

1.95

5.49

1.6

1.5

0.37

0.36

g/l

0.05

206

Benign neoplasm of mouth and pharynx

383

1.84

5.48

1.4

0.37

0.40

g/l

0.30

265

Contact with and exposure to communicable diseases

217

1543

1.41

5.47

1.4

0.30

0.38

g/l

3.61

110

1100

Injuries to the shoulder and upper arm

521

3374

1.25

5.45

1.4

0.41

g/l

0.12

369

2336

Chronic Coagulation defects

3.00

5.44

1.7

1.3

0.30

0.35

g/l

0.30

Other and unspecified epidermal thickening

2.99

5.44

1.3

0.35

0.40

g/l

0.27

Hypertrophic disorders of skin

192

2.21

5.42

1.3

1.4

0.36

0.38

g/l

0.16

134

Excessive earwax

316

2339

1.32

5.39

1.5

1.4

0.44

0.42

g/l

0.16

207

1646

Major coronary heart disease event excluding revascularizations

311

1556

1.33

5.39

1.3

1.4

0.45

0.41

g/l

0.93

224

1046

Other abnormal uterine and vaginal bleeding

137

636

1.55

5.38

1.2

1.4

0.38

0.39

g/l

0.18

433

Allergic contact dermatitis

511

1.71

5.36

1.3

1.4

0.36

0.40

g/l

0.57

356

Visual impairment including blindness (binocular or monocular)

180

2.24

5.35

1.3

0.39

0.42

g/l

0.18

127

Benign neoplasm: Rectum, anus and anal canal

113

710

1.60

5.35

1.4

1.3

0.38

0.42

g/l

0.71

496

Other disorders of central nervous system

4.83

5.35

1.4

0.28

0.37

g/l

—

Acne vulgaris

301

1.94

5.34

1.2

1.3

0.40

0.38

g/l

0.22

205

Localized scleroderma [morphea]

4.82

5.34

1.4

1.2

0.31

0.34

g/l

0.18

Complications following infusion, transfusion and therapeutic injection

4.81

5.33

1.5

1.3

0.35

0.37

g/l

—

Autoimmune thyroiditis

3.34

5.33

1.3

0.27

0.41

g/l

1.78

Acute epiglottitis

4.81

5.33

1.6

1.3

0.40

0.39

g/l

—

Haemorrhage in early pregnancy

181

1224

1.45

5.32

1.2

1.4

0.33

0.39

g/l

2.11

135

876

Lichen ruber planus, wide definition including periferal and oral lichen planus

131

853

1.54

5.32

1.7

1.4

0.36

0.41

g/l

1.12

590

Extrapyramidal and movement disorders

209

1491

1.41

5.31

1.5

1.3

0.38

0.43

g/l

1.51

145

1033

Other disorders of bladder

358

1.85

5.31

1.2

1.3

0.48

0.43

g/l

0.20

253

Plantar fascial fibromatosis

302

1.93

5.29

1.4

1.3

0.36

0.42

g/l

1.14

211

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

536

1.69

5.27

1.4

0.39

0.42

g/l

0.30

381

Benign neoplasm: Parotid gland

241

2.05

5.25

1.5

1.4

0.34

0.40

g/l

0.52

167

Disorder of the sleep-wake schedule

3.39

5.19

1.3

1.4

0.37

g/l

0.01

Fracture of foot, except ankle

157

1068

1.48

5.18

1.4

1.3

0.37

0.40

g/l

0.68

116

737

Other disorders of nervous system

196

2.16

5.16

1.3

1.5

0.42

0.37

g/l

0.34

138

Infections with a predominantly sexual mode of transmission

202

1439

1.41

5.15

1.3

1.4

0.39

0.38

g/l

0.02

149

986

Bacterial, viral and other infectious agents

355

1.84

5.14

1.3

1.4

0.36

0.37

g/l

0.18

243

Caries of enamel

579

3414

1.23

5.13

1.4

0.41

0.40

g/l

0.26

443

2346

Other hammer toe(s) (acquired)

476

1.69

5.11

1.5

0.37

0.42

g/l

0.80

329

Tinnitus

137

909

1.51

5.11

1.4

0.38

0.41

g/l

0.54

628

Atrophic disorders of skin

541

1.67

5.11

1.5

1.4

0.35

0.40

g/l

1.17

376

Otitis externa, unspecified

429

1.76

5.10

1.4

0.39

0.40

g/l

0.04

304

Alopecia areata

2.94

5.05

1.5

1.3

0.36

0.38

g/l

0.11

Nonpyogenic thrombosis of intracranial venous system

4.85

5.05

1.3

0.27

0.37

g/l

—

Other and unspecified aplastic anaemias

4.82

5.04

1.3

0.41

0.30

g/l

—

Injuries to the neck

145

978

1.49

5.01

1.4

1.3

0.35

0.40

g/l

1.40

110

669

AV-block

415

1.72

4.98

1.2

1.3

0.47

0.42

g/l

0.64

301

Other disorders starting during childhood or adolecense, excluding more controls

190

2.14

4.98

1.3

0.36

0.35

g/l

0.07

142

Injuries to the hip and thigh

257

1733

1.35

4.97

1.3

1.4

0.43

0.42

g/l

0.08

192

1195

Fracture at wrist and hand level

219

1592

1.38

4.95

1.3

1.4

0.38

0.40

g/l

0.39

145

1094

Malignant neoplasm

533

2558

1.23

4.94

1.3

1.4

0.40

g/l

0.12

356

1809

Osteomyelitis

180

2.18

4.94

1.5

1.2

0.41

0.42

g/l

0.04

128

Hypocalcemia

3.16

4.94

1.4

1.3

0.47

0.39

g/l

0.27

Injury of muscle and tendon at forearm level

3.27

4.92

1.3

0.52

0.37

g/l

0.33

Other disorders of patella

101

633

1.60

4.87

1.2

1.4

0.38

0.41

g/l

0.53

423

Problems related to lifestyle

376

1.79

4.87

1.3

0.39

g/l

0.03

249

Abscess of anal and rectal regions

297

1.90

4.87

1.3

0.37

0.39

g/l

0.18

202

Other/unspecified enthesopathies of lower limb, excluding foot

221

2.05

4.87

1.2

1.4

0.47

0.43

g/l

0.29

159

Maternal care for other conditions predominantly related to pregnancy

142

941

1.49

4.86

1.2

1.4

0.38

0.37

g/l

0.04

100

678

Striking against or struck by other objects

213

1549

1.38

4.85

1.4

1.3

0.35

0.40

g/l

1.87

141

1070

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

177

1249

1.42

4.84

1.2

1.3

0.40

g/l

0.08

126

854

Occupational exposure to risk-factors

2.66

4.84

1.7

1.3

0.55

0.39

g/l

0.96

Squamous cell neoplasms and carcinomas of the skin

175

2.18

4.83

1.1

1.3

0.49

0.44

g/l

0.20

129

Follicular lymphoma, hilmo

119

2.46

4.81

1.7

1.4

0.25

0.39

g/l

1.93

Female infertility

177

749

1.44

4.79

1.4

0.40

g/l

0.00

128

518

Amenorrhoea

264

1.95

4.78

1.8

1.5

0.33

0.39

g/l

1.02

182

D07AA Corticosteroids, weak (group I)

106

675

1.58

4.77

1.4

0.34

0.39

g/l

1.25

488

Disorders of psychological development

475

1.67

4.75

1.3

1.4

0.35

0.37

g/l

0.19

334

DVT of lower extremities

104

661

1.58

4.74

1.4

1.3

0.38

0.41

g/l

0.45

465

Other maternal disorders predominantly related to pregnancy

360

1761

1.28

4.74

1.2

1.4

0.35

0.40

g/l

1.89

259

1260

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

272

1.93

4.73

1.3

0.39

0.36

g/l

0.28

184

Gluteal tendinitis

102

2.57

4.73

1.4

1.5

0.32

0.40

g/l

0.78

Sequelae of injuries, of poisoning and of other consequences of external causes

146

1000

1.47

4.70

1.4

1.3

0.36

0.40

g/l

0.73

693

Chronic mastoiditis

3.06

4.69

1.9

1.3

0.42

0.41

g/l

0.02

Testicular dysfunction

133

2.36

4.68

1.3

1.2

0.37

0.39

g/l

0.06

Ptosis of eyelid

330

1.83

4.67

1.8

1.3

0.29

0.43

g/l

3.60

230

Scar conditions and fibrosis of skin

127

2.39

4.66

1.2

1.4

0.29

0.39

g/l

1.41

Other superficial mycoses

3.15

4.66

1.6

1.2

0.43

0.38

g/l

0.23

Intracranial injury

350

2599

1.28

4.65

1.6

1.4

0.38

0.41

g/l

0.85

244

1818

Artificial joint operation, meniscal resection

538

2861

1.22

4.65

1.4

0.40

0.41

g/l

0.26

363

1987

Acute gastritis

198

2.08

4.65

1.5

1.3

0.37

0.40

g/l

0.24

139

Acute appendicitis

434

3266

1.24

4.64

1.4

0.41

0.40

g/l

0.08

290

2287

Female infertility, cervical, vaginal, other or unspecified origin

163

734

1.45

4.64

1.4

0.38

0.40

g/l

0.14

121

506

Alcohol abuse, main dg, excluding more controls

548

1.63

4.64

1.3

0.39

0.40

g/l

0.08

369

Convalescence

172

2.17

4.63

1.5

1.4

0.32

0.38

g/l

0.78

119

Vitamin B12 deficiency anaemia

267

1.92

4.62

1.1

1.3

0.44

0.42

g/l

0.11

185

Acute posthaemorrhagic anaemia

2.93

4.61

1.3

0.35

0.42

g/l

0.30

Tubulo-interstitial nephritis, not specified as acute or chronic

179

2.14

4.59

1.3

1.4

0.51

0.40

g/l

0.79

124

Valvular operations

413

1.73

4.58

1.5

1.3

0.50

0.41

g/l

1.11

292

Congenital malformations of the urinary system

213

2.04

4.57

1.2

1.3

0.41

0.38

g/l

0.23

153

Anti-inflammatory and antirheumatic products, non-steroids

167

580

1.45

4.57

1.4

1.3

0.37

0.43

g/l

1.24

120

404

Disorder of lipoprotein metabolism, unspecified

406

1.73

4.57

1.3

1.4

0.42

0.44

g/l

0.19

277

Specific personality disorders

157

1097

1.44

4.56

1.3

1.4

0.38

g/l

0.05

113

759

Respiratory tuberculosis, confirmed and not-confirmed

122

2.39

4.56

2.1

1.3

0.47

0.42

g/l

0.29

Respiratory tuberculosis

122

2.39

4.56

2.1

1.3

0.47

0.42

g/l

0.29

Other specified/unspecified dorsopathies

2.83

4.56

1.6

1.5

0.35

0.39

g/l

0.25

Trigger finger

474

1.67

4.56

1.3

0.38

0.42

g/l

0.64

329

Dermatitis due to ingested food

147

2.24

4.56

1.3

1.5

0.30

0.37

g/l

1.16

120

Abrasion of teeth

208

1526

1.37

4.55

1.3

1.4

0.37

0.40

g/l

0.54

145

1067

Ventral hernia

131

885

1.49

4.53

1.4

1.3

0.41

g/l

0.03

616

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.75

4.53

1.3

1.4

0.50

0.35

g/l

0.24

Other shoulder lesions

298

1.86

4.51

1.3

0.35

0.42

g/l

0.78

207

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.5

0.35

0.43

g/l

0.57

Viral conjunctivitis

117

2.42

4.49

1.3

0.30

0.38

g/l

0.82

Superficial injury of wrist and hand

135

920

1.47

4.48

1.4

0.35

0.40

g/l

0.89

648

Other erythematous conditions

2.55

4.48

1.3

1.4

0.29

0.37

g/l

0.65

Endometriosis ASRM stages 1,2

117

775

1.52

4.47

1.4

0.46

0.38

g/l

0.63

541

Unspecified nephritic syndrome

2.97

4.46

1.5

1.3

0.68

0.40

g/l

1.27

Recurrent dislocation of patella

162

2.18

4.43

1.1

1.4

0.35

0.39

g/l

0.36

107

Generalized anxiety disorder

101

649

1.56

4.43

1.3

0.37

0.39

g/l

0.24

437

Hyperfunction of pituitary gland

169

2.15

4.41

1.3

0.38

0.42

g/l

0.26

114

Benign neoplasm: Pituitary gland, craniopharyngeal duct

169

2.15

4.41

1.4

1.3

0.34

0.40

g/l

0.37

118

Arterial embolism and thrombosis

124

2.35

4.40

1.3

1.2

0.34

0.44

g/l

1.05

Paralytic strabismus

210

2.01

4.37

1.7

1.4

0.38

0.40

g/l

0.18

144

Campylobacter enteritis

2.76

4.37

1.2

1.4

0.40

0.32

g/l

0.56

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

302

1.83

4.34

1.3

1.4

0.50

0.39

g/l

1.04

210

Schizophrenia

690

0.49

4.32

1.1

1.4

0.40

0.39

g/l

0.04

470

Hyperaldosteronism

2.81

4.30

1.6

1.2

0.38

0.42

g/l

0.14

Pure hyperglyceridaemia

2.99

4.30

1.4

0.43

0.41

g/l

—

Abdominal aortic aneurysm (AAA)

223

1.97

4.29

1.3

1.2

0.45

0.48

g/l

0.20

160

Endometriosis of rectovaginal septum and vagina

254

1.90

4.25

1.5

0.34

0.42

g/l

0.79

172

Spirochaetal infections, other/unspecified

297

1.83

4.25

1.2

1.4

0.36

0.41

g/l

0.54

201

Artificial opening status

152

2.19

4.25

1.4

0.34

0.43

g/l

0.83

113

Bruxism

2.79

4.21

1.3

1.4

0.44

0.34

g/l

0.23

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

618

1.56

4.20

1.2

1.4

0.41

g/l

0.02

442

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

279

1876

1.30

4.19

1.5

1.4

0.43

0.39

g/l

0.41

204

1342

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

107

706

1.52

4.19

1.4

1.3

0.40

0.38

g/l

0.19

487

Mixed and other personality disorders

328

1.78

4.18

1.5

1.4

0.27

0.37

g/l

2.68

231

Benign neoplasm: Sigmoid colon

103

675

1.53

4.16

1.5

1.4

0.40

0.42

g/l

0.23

473

Visual field defects

249

1.90

4.15

1.5

1.3

0.39

0.41

g/l

0.19

170

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

109

2.41

4.15

2.0

1.3

0.36

0.37

g/l

0.02

Iron deficiency

2.51

4.15

1.2

1.3

0.41

0.38

g/l

0.14

Speech therapy

149

1053

1.42

4.11

1.5

1.4

0.41

g/l

0.06

138

722

Alzheimer disease, including avohilmo

761

0.60

4.08

1.4

0.44

0.45

g/l

0.09

533

Congenital malformations of the urinary system

230

1.93

4.06

1.2

1.3

0.41

0.38

g/l

0.26

164

Other condition

576

1.57

4.05

1.7

1.3

0.36

0.40

g/l

0.80

400

Cholesteatoma of middle ear

136

2.22

4.03

1.9

1.3

0.31

0.42

g/l

1.27

Mature T/NK-cell lymphomas, hilmo

3.97

4.02

1.3

1.2

0.27

0.31

g/l

—

Convergence insufficiency and excess

3.96

4.02

1.2

1.3

0.29

0.34

g/l

—

Radial styloid tenosynovitis [de Quervain]

169

2.09

4.02

1.7

1.4

0.47

0.36

g/l

0.98

121

Normotensive glaucoma

217

1.95

4.01

1.4

1.3

0.41

0.45

g/l

0.26

156

Hydronephrosis

347

1.74

4.01

1.4

1.3

0.45

0.40

g/l

0.22

249

Persistent mood disorders

113

762

1.49

4.00

1.3

0.35

0.41

g/l

1.53

514

Myocardial infarction, without ST-elevation

185

1239

1.36

4.00

1.4

0.45

0.43

g/l

0.28

143

842

Other disorders of the musculoskeletal system and connective tissue

547

1.58

3.99

1.6

1.3

0.37

0.40

g/l

0.30

383

Idiopathic urticaria

2.85

3.97

1.4

1.3

0.34

0.36

g/l

0.12

Thyrotoxicosis

145

1027

1.42

3.97

1.5

1.4

0.36

0.40

g/l

0.71

703

Epilepsy

168

1217

1.38

3.95

1.3

1.4

0.39

0.41

g/l

0.27

125

867

Type 1 diabetes, wide definition, subgroup 1

122

837

1.46

3.94

1.4

1.3

0.36

0.38

g/l

0.23

618

Tuberculosis of other organs, strict

3.16

3.94

2.1

1.3

0.57

0.46

g/l

—

Benign neoplasm of other and unspecified endocrine glands

510

1.60

3.93

1.4

1.3

0.32

0.40

g/l

1.46

358

Other disorders of glucose regulation and pancreatic internal secretion

283

1.81

3.92

1.8

1.3

0.40

0.38

g/l

0.11

194

Tuberculosis of other organs

3.30

3.92

2.1

1.3

0.57

0.44

g/l

—

Poisoning by drugs, medicaments and biological substances

151

1080

1.40

3.92

1.3

0.37

0.40

g/l

0.58

107

750

Bacterial, viral and other infectious agents

335

1.74

3.91

1.3

0.36

0.38

g/l

0.17

228

Calculus of kidney and ureter

160

1156

1.39

3.91

1.4

1.3

0.37

0.43

g/l

1.18

112

803

Left ventricular outflow tract obstruction (LVOTO), broad definition

418

1.66

3.91

1.6

1.3

0.36

0.39

g/l

0.34

296

Suppurative otitis media, unspecified

2.91

3.91

1.7

1.4

0.46

0.38

g/l

0.22

Other dialysis

2.48

3.90

1.3

0.43

0.39

g/l

0.27

Other symptoms and signs involving general sensations and perceptions

100

2.42

3.90

1.2

1.3

0.42

0.44

g/l

0.05

192

1309

1.35

3.86

1.5

1.4

0.39

0.44

g/l

1.18

137

899

Other specified disorders of muscle

2.80

3.86

1.6

1.2

0.38

0.36

g/l

0.09

Flat foot [pes planus] (acquired)

292

1.79

3.85

1.3

1.5

0.31

0.43

g/l

2.38

207

Presbycusis

304

1.77

3.83

1.6

1.2

0.31

0.50

g/l

3.52

220

Disorders of tooth development and eruption

483

1.55

3.81

1.5

1.3

0.33

0.41

g/l

1.62

334

Respiratory tuberculosis, not confirmed

2.55

3.80

2.3

1.3

0.49

0.44

g/l

0.24

Injury of nerves at forearm level

3.24

3.80

1.4

0.37

0.33

g/l

—

Myopia

538

1.57

3.80

1.3

1.4

0.36

0.38

g/l

0.26

370

Tobacco use

173

2.04

3.80

1.3

0.40

g/l

0.01

117

Other peripheral vertigo

301

1.77

3.79

1.5

1.4

0.38

0.40

g/l

0.18

214

Gonarthrosis,primary

497

2543

1.21

3.79

1.3

1.4

0.41

g/l

0.04

353

1768

Respiratory conditions due to other external agents

3.22

3.79

1.4

1.2

0.45

0.38

g/l

—

Herpesviral keratitis and keratoconjunctivitis

114

2.30

3.79

1.6

1.3

0.43

0.38

g/l

0.25

KRA_PSY_EATING, excluding more controls

285

1.79

3.78

1.2

1.3

0.31

0.40

g/l

1.54

194

Alzheimer disease

636

0.57

3.78

1.2

1.3

0.42

0.47

g/l

0.33

449

Scoliosis

272

1.81

3.78

1.3

1.4

0.39

0.43

g/l

0.43

191

Infliximab

2.77

3.78

1.1

1.3

0.26

0.35

g/l

—

Strabismus

163

1186

1.38

3.77

1.7

1.3

0.40

0.39

g/l

0.14

110

835

Delirium, not induced by alcohol and other psychoactive substances

301

1.76

3.76

1.4

1.3

0.47

0.44

g/l

0.20

212

Thyrotoxicosis, other and/or unspecified

114

781

1.47

3.76

1.4

0.35

0.39

g/l

1.11

540

Lichen planus, including avohilmo

107

724

1.48

3.76

1.7

1.4

0.36

0.40

g/l

0.76

498

Open wound of ankle and foot

392

1.67

3.76

1.3

0.39

g/l

0.00

269

Other diseases of spinal cord

2.67

3.74

1.3

0.30

0.36

g/l

0.44

Oesophageal obstruction

2.66

3.74

1.2

0.74

0.41

g/l

0.54

Contusion of toe(s) without damage to nail

2.60

3.73

1.1

1.2

0.42

0.35

g/l

0.42

Other and unspecified local infections of skin and subcutaneous tissue

325

1.73

3.72

1.4

1.3

0.44

0.39

g/l

0.21

232

Speech and linguistic disorders

377

1.66

3.71

1.4

1.3

0.37

0.36

g/l

0.09

276

Benign lipomatous neoplasm of other sites/unspecified

252

1.84

3.71

1.2

1.4

0.41

0.40

g/l

0.03

177

Poisoning by medicine

137

974

1.41

3.70

1.3

1.4

0.36

0.39

g/l

0.40

667

Propionic acid derivatives

161

580

1.40

3.70

1.3

0.34

0.43

g/l

2.53

116

404

Psychotic depression

182

1.99

3.68

1.1

1.5

0.43

0.41

g/l

0.06

124

Degeneration of macula and posterior pole

223

1356

1.31

3.67

1.4

0.38

0.44

g/l

1.16

154

949

Molar incisor enamel hypoplasia

169

2.02

3.66

1.5

1.3

0.38

0.37

g/l

0.10

139

Degenerative diseases of the nervous system

779

0.62

3.66

1.2

1.4

0.41

0.46

g/l

0.47

550

Sequelae of injuries of neck and trunk

2.50

3.64

1.6

1.3

0.27

0.37

g/l

0.78

Cardiac arrest

120

2.15

3.64

1.2

1.3

0.36

0.41

g/l

0.44

Left hemicolectomy

2.89

3.64

1.4

1.2

0.46

0.41

g/l

—

Benign neoplasm of middle ear and respiratory system

232

1.86

3.64

1.7

1.3

0.38

0.40

g/l

0.20

156

Other and unspecified disorders of skin and subcutaneous tissue

176

2.00

3.64

1.5

1.4

0.29

0.40

g/l

2.04

123

Superficial injury of ankle and foot

505

1.57

3.62

1.4

0.39

0.38

g/l

0.11

349

Golimumab

123

2.22

3.62

1.1

1.3

0.36

g/l

0.02

Hemiplegia

136

2.15

3.61

1.3

0.34

0.40

g/l

0.61

Other specified and unspecified personality disorders

351

1.69

3.60

1.3

1.4

0.33

0.38

g/l

0.67

242

Other local infections of skin and subcutaneous tissue

351

1.69

3.60

1.4

1.3

0.43

0.39

g/l

0.18

249

Other acquired deformities of musculoskeletal system and connective tissue

150

2.09

3.58

2.0

1.3

0.46

0.39

g/l

0.34

Other disorders of binocular movement

2.68

3.58

1.5

1.3

0.31

0.36

g/l

0.39

Follicular cysts of skin and subcutaneous tissue

107

732

1.47

3.58

1.4

1.3

0.34

0.41

g/l

1.73

511

Actinic keratosis

170

1165

1.35

3.57

1.5

1.4

0.39

0.46

g/l

1.48

119

792

Melanocytic naevi

176

1314

1.34

3.54

1.3

0.42

0.40

g/l

0.07

138

906

Deficiency of other B group vitamins

3.08

3.54

1.2

1.3

0.51

0.32

g/l

—

Routine general health check-up of defined subpopulation

3.07

3.54

1.4

1.2

0.34

0.43

g/l

0.45

Artificial joint re-operation

185

1.96

3.53

1.3

1.5

0.44

0.43

g/l

0.09

133

Erosion of teeth , including avohilmo

156

1145

1.37

3.51

1.3

1.4

0.39

0.38

g/l

0.10

106

792

Malignant neoplasm of breast, HER2-negative

137

1241

0.72

3.51

1.1

1.4

0.42

0.39

g/l

0.31

894

Achilles tendinitis

331

1.70

3.51

1.8

1.3

0.38

0.44

g/l

1.04

231

Benign neoplasm: Rectosigmoid junction

2.34

3.51

1.2

1.3

0.42

0.41

g/l

0.05

Other misadventures during surgical and medical care

2.73

3.50

1.1

1.3

0.31

0.40

g/l

0.54

Malignant neoplasm of breast

139

1252

0.72

3.50

1.2

1.4

0.43

0.39

g/l

0.44

902

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

183

1377

1.33

3.50

1.2

1.4

0.34

0.39

g/l

1.57

123

958

Chondropathies

638

1.50

3.49

1.5

1.4

0.33

0.40

g/l

1.65

434

Persons encountering health services in circumstances related to reproduction

373

2051

1.23

3.48

1.3

1.4

0.35

0.39

g/l

1.70

259

1433

Other facial nerve disorders

2.50

3.47

1.5

1.3

0.33

0.36

g/l

0.19

Other and unspecified injuries of lower leg

280

1.76

3.47

1.5

1.3

0.40

0.37

g/l

0.18

188

Leisure time condition

107

737

1.46

3.47

1.8

1.3

0.41

g/l

0.00

514

Ankylosing spondylitis, strict definition

159

2.03

3.46

1.2

1.3

0.44

0.35

g/l

0.69

112

Skin changes due to chronic exposure to nonionizing radiation

176

1215

1.34

3.44

1.5

1.4

0.40

0.45

g/l

1.19

123

827

Mixed conductive and sensorineural hearing loss

379

1.64

3.43

1.3

0.41

0.42

g/l

0.08

265

Heart failure and hypertrophic cardiomyopathy

3.02

3.43

1.4

1.3

0.46

0.43

g/l

—

Dementia, including avohilmo

117

1137

0.71

3.42

1.2

1.4

0.41

0.45

g/l

0.36

776

Other degenerative diseases of the nervous system

129

683

1.41

3.42

1.4

1.3

0.35

0.44

g/l

2.31

463

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

108

724

1.45

3.41

1.3

1.4

0.38

0.39

g/l

0.11

530

Mantle cell lymphoma, including Hilmo

3.81

3.41

2.1

1.3

0.27

0.31

g/l

—

Status epilepticus

2.41

3.40

1.3

0.34

0.42

g/l

0.57

2.53

3.39

1.2

0.25

0.32

g/l

0.91

Chromosomal abnormalities, not elsewhere classified

107

2.27

3.39

1.4

1.3

0.49

0.36

g/l

0.78

Abnormalities of gait and mobility

373

1.64

3.38

1.5

1.3

0.39

0.42

g/l

0.31

269

Speech disturbances, not elsewhere classified

246

1.80

3.35

1.3

1.4

0.36

0.41

g/l

0.37

171

Primary open-angle glaucoma

144

1016

1.37

3.35

1.3

1.4

0.34

0.45

g/l

4.67

697

Deep endometriosis

351

1.66

3.35

1.5

1.4

0.35

0.38

g/l

0.24

245

Monoamine oxidase A inhibitors

413

1.61

3.34

1.2

1.3

0.44

0.42

g/l

0.16

283

Glaucoma-related operations

134

2.10

3.34

1.4

0.34

0.43

g/l

0.92

Hypertrophy of breast in women and men

120

851

1.42

3.34

1.4

1.3

0.34

0.38

g/l

0.79

591

Chondrocostal junction syndrome [Tietze]

108

2.24

3.33

1.5

1.4

0.33

0.37

g/l

0.33

Benign neoplasm of eye and adnexa

329

1.68

3.32

1.7

1.4

0.33

0.41

g/l

0.87

237

Mental and behavioural disorders due to alcohol

287

2214

1.25

3.32

1.3

1.4

0.41

g/l

0.19

180

1518

Female genital prolapse

159

659

1.37

3.31

1.5

1.4

0.38

0.39

g/l

0.08

110

454

Dementia

107

1050

0.70

3.31

1.2

1.4

0.40

0.45

g/l

0.72

715

Dissociative [conversion] disorders

128

2.13

3.30

1.2

1.3

0.28

0.40

g/l

1.66

Pilonidal cyst

338

1.67

3.27

1.4

1.3

0.46

0.38

g/l

1.02

232

Event of undetermined intent

241

1.80

3.27

1.2

1.3

0.40

0.39

g/l

0.07

169

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

1.77

3.27

1.3

0.35

0.36

g/l

0.05

190

Hypertrophic cardiomyopathy

122

2.15

3.27

1.4

1.3

0.36

0.40

g/l

0.25

Early lumbar disc prolapse, operated

369

1.63

3.26

1.3

0.37

g/l

0.02

244

Amiodarone users

293

1.72

3.26

1.2

1.4

0.42

g/l

0.00

206

Hypertrophy of tongue papillae

3.40

3.24

1.6

1.3

0.53

0.35

g/l

—

Use of memantine

582

0.57

3.23

1.3

0.37

0.47

g/l

1.16

414

Use of other anti-dementia drugs

582

0.57

3.23

1.3

0.37

0.47

g/l

1.16

414

Melanoma in situ

116

2.17

3.23

1.5

1.4

0.36

0.41

g/l

0.25

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

112

766

1.42

3.22

1.3

1.4

0.38

0.39

g/l

0.09

558

L01XX Other antineoplastic agents

143

2.04

3.21

1.2

1.4

0.36

0.41

g/l

0.20

103

Other problems related to primary support group, including family circumstances

514

1.52

3.21

1.4

0.36

0.38

g/l

0.14

370

Primary open-angle glaucoma, strict

118

839

1.41

3.20

1.3

1.4

0.34

0.45

g/l

3.64

576

Ingrowing nail

185

1.91

3.20

1.2

1.3

0.46

0.40

g/l

0.35

129

Cerebrovascular diseases

398

2322

1.21

3.19

1.3

1.4

0.45

0.41

g/l

0.51

293

1587

Dislocation, sprain and strain of joint and ligaments of hip

2.33

3.18

1.1

1.3

0.31

0.39

g/l

0.60

Cauda equina syndrome

3.31

3.16

1.2

1.4

0.31

0.32

g/l

—

Urolithiasis

167

1261

1.33

3.16

1.4

1.3

0.38

0.43

g/l

1.23

114

871

Acute myeloid leukaemia and myelodysplastic syndromes

2.99

3.14

1.5

1.2

0.50

0.37

g/l

—

Impotence

165

1.95

3.14

1.4

1.3

0.35

0.43

g/l

1.11

106

Use of antiglaucoma preparations and miotics

179

1.91

3.14

1.4

1.3

0.33

0.45

g/l

1.53

127

Dronedarone medication

2.56

3.13

1.3

1.1

0.28

0.38

g/l

—

Muscle strain

2.49

3.13

1.2

0.32

0.37

g/l

—

Melanocytic naevi, other sites/unspecified

275

1.72

3.10

1.7

1.4

0.30

0.39

g/l

1.34

192

Acidosis

2.83

3.10

1.1

1.3

0.33

0.44

g/l

—

Embedded teeth, including avohilmo

359

1.62

3.10

1.4

0.42

0.37

g/l

0.55

246

Biguanides

564

2945

1.17

3.09

1.4

0.42

0.40

g/l

0.32

386

2068

IgA nephropathy (IgA glomerulonephritis)

2.53

3.05

1.4

0.56

0.39

g/l

0.71

Other disorders of bone density and structure

2.61

3.05

1.4

1.3

0.41

0.33

g/l

—

N06DA Anticholinesterases

798

0.65

3.05

1.3

1.4

0.43

0.45

g/l

0.22

551

Use of anticholinesterases

798

0.65

3.05

1.3

1.4

0.43

0.45

g/l

0.22

551

Seborrhoeic dermatitis

315

1.66

3.02

1.3

0.46

0.42

g/l

0.31

232

Postmenopausal bleeding

138

536

1.38

3.01

1.3

0.37

0.38

g/l

0.29

367

Dysplasia of cervi uteri

132

697

1.37

3.01

1.3

1.4

0.38

0.40

g/l

0.33

483

Hypertrophic scar

175

1.90

3.00

1.4

1.3

0.33

0.39

g/l

0.54

123

Other secondary gonarthrosis

154

1.96

3.00

1.2

1.5

0.30

0.38

g/l

0.74

108

Exposure to other and unspecified inanimate mechanical forces

278

1.70

2.99

1.4

1.3

0.39

0.38

g/l

0.09

196

Malignant neoplasm of eye, brain and central nervous system

120

2.10

2.99

1.5

1.2

0.35

0.36

g/l

0.03

Other female pelvic inflammatory diseases

628

1.45

2.98

1.2

1.4

0.36

0.40

g/l

0.35

433

Other specified/unspecified hearing loss

241

1.75

2.97

1.6

1.4

0.41

0.43

g/l

0.10

174

Complications of other internal prosthetic devices, implants and grafts

2.25

2.97

1.1

1.3

0.39

0.41

g/l

0.12

Tooth eruption problems

637

1.44

2.96

1.4

0.38

g/l

0.01

456

Oligomenorrhoea

114

2.12

2.95

1.6

1.4

0.27

0.40

g/l

2.07

Gestational [pregnancy-induced] hypertension

152

1143

1.33

2.94

1.6

1.4

0.47

0.38

g/l

0.44

109

808

Benign neoplasm: Skin, unspecified

121

2.08

2.93

1.2

1.4

0.33

0.37

g/l

0.27

Social phobias

318

1.64

2.93

1.5

1.3

0.33

0.40

g/l

1.13

211

Salpingitis and oophoritis

103

730

1.42

2.93

1.4

0.32

0.39

g/l

2.10

508

2.34

2.92

1.8

1.3

0.42

0.33

g/l

0.79

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

171

1312

1.31

2.92

1.2

1.3

0.39

g/l

0.03

127

911

Diseases of male genital organs

297

1214

1.24

2.92

1.3

1.4

0.36

0.41

g/l

2.11

202

825

Aortic valve malfunction, age under 60 years

373

1.59

2.91

1.6

1.3

0.39

0.38

g/l

0.06

261

Kyphosis

3.49

2.91

1.2

1.3

0.42

0.53

g/l

—

Unstable angina pectoris

161

963

1.32

2.89

1.4

0.45

0.43

g/l

0.27

124

623

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

340

2230

1.21

2.88

1.4

0.38

0.40

g/l

0.69

230

1602

Allergic contact dermatitis due to drugs in contact with skin

2.53

2.88

1.3

0.39

0.35

g/l

—

Dilated cardiomyopathy

390

1.57

2.87

1.4

1.3

0.51

0.41

g/l

1.05

269

Discitis, unspecified

3.20

2.86

1.5

1.3

0.58

0.47

g/l

—

Diabetic retinopathy, excluding more controls

144

599

1.35

2.84

1.4

0.44

0.41

g/l

0.31

382

Medicines for HER+ breast cancer

116

1496

0.73

2.84

1.2

1.4

0.41

0.39

g/l

0.21

1066

Other benign neoplasms of skin

197

1546

1.28

2.84

1.6

1.3

0.37

0.42

g/l

1.00

140

1066

Malignant neoplasm of endocrine gland

245

1.72

2.83

1.7

1.4

0.33

0.38

g/l

0.46

171

Use of donepezil

473

0.52

2.83

1.3

1.2

0.44

0.48

g/l

0.17

341

Unspecified privation

384

1.57

2.82

1.7

1.4

0.32

0.39

g/l

1.33

269

Malignant neoplasm of breast, including Hilmo

149

1271

0.76

2.82

1.1

1.4

0.44

0.39

g/l

0.54

916

Malignant neoplasm of breast, HER2-negative, including Hilmo

149

1271

0.76

2.82

1.1

1.4

0.44

0.39

g/l

0.54

916

Inflammatory disease of uterus

586

1.46

2.82

1.4

1.3

0.34

0.38

g/l

0.65

405

Transport accidents

272

1903

1.23

2.81

1.5

1.3

0.37

0.41

g/l

1.34

190

1337

Glucagon-like peptide-1 (GLP-1) analogues

163

1250

1.31

2.81

1.2

1.4

0.39

0.41

g/l

0.32

117

867

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

163

1250

1.31

2.81

1.2

1.4

0.39

0.41

g/l

0.32

117

867

Dermatophytosis

342

2848

1.20

2.81

1.4

0.39

0.40

g/l

0.26

234

1993

Injuries to unspecified part of trunk, limb or body region

361

1.59

2.80

1.6

1.3

0.36

0.41

g/l

0.64

255

Contraceptive management

259

1466

1.24

2.80

1.3

1.4

0.37

0.39

g/l

0.29

185

1031

535

1.46

2.80

1.3

0.41

0.48

g/l

0.63

381

Hypoglycaemia, other or unspecified

216

1.77

2.80

2.0

1.3

0.34

0.38

g/l

0.62

147

Other chondrocalcinosis

3.63

2.80

1.9

1.2

0.36

0.45

g/l

—

Statin medication

433

2061

1.18

2.77

1.4

0.38

0.40

g/l

0.38

298

1411

Other predominantly sexually transmitted diseases, not elsewhere classified

128

951

1.35

2.76

1.2

1.4

0.36

0.38

g/l

0.28

658

Unspecified event, undetermined intent

2.33

2.75

1.4

1.3

0.34

0.36

g/l

0.11

Embedded and impacted teeth

168

1069

1.30

2.72

1.3

0.43

0.37

g/l

1.52

133

741

Pain associated with micturition

404

1.54

2.71

1.3

1.4

0.58

0.41

g/l

0.30

283

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

0.75

0.42

g/l

—

Malignant neoplasm of breast, HER-positive

1060

0.72

2.69

1.2

1.4

0.40

g/l

0.00

764

Impacted teeth

122

802

1.36

2.69

1.3

0.42

0.38

g/l

0.53

552

Retinal vascular occlusion

318

1.61

2.68

1.2

1.3

0.37

0.44

g/l

1.07

222

Other disorders starting during childhood or adolescence

247

1.70

2.67

1.3

1.4

0.36

g/l

0.01

189

Sub-endpoint used in defining T1D endpoints

162

1230

1.30

2.67

1.4

1.3

0.39

0.40

g/l

0.06

113

861

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

126

2.00

2.66

1.4

1.3

0.34

0.38

g/l

0.43

Other congenital malformations of skin

140

1.94

2.66

1.3

0.44

0.39

g/l

0.37

104

Malignant neoplasm of digestive organs

181

1116

1.28

2.65

1.3

1.4

0.44

0.43

g/l

0.10

113

779

Corns and callosities

198

1.78

2.64

1.2

1.4

0.46

0.42

g/l

0.36

140

Obsessive-compulsive disorder

228

1.72

2.63

1.4

1.3

0.35

0.38

g/l

0.36

151

Disorders of breast

279

2084

1.22

2.62

1.5

1.4

0.37

0.40

g/l

0.65

205

1470

119

766

1.36

2.61

1.2

1.4

0.41

0.46

g/l

0.59

535

Hyperprolactinaemia

120

2.02

2.61

1.3

1.2

0.31

0.37

g/l

0.51

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

0.43

0.38

g/l

0.30

101

Crossbite

296

1.60

2.60

1.3

1.4

0.47

0.35

g/l

1.44

228

Malignant neoplasm of thyroid gland

229

1.71

2.59

1.8

1.4

0.33

0.38

g/l

0.47

159

Familial hypercholesterolemia, with ischemic heart disease

229

1.71

2.59

1.5

1.2

0.34

0.45

g/l

1.73

163

Dislocation, sprain and strain of joints and ligaments at neck level

647

1.41

2.59

1.5

1.4

0.34

0.38

g/l

0.67

436

Disorders of speech understanding and production

174

1.82

2.58

1.4

1.3

0.40

0.38

g/l

0.11

137

Retinal vascular disorders

322

1.59

2.56

1.2

1.3

0.37

0.44

g/l

1.04

225

Malignant neoplasm of breast, ER-positive, including Hilmo

102

1075

0.73

2.56

1.2

1.4

0.42

0.40

g/l

0.19

774

Mental and behavioural disorders due to opioids

135

1.94

2.56

1.3

0.47

0.34

g/l

0.86

Other and unspecified trigeminal disorders

2.89

2.56

1.2

1.5

0.30

0.32

g/l

—

Other appendicitis

307

1.60

2.55

1.2

1.4

0.33

0.38

g/l

0.73

209

Suicide or other Intentional self-harm

143

1094

1.31

2.55

1.3

0.35

0.39

g/l

0.95

757

Secondary polycythaemia

2.44

2.55

1.5

1.3

0.37

0.33

g/l

—

Other noninflammatory disorders of vagina

261

1.66

2.54

1.3

0.37

0.41

g/l

0.25

175

Prolonged pregnancy

636

0.63

2.53

1.2

1.4

0.38

0.35

g/l

0.24

452

Palmar fascial fibromatosis [Dupuytren]

427

1.50

2.53

1.4

1.3

0.55

0.47

g/l

0.29

292

Status post-ami

106

589

1.37

2.51

1.2

1.3

0.44

g/l

0.10

393

Chalazion

412

1.51

2.50

1.7

1.4

0.36

0.40

g/l

0.54

285

Pregnancy hypertension

240

1752

1.23

2.50

1.5

1.4

0.44

0.39

g/l

0.41

174

1251

Other predominantly sexually transmitted diseases, not elsewhere classified

107

787

1.36

2.50

1.2

1.4

0.36

0.38

g/l

0.31

541

Major anomalies of jaw size

2.13

2.50

1.4

1.3

0.37

0.35

g/l

0.09

Specific development disorders of scholastic skills

199

1.75

2.49

1.4

1.3

0.30

0.38

g/l

1.02

144

Any dementia

868

0.72

2.48

1.2

1.4

0.43

0.45

g/l

0.20

600

Congenital malformations of eye, ear, face and neck

255

1.66

2.48

1.3

0.43

0.39

g/l

0.25

176

Other otitis externa (chronic)

217

1.71

2.48

1.4

1.3

0.35

0.38

g/l

0.29

158

Superficial injury of forearm

381

1.53

2.47

1.4

0.37

0.38

g/l

0.03

265

Dislocation, sprain and strain of joints and ligaments of head

151

1.87

2.47

1.5

1.3

0.42

0.40

g/l

0.08

104

Alzheimer’s disease, strict definition

525

0.61

2.47

1.1

1.3

0.48

0.47

g/l

0.04

373

Benign neoplasm: Skin of trunk

130

1.94

2.46

2.1

1.3

0.37

0.38

g/l

0.06

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.15

2.45

1.2

1.3

0.35

g/l

0.01

Benign neoplasm of meninges

334

1.56

2.45

1.6

1.4

0.34

0.40

g/l

1.03

229

Acute nephritic syndrome

2.57

2.45

1.2

0.32

0.41

g/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

225

1820

1.23

2.45

1.4

1.3

0.42

0.38

g/l

0.24

172

1261

Malignant neoplasm of small intestine, including Hilmo

2.26

2.45

1.1

1.4

0.39

0.37

g/l

—

Gonarthrosis, primary, with knee surgery

285

1883

1.21

2.45

1.4

0.43

0.41

g/l

0.30

199

1314

Necrosis of pulp, including avohilmo

342

2885

1.18

2.44

1.4

0.40

g/l

0.03

229

2020

Cystic kidney disease

2.10

2.43

1.3

0.49

0.41

g/l

0.37

Malignant neoplasm of thyroid gland, including Hilmo

272

1.63

2.43

1.8

1.4

0.32

0.38

g/l

0.54

192

Type 1 diabetes, wide definition

126

954

1.32

2.42

1.4

1.3

0.37

0.38

g/l

0.14

679

Benign neoplasm: Skin of eyelid, including canthus

547

1.43

2.41

1.7

1.4

0.36

0.40

g/l

0.61

381

Injury of unspecified body region

242

1.66

2.40

1.5

1.3

0.34

0.40

g/l

0.58

170

Effects of foreign body entering through natural orifice

138

1061

1.30

2.40

1.3

1.4

0.39

0.40

g/l

0.12

725

L02BG Aromatase inhibitors

1233

0.73

2.39

1.2

1.4

0.42

0.39

g/l

0.33

864

Residual foreign body in soft tissue

160

1.82

2.39

1.4

1.3

0.30

0.39

g/l

1.11

106

Thyrotoxicosis with diffuse goitre

540

1.43

2.39

1.5

1.3

0.33

0.39

g/l

0.93

376

Emotional disorders and disorders of social functioning with onset specific to childhood

201

1.72

2.39

1.4

0.33

0.37

g/l

0.51

147

Stroke, excluding SAH

295

1796

1.20

2.38

1.3

1.4

0.48

0.42

g/l

0.53

218

1225

Contusion of other and unspecified parts of foot

175

1.78

2.38

1.2

1.3

0.35

0.36

g/l

0.08

117

Congenital malformations of the circulatory system

630

1.39

2.37

1.6

1.4

0.37

0.40

g/l

0.32

458

Superficial injury of head

123

932

1.32

2.37

1.6

1.3

0.36

0.40

g/l

0.98

100

641

Papillary adenocarcinoma of thyroid gland

168

1.80

2.37

2.0

1.5

0.34

0.38

g/l

0.21

119

Foreign body in respiratory tract

168

1.80

2.37

1.5

1.4

0.55

0.38

g/l

0.90

119

Coxarthrosis, primary

290

2050

1.20

2.36

1.3

1.4

0.45

0.42

g/l

0.65

232

1412

Malignant neoplasm of bronchus and lung, including Hilmo

549

1.39

2.36

1.2

1.5

0.52

0.43

g/l

1.06

392

Alcohol abuse, main dg

643

1.39

2.34

1.3

0.39

g/l

0.03

435

Hallux rigidus

435

1.48

2.34

1.4

1.5

0.39

0.43

g/l

0.42

302

Presence of other devices

104

768

1.35

2.32

1.3

1.4

0.37

0.45

g/l

1.81

561

Congenital malformations of ovaries, fallopian tubes and broad ligaments

214

1.69

2.32

1.2

1.4

0.37

0.39

g/l

0.13

151

Urethral stricture

140

1.87

2.32

1.2

0.44

0.43

g/l

0.06

100

Disturbances of smell and taste

119

1.95

2.31

1.3

1.6

0.35

g/l

0.02

Certain conditions originating in the perinatal period

350

1.50

2.30

1.3

0.38

0.37

g/l

0.15

259

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

177

1.76

2.30

2.2

1.5

0.33

0.40

g/l

0.60

124

Personal history of other diseases and conditions

484

1.45

2.30

1.5

1.4

0.34

0.40

g/l

0.68

358

Other menopausal disorders

147

639

1.30

2.30

1.8

1.4

0.38

0.39

g/l

0.04

104

440

Other disorders of veins

214

1734

1.23

2.29

1.3

1.4

0.34

0.40

g/l

2.24

143

1231

Injury of muscle and tendon at shoulder and upper arm level

178

1423

1.25

2.28

1.4

0.42

g/l

0.11

122

983

Other specified disorders of kidney and ureter

2.08

2.27

1.5

1.3

0.37

0.42

g/l

0.25

All dysplastic lesions of the vagina

2.17

2.25

1.5

1.4

0.44

0.34

g/l

0.29

Primary hyperparathyroidism

358

1.51

2.24

1.6

1.4

0.34

0.40

g/l

0.61

245

Degenerative macular diseases

318

1.55

2.23

1.4

1.3

0.41

0.43

g/l

0.12

223

Use of glatiramer acetate

2.36

2.23

1.4

0.36

0.33

g/l

—

Biomechanical lesions, not elsewhere classified

135

1.86

2.22

1.2

1.4

0.38

g/l

0.02

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

240

1.63

2.22

1.4

1.3

0.39

0.37

g/l

0.12

166

Periodontal disease, other/unspecified

2.21

1.3

0.29

0.39

g/l

—

Hypertrophy of breast

102

761

1.34

2.21

1.5

1.3

0.35

0.38

g/l

0.45

529

Other abnormal findings in urine

2.89

2.21

1.5

1.2

0.18

0.46

g/l

—

Benign neoplasm: Cerebral meninges

303

1.56

2.21

1.7

1.4

0.34

0.41

g/l

0.95

210

Meralgia paraesthetica

100

2.02

2.21

1.6

1.4

0.34

0.37

g/l

0.13

Cystic kidney disease

100

2.02

2.21

1.3

0.49

0.40

g/l

0.39

Other symptoms and signs involving the urinary system

335

1.53

2.21

1.5

1.3

0.32

0.41

g/l

1.37

232

Benign neoplasm: Long bones of lower limb

107

1.98

2.21

1.9

1.4

0.27

0.31

g/l

0.28

Other/unspecified disorders of vestibular function

114

1.94

2.21

1.1

1.4

0.34

0.41

g/l

0.57

Alcohol use disorder, ICD-based

222

1826

1.22

2.19

1.2

1.4

0.41

g/l

0.01

138

1259

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

100

746

1.34

2.18

1.3

1.4

0.33

0.38

g/l

0.76

503

Blepharochalasis

135

1051

1.29

2.17

1.5

1.4

0.40

0.42

g/l

0.32

735

Endometriosis of ovary

628

1.37

2.16

1.3

1.4

0.41

0.40

g/l

0.06

431

Cyst of kidney

196

1.69

2.15

1.5

1.4

0.39

0.41

g/l

0.16

133

Amputation

250

1.60

2.14

1.3

1.2

0.56

0.43

g/l

1.00

175

Arthropod-borne viral fevers and viral haemorrhagic fevers

330

1.52

2.13

1.4

1.3

0.39

0.40

g/l

0.17

231

Open wound of wrist and hand

256

2092

1.20

2.13

1.3

1.4

0.39

0.40

g/l

0.20

187

1442

Benign neoplasm: Choroid

174

1.73

2.13

1.2

1.5

0.33

0.39

g/l

0.53

120

Other noninflammatory disorders of uterus, except cervix

105

529

1.34

2.13

1.5

1.4

0.46

0.39

g/l

0.69

362

Autism spe, excluding more controls

2.12

2.13

1.4

0.24

0.35

g/l

—

Any event in cancer register

554

2879

1.13

2.13

1.3

1.4

0.41

0.40

g/l

0.21

371

2037

Other and unspecified mood [affective] disorders

259

1.59

2.12

1.2

1.4

0.30

0.38

g/l

1.05

177

Short stature starting before birth

2.82

2.11

1.4

1.2

0.46

0.43

g/l

—

Family history of other conditions

2.48

2.11

1.1

1.3

0.41

0.37

g/l

—

Infective bursitis

2.22

2.11

1.3

0.25

0.39

g/l

—

Sixth [abducent] nerve palsy

2.02

2.11

1.6

1.3

0.29

0.41

g/l

1.18

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

0.34

0.33

g/l

—

Myeloproliferative diseases

236

1.62

2.10

1.2

1.4

0.39

0.42

g/l

0.14

163

Varicose veins

315

2023

1.18

2.09

1.5

1.4

0.38

0.42

g/l

0.89

211

1435

Other conjunctival vascular disorders and cysts

2.28

2.08

1.6

1.2

0.37

0.39

g/l

—

UC patients in KELA-register (code 208), prior to 1994

131

1.84

2.08

1.6

1.3

0.27

0.35

g/l

0.81

Malignant neoplasm of respiratory system and intrathoracic organs

538

1.36

2.07

1.2

1.5

0.46

0.44

g/l

0.19

381

Other eating disorders

191

1.68

2.06

1.2

1.4

0.34

0.37

g/l

0.27

126

Other puerperal infections

333

1.51

2.06

1.5

1.4

0.30

0.38

g/l

1.73

233

Sequelae of other external causes

176

1.71

2.06

1.6

1.3

0.40

0.38

g/l

0.15

124

Inflammatory diseases of prostate (prostatitis)

415

1.45

2.05

1.2

1.4

0.31

0.46

g/l

4.80

278

Other strabismus

127

986

1.29

2.05

1.6

1.3

0.42

0.38

g/l

0.56

689

Pustular psoriasis

154

1.76

2.04

1.2

1.5

0.43

0.35

g/l

0.64

105

Ischaemic Stroke, excluding all haemorrhages

269

1684

1.19

2.04

1.3

1.4

0.49

0.43

g/l

0.52

195

1150

Other benign neoplasms of connective and other soft tissue

342

1.50

2.03

1.5

1.4

0.35

0.40

g/l

0.39

238

Mental and behavioural disorders due to sedatives or hypnotics

254

1.58

2.03

1.3

1.4

0.37

0.38

g/l

0.09

180

Transient ischemic attack

249

1686

1.20

2.03

1.4

0.41

0.42

g/l

0.18

175

1160

Background retinopathy and retinal vascular changes

2.42

2.03

1.3

1.2

0.42

0.36

g/l

—

Other congenital malformations of circulatory system

2.12

2.03

2.6

1.3

0.44

0.32

g/l

—

Emotionally unstable personality disorder

533

1.39

2.03

1.3

1.4

0.40

0.38

g/l

0.18

364

Bicipital tendinitis

125

1.85

2.02

1.3

0.39

0.37

g/l

0.11

Somnolence, stupor and coma

118

1.87

2.02

1.3

1.4

0.41

g/l

0.02

Specific development disorders of speech and language

245

1.58

2.01

1.4

1.3

0.42

0.36

g/l

0.52

185

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

0.37

g/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.01

1.5

1.3

0.29

0.36

g/l

1.29

112

Psoriasis (vulgaris), strict definition

2.01

1.1

1.3

0.40

0.35

g/l

0.34

Wet age-related macular degeneration

412

1.44

2.00

1.2

1.4

0.44

0.47

g/l

0.11

304

Lesion of sciatic nerve

2.01

2.00

1.3

0.46

0.42

g/l

0.18

Fracture of femur

108

748

1.31

2.00

1.4

0.50

0.44

g/l

0.66

525

Pustulosis palmaris et plantaris

133

1.82

2.00

1.1

1.5

0.40

0.36

g/l

0.24

Scabies

163

1.73

1.98

1.7

1.3

0.44

0.37

g/l

0.62

110

Viral haemorrhagic fevers, not elsewhere classified/unspecified

256

1.57

1.98

1.4

1.3

0.37

0.40

g/l

0.18

176

Glucosamine medication

224

1486

1.20

1.97

1.3

1.4

0.42

g/l

0.04

152

1042

Peripheral arterial reconstruction

477

1.41

1.97

1.2

1.4

0.48

0.46

g/l

0.14

339

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

163

1.72

1.97

1.5

1.4

0.51

0.42

g/l

0.36

116

Contact with other hot fluids

105

1.92

1.96

1.5

1.3

0.37

0.38

g/l

0.05

Benign neoplasm of bone and articular cartilage

321

1.50

1.95

2.0

1.4

0.28

0.37

g/l

1.75

223

Atlantoaxial subluxation

3.81

1.94

1.2

1.6

0.31

0.35

g/l

—

Astigmatism

249

1.57

1.94

1.2

1.4

0.43

0.37

g/l

0.58

177

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

0.36

0.29

g/l

—

Behavioural disorders, excluding more controls

2.20

1.94

1.3

0.38

0.37

g/l

—

Peripheral artery operations in Hilmo

330

1.49

1.92

1.3

0.56

0.43

g/l

1.05

231

Congenital malformations of genital organs

427

1.43

1.92

1.2

1.4

0.36

0.38

g/l

0.25

313

Stroke, including SAH

313

1946

1.17

1.92

1.2

1.4

0.47

0.42

g/l

0.46

232

1324

Malignant neoplasm, without specification of site, including Hilmo

1.93

1.90

1.4

0.52

0.39

g/l

0.55

Unspecified urinary incontinence

267

1.54

1.89

1.4

0.35

0.42

g/l

0.64

184

Other disorders of pigmentation

121

1.83

1.88

1.4

0.45

0.40

g/l

0.30

Medical abortion

361

1694

1.16

1.88

1.3

1.4

0.41

0.38

g/l

0.81

251

1206

Impacted maxillary molar

220

1.60

1.88

1.5

1.4

0.42

0.36

g/l

0.44

147

Arthropod-borne viral fevers and viral haemorrhagic fevers

749

1.31

1.85

1.4

1.3

0.38

0.40

g/l

0.39

526

Melanocytic naevi of lower limb, including hip

144

1.75

1.85

1.5

1.3

0.25

0.39

g/l

2.20

Mental and behavioural disorders due to alcohol, excluding acute intoxication

234

1963

1.19

1.84

1.2

1.4

0.41

g/l

0.08

145

1355

Implicit parasitic Sepsis

4.25

1.83

1.6

1.2

0.34

0.28

g/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

112

874

1.28

1.82

1.8

1.4

0.32

0.40

g/l

2.36

599

Exposure to other and unspecified animate mechanical forces

101

1.89

1.81

1.2

1.3

0.38

0.39

g/l

0.04

Lesion of femoral nerve

3.09

1.81

1.1

1.4

0.46

0.27

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

233

1330

1.19

1.79

1.6

1.4

0.38

0.42

g/l

1.00

162

940

Brain meningioma, including Hilmo

154

1.70

1.76

1.5

0.30

0.36

g/l

0.74

107

Other salmonella infections

124

1.78

1.76

1.6

1.3

0.50

0.34

g/l

0.59

Disorder of external ear, unspecified

1.94

1.75

1.6

1.3

0.49

0.33

g/l

—

Carcinoma in situ of skin of other and unspecified parts of face

185

1.63

1.75

1.2

1.3

0.48

0.42

g/l

0.21

139

Haemangioma, any site

305

1.48

1.75

1.6

1.3

0.40

g/l

0.02

209

Arterial embolism and thrombosis of lower extremity artery

2.04

1.75

1.1

1.2

0.37

0.45

g/l

—

Cysts of oral region, not elsewhere classified

193

1.61

1.75

1.8

1.4

0.31

0.38

g/l

0.92

135

Haemangioma and lymphangioma, any site

338

1.46

1.74

1.5

1.4

0.39

0.40

g/l

0.02

237

Malignant neoplasm of small intestine

2.24

1.74

1.1

1.2

0.36

0.40

g/l

—

!Aliquae complicationes praecoces traumatis

132

1.75

1.74

1.4

1.3

0.35

0.40

g/l

0.35

Early complications of trauma

132

1.75

1.74

1.4

1.3

0.35

0.40

g/l

0.35

Cerebral aneurysm, nonruptured

314

1.47

1.73

1.3

1.4

0.40

0.39

g/l

0.08

213

Female infertility, associated with anovulation

314

1.47

1.73

1.5

0.33

0.39

g/l

1.23

216

Endometriosis ASRM stages 3,4

122

970

1.26

1.73

1.3

1.4

0.38

0.37

g/l

0.09

668

Glaucoma, exfoliation

225

1.56

1.72

1.3

0.35

0.45

g/l

1.25

167

Essential (haemorrhagic) thrombocythaemia

103

1.86

1.72

1.1

1.4

0.34

0.36

g/l

—

Maltreatment syndromes

194

1.61

1.71

1.2

1.3

0.44

0.34

g/l

0.84

138

Parkinson's disease

446

0.63

1.71

1.3

0.33

0.45

g/l

1.24

313

Fracture of lower leg, including ankle

296

2534

1.16

1.71

1.5

1.3

0.42

0.41

g/l

0.19

216

1753

Congenital ovarian cysts

171

1.65

1.71

1.3

1.4

0.35

0.38

g/l

0.18

121

Myeloproliferative diseases (CML excluded)

210

1.58

1.70

1.1

1.4

0.41

0.42

g/l

0.03

143

Acute alcohol intoxication, ICD10

106

830

1.28

1.70

1.4

0.42

0.39

g/l

0.33

571

Other and unspecified injuries of ankle and foot

133

1.74

1.70

1.8

1.2

0.42

0.37

g/l

0.24

Other congenital malformations of skin

299

1.48

1.70

1.3

0.41

0.39

g/l

0.16

210

Varicella [chickenpox]

187

1.61

1.69

1.2

1.3

0.26

0.38

g/l

1.40

130

Fracture of neck

156

1.67

1.69

1.0

1.3

0.31

0.44

g/l

1.47

109

Any dementia, excluding more controls

773

0.76

1.69

1.2

1.4

0.43

0.46

g/l

0.25

531

Single spontaneous delivery

152

987

0.81

1.69

1.4

0.35

0.39

g/l

0.75

731

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

275

1.50

1.68

1.3

1.4

0.41

0.38

g/l

0.25

190

Fall on same level involving ice and snow

312

2714

1.15

1.68

1.5

1.4

0.39

0.40

g/l

0.26

216

1900

Ménière disease

308

1.47

1.68

1.5

1.4

0.39

0.40

g/l

0.11

215

Bursitis of shoulder

2.20

1.68

1.4

1.5

0.44

0.32

g/l

—

Congenital lens malformations

3.23

1.67

1.2

1.4

0.32

0.31

g/l

—

Whooping cough

2.53

1.67

1.2

0.44

0.33

g/l

—

Additional codes for the location of defect, injury or illness

180

1.62

1.66

1.2

1.3

0.35

0.38

g/l

0.20

125

Open wound of abdomen, lower back and pelvis

1.87

1.66

1.1

1.2

0.42

0.37

g/l

0.31

Eating disorders

442

1.38

1.66

1.2

1.4

0.46

0.40

g/l

0.24

306

Other salmonella infections

1.90

1.65

1.4

1.3

0.59

0.33

g/l

0.76

Postprocedural musculoskeletal disorders, not elsewhere classified

212

1.56

1.65

1.5

0.30

0.40

g/l

1.14

146

Other superficial mycoses

401

1.40

1.65

1.2

1.4

0.32

0.37

g/l

0.81

276

Injuries to the elbow and forearm

402

3129

1.13

1.64

1.4

0.41

0.40

g/l

0.17

284

2201

Benign neoplasm of urinary organs

127

1.74

1.64

1.2

1.4

0.33

0.36

g/l

0.25

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

150

1.68

1.63

1.6

1.3

0.35

0.34

g/l

0.12

113

Laparoscopic right hemicolectomy

150

1.67

1.63

1.2

1.3

0.53

0.44

g/l

0.24

105

Benign lipomatous neoplasm

146

1195

1.22

1.61

1.3

1.4

0.41

0.40

g/l

0.14

833

Diabetic nephropathy, excluding more controls

442

1.34

1.61

1.4

1.5

0.43

0.41

g/l

0.22

279

Coxarthrosis, primary, with hip surgery

215

1706

1.18

1.61

1.3

1.4

0.47

0.42

g/l

0.77

170

1170

Sequelae of injuries of upper limb

378

1.41

1.60

1.2

1.4

0.34

0.37

g/l

0.25

267

Female infertility, tubal origin

182

1.60

1.1

1.4

0.38

0.37

g/l

0.03

132

Viral haemorrhagic fevers, not elsewhere classified/unspecified

653

1.30

1.59

1.4

0.38

0.41

g/l

0.38

468

Other and unspecified mononeuropathies of lower limb

2.01

1.59

1.2

1.3

0.52

0.40

g/l

—

Retinal detachments and breaks

163

1351

1.21

1.59

1.6

1.4

0.35

0.43

g/l

2.54

117

945

Hypermetropia

279

1.47

1.58

1.5

1.4

0.42

0.36

g/l

0.39

204

Alzheimer’s disease (Late onset)

468

0.68

1.57

1.1

1.3

0.48

g/l

0.01

331

Vitreous haemorrhage

314

1.44

1.54

1.6

1.4

0.34

0.40

g/l

0.73

219

Amputation of toe

184

1.58

1.54

1.1

1.3

0.55

0.42

g/l

0.65

125

Anomalies of dental arch relationship, including avohilmo

117

847

1.25

1.54

1.3

1.4

0.40

0.38

g/l

0.36

592

Bitten or struck by other mammals

467

1.35

1.53

1.4

0.45

0.38

g/l

0.62

322

Parkinson's disease, strict definition

396

0.63

1.53

1.3

0.33

0.44

g/l

1.02

277

Nontoxic multinodular goitre

685

1.29

1.52

1.5

1.3

0.42

g/l

0.04

475

Hydatidiform mole

0.00

1.52

0.0

1.5

—

0.35

—

Sequelae of cerebrovascular disease

153

1092

1.21

1.51

1.2

1.4

0.43

g/l

0.05

115

739

Superficial injury of thorax

546

1.32

1.50

1.5

1.3

0.42

0.40

g/l

0.18

383

Diffuse brain injury

1.91

1.49

1.1

1.4

0.35

0.39

g/l

—

Preterm labour and delivery

139

1143

1.22

1.49

1.4

0.45

0.37

g/l

0.73

815

Insulin, fast-acting (human)

547

1.32

1.49

1.3

0.37

0.38

g/l

0.07

373

Endometriosis diagnosis and infertility diagnosis occurring together

478

1.34

1.49

1.4

0.43

0.38

g/l

0.20

327

Benign neoplasm of ovary

635

1.29

1.48

1.2

1.4

0.34

0.39

g/l

1.30

442

Primary gonarthrosis, bilateral

242

1789

1.16

1.47

1.3

1.4

0.43

0.42

g/l

0.16

181

1246

LSIL lesion of the cervix uteri, vagina or vulva

628

1.29

1.45

1.3

1.4

0.38

0.37

g/l

0.04

429

Fracture of shoulder and upper arm

179

1511

1.18

1.44

1.5

1.3

0.40

0.41

g/l

0.15

129

1046

Conductive hearing loss, unspecified

277

1.45

1.44

1.3

0.41

g/l

0.03

198

Retinal haemorrhage

1.98

1.44

1.5

1.3

0.23

0.41

g/l

—

Open wound of forearm

336

1.40

1.43

1.3

0.54

0.41

g/l

0.85

232

Outcome of delivery

482

0.74

1.43

1.2

1.4

0.35

0.34

g/l

0.14

349

Other malignant neoplasms of skin (=non-melanoma skin cancer)

208

1217

1.17

1.43

1.6

1.4

0.39

0.42

g/l

0.67

145

855

Contusion of ankle

133

1.66

1.42

1.5

1.3

0.51

0.38

g/l

0.36

Alzheimer disease, excluding more controls

337

0.68

1.42

1.3

1.5

0.42

0.46

g/l

0.22

221

Entropion and trichiasis of eyelid

180

1.56

1.42

1.5

1.3

0.36

0.46

g/l

0.62

129

Impacted cerumen

303

1.42

1.4

0.43

0.42

g/l

0.03

214

Malignant neoplasm of prostate, including Hilmo

611

0.78

1.41

1.1

1.4

0.50

0.45

g/l

0.54

426

Brain meningioma

149

1.62

1.41

1.5

0.30

0.36

g/l

0.57

104

Wide developmental disorders, excluding more controls

124

1.68

1.40

1.3

0.27

0.38

g/l

2.05

Mental disorders, not otherwise specified

321

1.41

1.39

1.3

1.4

0.31

0.36

g/l

0.97

225

Sequelae of infectious and parasitic diseases

255

1.46

1.38

1.4

1.3

0.36

0.38

g/l

0.18

175

Persistent delusional disorders

249

0.56

1.37

1.1

1.4

0.30

0.38

g/l

—

169

Separation of retinal layers (serosa)

127

1.66

1.37

2.4

1.2

0.46

0.36

g/l

0.63

malignant neoplasm of male genital organs

629

0.78

1.36

1.3

1.4

0.49

0.45

g/l

0.38

437

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

135

1.64

1.36

1.2

1.4

0.44

0.36

g/l

0.36

Adenomyosis (Endometriosis of uterus)

477

1.32

1.36

1.2

1.4

0.41

0.39

g/l

0.19

326

Benign neoplasm: Adrenal gland

248

1.46

1.35

1.2

1.4

0.28

0.38

g/l

1.70

171

Fitting and adjustment of other devices

155

1175

1.19

1.35

1.4

0.34

0.44

g/l

4.51

130

814

Calcific tendinitis of shoulder

175

1.55

1.34

1.1

1.4

0.37

g/l

0.00

116

Complications predominantly related to the puerperium

144

1204

1.20

1.34

1.5

1.4

0.34

0.39

g/l

1.15

107

849

Primary coxarthrosis, bilateral

123

1013

1.22

1.33

1.4

0.45

0.43

g/l

0.20

100

686

Use of interferon beta-1a

1.79

1.33

1.4

0.34

0.33

g/l

—

Other and unspecified injuries of shoulder and upper arm

1.79

1.33

1.2

0.35

0.34

g/l

0.04

Benign neoplasm: Kidney

1.79

1.33

1.3

1.4

0.26

0.38

g/l

—

Other lesions of median nerve

1.98

1.33

1.1

1.3

0.26

0.43

g/l

—

Recurrent dislocation and subluxation of joint

249

1.45

1.32

1.3

1.4

0.35

0.39

g/l

0.28

164

Anorexia (incl.atypical)

216

1.49

1.32

1.1

1.4

0.56

0.40

g/l

0.37

139

Carcinoma in situ of breast, intraductal

308

0.61

1.32

1.2

1.4

0.57

0.37

g/l

0.41

214

Other vitreous opacities

113

1.69

1.32

1.4

1.3

0.39

0.36

g/l

0.12

Cicatricial alopecia [scarring hair loss]

2.53

1.31

1.7

1.4

0.35

0.28

g/l

—

Malignant neoplasm of oral cavity, including Hilmo

121

1.66

1.30

1.2

1.3

0.44

0.37

g/l

0.40

Delivery

158

988

0.84

1.30

1.4

0.37

0.39

g/l

0.25

731

Benign mammary dysplasia

516

1.30

1.29

1.5

1.4

0.42

0.40

g/l

0.13

350

Amblyopia ex anopsia

145

1.59

1.29

1.2

1.3

0.47

0.36

g/l

0.77

110

Granulomatous disorders of skin and subcutaneous tissue

1.90

1.29

1.6

1.2

0.41

0.42

g/l

—

Delivery, wide proxy

123

791

0.82

1.28

1.4

0.35

0.37

g/l

0.24

571

L02BB Anti-androgens

231

0.56

1.28

2.2

1.2

0.51

0.48

g/l

—

166

Eating disorder

378

1.35

1.27

1.2

1.4

0.31

0.40

g/l

1.59

266

Diabetic retinopathy

171

905

1.18

1.27

1.5

1.4

0.42

g/l

0.04

101

602

Infectious mononucleosis

345

1.37

1.26

2.1

1.4

0.38

g/l

0.00

234

Conduct disorder

1.83

1.26

1.3

0.38

0.35

g/l

—

Pedestrian injured in transport accident

219

1.47

1.25

1.2

1.3

0.41

0.40

g/l

0.04

149

False labour

174

925

1.17

1.24

1.3

1.4

0.37

0.36

g/l

0.04

120

665

Congenital cataract

2.68

1.22

1.0

1.4

0.31

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

0.29

0.37

g/l

—

Exposure to other and unspecified forces of nature

2.67

1.22

2.0

1.1

0.20

0.42

g/l

—

Other disorders of cornea

313

1.38

1.22

1.1

1.4

0.35

0.39

g/l

0.26

218

Pediculosis, acariasis and other infestations

726

1.24

1.21

1.5

1.4

0.40

0.39

g/l

0.16

508

Oral leukoplakia, including avohilmo

1.81

1.21

1.4

1.3

0.47

0.39

g/l

—

Sequelae of injuries of head

180

1.51

1.21

1.5

1.3

0.38

0.37

g/l

0.02

122

Pregnancy with abortive outcome

364

1703

1.12

1.21

1.3

1.4

0.42

0.38

g/l

0.81

251

1212

Left bundle-branch block

180

1.50

1.20

1.4

1.3

0.39

0.38

g/l

0.03

124

Lichen sclerosus et atrophicus

348

1.35

1.20

1.6

1.4

0.37

0.40

g/l

0.22

239

Acute alcohol intoxication

124

1035

1.20

1.4

0.43

0.41

g/l

0.20

720

Myocardial infarction, with ST-elevation

531

1.28

1.20

1.2

1.4

0.40

0.45

g/l

0.91

371

Vestibular neuronitis

297

1.38

1.20

1.3

1.4

0.43

0.41

g/l

0.10

213

Non-small cell lung cancer, adenocarcinoma

148

1.56

1.20

1.1

1.4

0.42

0.39

g/l

0.15

109

Parkinson's disease, including avohilmo

466

0.71

1.20

1.7

1.3

0.40

0.45

g/l

0.38

329

Hepatocellular carcinoma, including Hilmo

1.84

1.19

1.5

1.2

0.35

0.43

g/l

—

Malignant neoplasm of bronchus and lung

462

1.28

1.19

1.2

1.4

0.51

0.44

g/l

0.66

331

Pediculosis, acariasis and other infestations

222

1.45

1.19

1.6

1.3

0.47

0.38

g/l

0.61

151

Primary ovarian failure

1.89

1.18

1.3

0.49

0.37

g/l

—

Dementia in Alzheimer disease

344

0.69

1.18

1.1

1.3

0.43

0.50

g/l

0.36

246

Other disorders of breast

515

1.28

1.18

1.4

0.39

g/l

0.02

354

Sequelae of injuries of lower limb

358

1.34

1.18

1.6

1.3

0.39

0.38

g/l

0.13

250

Long labour

984

0.82

1.17

1.3

1.4

0.38

0.35

g/l

0.60

708

Other and unspecified vascular occlusions

231

1.43

1.17

1.2

1.4

0.35

0.44

g/l

1.51

167

L02BA Anti-estrogens

646

0.76

1.16

1.1

1.4

0.38

0.39

g/l

0.09

448

Other spirochaetal diseases

155

1325

1.17

1.16

1.4

0.36

0.41

g/l

1.44

124

922

Postmenopausal atrophic vaginitis

122

560

1.20

1.14

1.4

0.43

0.39

g/l

0.36

382

Macular pucker

474

1.29

1.14

1.7

1.4

0.40

0.44

g/l

0.20

335

Other spirochaetal diseases

153

1309

1.17

1.13

1.4

0.36

0.41

g/l

1.55

123

909

Other renal tubulo-interstitial diseases

1.86

1.13

1.1

1.3

0.39

0.34

g/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

309

1.36

1.13

1.0

1.4

0.34

0.42

g/l

0.92

224

Foreign body on external eye

581

1.26

1.13

1.2

1.3

0.36

0.40

g/l

0.57

391

Coronary artery bypass grafting

551

1.23

1.12

1.6

1.3

0.46

0.44

g/l

0.11

360

Retinoschisis and retinal cysts

1.91

1.12

2.8

1.3

0.35

0.37

g/l

—

Presbyopia

259

1.40

1.11

1.4

0.38

0.36

g/l

0.11

179

Injury of muscle and tendon at hip and thigh level

371

1.32

1.11

1.1

1.4

0.41

0.37

g/l

0.35

254

Vertical strabismus

104

1.64

1.09

1.4

0.53

0.38

g/l

0.64

Impacted maxillary canine

1.97

1.09

1.3

1.2

0.51

0.41

g/l

—

Thyrotoxicosis with toxic single thyroid nodule

2.40

1.09

1.8

1.5

0.44

0.27

g/l

—

Colitis due to radiation

2.40

1.09

1.4

0.18

0.38

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

346

1.33

1.09

1.1

1.4

0.41

0.38

g/l

0.28

236

256

0.62

1.09

1.1

1.3

0.58

0.41

g/l

—

181

Dementia in other diseases classified elsewhere

112

1.61

1.09

1.2

0.42

0.47

g/l

—

Nonalcoholic steatohepatitis

2.21

1.08

1.6

1.3

0.46

0.37

g/l

—

In situ neoplasms

178

1548

1.15

1.08

1.4

0.45

0.42

g/l

0.34

114

1081

Polyp of the female genital tract

147

720

1.17

1.07

1.3

1.4

0.35

0.40

g/l

0.75

108

494

Congenital musculoskeletal deformities of head, face, spine and chest

1.94

1.07

1.6

1.3

0.30

0.35

g/l

—

LSIL lesion of the cervix uteri

507

1.27

1.05

1.3

1.4

0.39

0.37

g/l

0.16

351

Other congenital malformations of the digestive system

210

1.42

1.04

1.6

1.3

0.46

0.37

g/l

0.68

160

Diabetic nephropathy

580

1.24

1.04

1.4

1.5

0.44

0.45

g/l

0.08

378

Hereditary corneal dystrophies

1.67

1.04

1.1

1.5

0.20

0.39

g/l

—

Obstructed labour due to maternal pelvic abnormality

624

1.24

1.04

1.3

1.4

0.63

0.35

g/l

0.98

439

Gilbert syndrome

2.29

1.04

2.2

1.3

0.39

0.29

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

154

1.50

1.03

1.1

1.4

0.42

g/l

0.00

112

All dysplastic lesions of the cervix uteri, vagina or vulva

154

1311

1.16

1.03

1.3

1.4

0.37

0.38

g/l

0.10

112

931

Sequelae of other and unspecified infectious and parasitic diseases

204

1.43

1.03

1.5

1.4

0.35

0.37

g/l

0.10

140

Early lumbar disc prolapse operation

482

1.27

1.02

1.2

1.3

0.38

0.37

g/l

0.15

320

Malignant neoplasm of prostate

587

0.81

1.02

1.3

1.4

0.49

0.45

g/l

0.45

408

Fall on and from stairs and steps

126

1073

1.18

1.02

1.5

1.3

0.36

0.40

g/l

0.62

747

Schizophrenia or delusion

124

1453

0.85

1.01

1.2

1.3

0.39

g/l

0.02

984

Varicella [chickenpox]

230

1.40

1.01

1.2

1.3

0.29

0.37

g/l

0.87

166

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

0.27

0.30

g/l

—

Contact with heat and hot substances

197

1.43

1.00

1.4

1.3

0.39

g/l

0.07

137

Malignant neoplasm of rectum, including Hilmo

402

0.72

0.99

1.3

1.4

0.33

0.42

g/l

0.91

286

Motorcycle rider injured in other and unspecified transport accidents

223

1.39

0.98

1.5

1.2

0.42

0.36

g/l

0.61

152

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

0.98

0.0

1.2

—

0.39

—

Scabies

611

1.23

0.98

1.5

1.4

0.39

0.37

g/l

0.20

425

Schizophrenia, schizotypal and delusional disorders

125

1458

0.86

0.97

1.2

1.3

0.39

g/l

0.01

987

Other congenital malformations of heart

1.97

0.97

1.4

1.2

0.31

0.40

g/l

—

Other congenital malformations of the digestive system

180

1.44

0.97

1.7

1.3

0.46

0.37

g/l

0.70

136

Melanocytic naevi of trunk

459

1.27

0.97

1.2

1.4

0.35

0.39

g/l

0.55

326

Maternal care for other known or suspected fetal problems

136

738

1.17

0.97

1.3

1.4

0.39

0.36

g/l

0.46

536

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

0.25

0.37

g/l

—

Torticollis

1.81

0.97

1.1

1.3

0.43

0.36

g/l

—

Pathological resorption of teeth

108

1.58

0.96

1.2

0.72

0.39

g/l

0.76

Contact with machinery

389

1.29

0.96

1.2

1.3

0.42

0.39

g/l

0.16

267

Fracture of skull and facial bones

106

896

1.18

0.95

1.4

1.3

0.40

0.41

g/l

0.04

614

Overexertion and strenuous or repetitive movements

372

1.29

0.95

1.2

1.4

0.29

0.37

g/l

1.14

257

Perineal laceration during delivery

663

0.81

0.95

1.7

1.4

0.43

0.35

g/l

1.10

463

Male infertility

174

1.44

0.95

1.2

1.3

0.34

0.37

g/l

0.22

112

Behavioural disorders

1.66

0.94

1.3

1.2

0.38

0.35

g/l

—

Complications of the puerperium, not elsewhere classified

166

1.45

0.94

1.3

1.4

0.29

0.37

g/l

1.21

116

Malignant neoplasm of skin

230

1406

1.12

0.94

1.5

1.4

0.46

0.42

g/l

0.22

161

999

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

294

1.33

0.94

1.3

1.4

0.37

0.39

g/l

0.20

190

Autism spe

109

1.57

0.94

1.4

1.3

0.24

0.35

g/l

—

Autism

109

1.57

0.94

1.4

0.24

0.35

g/l

—

Juvenile osteochondrosis

109

1.57

0.93

1.8

1.4

0.33

0.36

g/l

0.24

Primary angle-closure glaucoma

101

1.59

0.93

1.8

1.3

0.34

0.46

g/l

1.18

Ovarian dysfunction

286

1.33

0.93

1.4

0.37

0.38

g/l

0.12

197

Other ill-defined and unspecified causes of mortality

175

1.43

0.92

1.2

0.52

0.47

g/l

0.28

124

Car occupant injured in other and unspecified transport accidents

798

1.19

0.92

1.6

1.4

0.36

0.39

g/l

0.45

551

Right hemicolectomy

142

1.48

0.92

1.2

1.3

0.79

0.43

g/l

1.18

Premature rupture of membranes

722

0.83

0.91

1.3

1.4

0.40

0.36

g/l

0.52

517

Erectile dysfunction

235

1.37

0.91

1.5

1.2

0.50

0.43

g/l

0.33

166

Carcinoma in situ of skin

227

1.37

0.90

1.3

0.49

0.43

g/l

0.28

163

Bipolar affective disorders

819

1.19

0.90

1.3

0.39

g/l

0.03

552

Non-small cell lung cancer, including Hilmo

429

1.25

0.89

1.1

1.4

0.52

0.44

g/l

0.92

304

Diabetic maculopathy

463

1.24

0.89

1.5

1.4

0.41

0.43

g/l

0.17

305

Malignant neoplasm of kidney, except renal pelvis

245

1.35

0.89

1.0

1.4

0.37

0.41

g/l

0.32

181

Thiazolidinediones

359

1.28

0.88

1.3

1.4

0.44

0.40

g/l

0.28

250

Sexual dysfunction

1.87

0.87

1.5

1.3

0.40

0.34

g/l

—

Non-small cell lung cancer

270

1.33

0.86

1.2

1.4

0.46

0.45

g/l

0.08

198

Pregnancy, childbirth and the puerperium

107

655

0.85

0.86

1.4

0.40

0.38

g/l

0.16

471

Assault

558

1.22

0.86

1.2

1.3

0.46

0.36

g/l

1.66

374

Mental and behavioural disorders due to cannabinoids

104

1.55

0.84

1.1

1.3

0.52

0.33

g/l

—

1.95

0.84

1.7

1.2

0.23

0.41

g/l

—

Benign neoplasm of thyroid gland

1.57

0.84

2.6

1.3

0.51

0.33

g/l

—

Diabetic neuropathy

404

1.26

0.84

1.5

1.4

0.46

0.45

g/l

0.06

263

Basal cell carcinoma, including avohilmo

202

1243

1.12

0.84

1.6

1.4

0.37

0.43

g/l

1.23

145

876

Abnormal findings in secretions and smears from cervix uteri vagina vulva

263

1802

1.10

0.83

1.4

0.37

0.39

g/l

0.56

189

1298

Congenital malformations of heart and great arteries

561

1.21

0.82

1.3

1.4

0.36

0.38

g/l

0.18

406

Infections of genitourinary tract in pregnancy

381

1.26

0.82

1.3

1.5

0.37

0.38

g/l

0.05

262

Other and unspecified injuries of abdomen, lower back and pelvis

1.88

0.82

1.0

1.1

0.43

0.30

g/l

—

Other and unspecified mononeuropathies, also in other diseases

1.61

0.81

1.4

1.3

0.44

0.37

g/l

0.24

Lyme disease

147

1295

1.14

0.81

1.4

0.35

0.41

g/l

1.55

120

896

HSIL lesion of the vulva

1.71

0.81

1.1

1.3

0.31

0.33

g/l

—

Other disorders of the genitourinary system

436

1.24

0.80

1.4

0.44

0.40

g/l

0.18

295

Congenital musculoskeletal deformities of head, face, spine and chest

1.74

0.80

1.6

1.3

0.30

0.35

g/l

—

Other chromosome abnormalities, not elsewhere classified

1.85

0.80

1.5

1.3

0.49

0.39

g/l

—

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

0.31

—

Malignant melanoma

491

1.22

0.79

1.3

1.4

0.69

0.41

g/l

0.49

346

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

0.32

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.79

0.0

1.3

—

0.35

—

Graves disease, strict definition

392

1.25

0.79

1.4

0.31

0.40

g/l

1.93

277

Organic, including symptomatic, mental disorders

176

1404

0.89

0.79

1.3

1.4

0.40

0.44

g/l

0.71

125

956

Femoral hernia

106

1.51

0.79

1.4

1.2

0.38

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

339

1.27

0.78

1.2

1.5

0.36

0.38

g/l

0.15

237

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

0.32

—

Spirochaetal infections, other/unspecified

148

1309

1.13

0.77

1.4

0.36

0.41

g/l

1.54

121

910

Injury of muscle and tendon at lower leg level

585

1.20

0.76

2.0

1.3

0.40

0.41

g/l

0.12

401

Emotional disorders starting during childhood or adolescence

207

1.34

0.76

1.5

1.4

0.29

0.37

g/l

1.62

157

Other and unspecified corneal deformities and disorders

1.52

0.75

1.2

1.4

0.44

0.38

g/l

—

Pre-eclampsia or poor fetal growth

158

1401

1.12

0.75

1.4

0.40

0.38

g/l

0.32

110

995

Basal cell carcinoma

189

1173

1.12

0.75

1.6

1.4

0.38

0.42

g/l

0.86

135

825

Solid cancers, helper endpoint

455

2505

1.07

0.75

1.3

1.4

0.42

0.40

g/l

0.43

303

1778

Benign neoplasm: Skin of other and unspecified parts of face

333

1.26

0.74

1.5

1.4

0.44

0.40

g/l

0.20

238

Other fall from one level to another

111

967

1.15

0.73

1.3

1.4

0.37

0.40

g/l

0.57

680

Supervision of normal pregnancy

612

0.86

0.73

1.2

1.4

0.32

0.37

g/l

1.02

446

Spontaneous abortion

243

1492

1.10

0.73

1.3

1.4

0.38

g/l

0.03

174

1071

Foreign body entering into or through eye or natural orifice

299

1.27

0.72

1.3

0.38

0.39

g/l

0.12

213

Intermittent heterotropia

237

1.31

0.72

1.4

0.45

0.36

g/l

0.52

168

Hydrocele

371

1.24

0.71

1.4

0.41

0.46

g/l

0.37

260

Parkinson's disease, strict definition, excluding more controls

317

0.75

0.71

1.3

1.4

0.33

0.46

g/l

1.30

208

Malignant neoplasm of brain

101

1.49

0.70

1.4

1.2

0.30

0.37

g/l

—

Open wound of head

271

2401

1.09

0.70

1.5

1.3

0.38

0.41

g/l

0.49

178

1642

Toxic effect of contact with venomous animals

143

1.40

0.70

1.2

1.3

0.27

0.39

g/l

2.40

Unspecified maternal hypertension

1.72

0.70

1.1

1.4

0.34

0.36

g/l

—

Varicose veins of other sites

212

1.32

0.70

1.2

1.3

0.52

0.37

g/l

0.75

146

Intracerebral haemorrhage

345

1.25

0.70

1.2

1.3

0.44

0.42

g/l

0.13

240

Other osteochondropathies

265

1.29

0.70

1.4

1.3

0.32

0.37

g/l

0.41

178

Unspecified abortion

195

1.34

0.69

1.5

1.4

0.35

0.32

g/l

0.20

136

Aneurysms, operations, SAH

583

1.19

0.68

1.3

1.4

0.45

0.39

g/l

0.40

397

Traumatic subdural haemorrhage

341

1.24

0.68

1.5

1.4

0.53

0.45

g/l

0.51

236

Inguinal hernia

290

1788

1.08

0.67

1.3

1.4

0.45

0.40

g/l

1.00

202

1210

Chronic periodontitis, including avohilmo

528

3334

1.06

0.67

1.4

0.42

0.40

g/l

0.35

375

2304

Alzheimer’s disease (Late onset), excluding more controls

261

0.78

0.67

1.1

1.4

0.52

0.44

g/l

0.36

166

Tibial collateral bursitis [Pellegrini-Stieda]

1.79

0.66

1.0

1.5

0.42

0.36

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

448

1.21

0.66

1.3

0.34

0.37

g/l

0.23

312

Inflammatory disorders of breast

232

1.30

0.66

1.7

1.4

0.38

0.36

g/l

0.19

159

Malignant neoplasm of breast, HER-negative

710

0.84

0.66

1.2

1.5

0.42

0.40

g/l

0.10

504

Alcohol dependence

122

1081

1.13

0.65

1.2

1.4

0.38

0.42

g/l

0.83

760

Nontoxic goitre/thyroid nodule

131

1166

1.12

0.65

1.9

1.4

0.38

0.40

g/l

0.32

810

Short Achilles tendon (acquired)

1.62

0.65

1.4

0.41

0.33

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

349

1.23

0.65

1.2

1.4

0.36

0.39

g/l

0.26

237

Crushed, pushed or stepped on by crowd or human stampede

304

1.25

0.65

1.2

1.3

0.40

0.39

g/l

0.09

212

Inguinal or femoral hernia, bilateral

340

1.24

0.65

1.2

1.3

0.56

0.42

g/l

0.53

239

Follow-up examination after treatment for malignant neoplasms

224

1.30

0.64

1.1

1.3

0.34

0.46

g/l

1.17

127

Superficial injury of shoulder and upper arm

413

1.21

0.64

1.7

1.4

0.49

0.39

g/l

1.19

289

Malignant melanoma, including Hilmo

588

1.18

0.63

1.3

1.4

0.64

0.41

g/l

0.43

420

Inguinal hernia, bilateral

332

1.24

0.63

1.2

1.3

0.56

0.42

g/l

0.49

234

Pervasive developmental disorders excl. Autism + Asperger

1.61

0.63

1.0

1.3

0.25

0.40

g/l

—

Foreign body or object entering through skin

225

1.29

0.63

1.4

1.3

0.41

0.35

g/l

0.27

157

Parkinson's disease, excluding more controls

338

0.78

0.62

1.3

1.4

0.33

0.46

g/l

1.39

225

Mandibular retrognathia

269

1.26

0.62

1.4

0.35

0.38

g/l

0.19

189

Redundant prepuce, phimosis and paraphimosis

851

1.14

0.62

1.2

1.3

0.35

0.41

g/l

2.03

571

Maternal care for known or suspected malpresentation of fetus

639

0.86

0.62

1.4

0.40

0.36

g/l

0.44

461

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

291

0.75

0.62

1.4

0.29

0.41

g/l

1.47

213

Malignant neoplasm of breast, ER-negative, including Hilmo

796

0.86

0.61

1.2

1.5

0.43

0.40

g/l

0.20

567

Malignant neoplasm of ovary

152

0.66

0.61

1.4

1.6

0.41

0.37

g/l

—

105

Injury of eye and orbit

600

1.17

0.61

1.2

1.3

0.40

0.41

g/l

0.03

406

All dysplastic lesions of the cervix uteri

133

1182

1.12

0.61

1.3

1.4

0.38

0.37

g/l

0.10

844

Malignant neoplasm of bladder, including Hilmo

314

1.24

0.60

1.6

1.4

0.37

0.46

g/l

0.91

233

Injury of muscle and tendon at wrist and hand level

536

1.18

0.60

1.3

1.4

0.36

0.39

g/l

0.44

374

Focal brain injury

165

1.34

0.60

1.6

1.3

0.51

0.41

g/l

0.31

112

Epidural haemorrhage

0.00

0.60

0.0

1.4

—

0.44

—

Diabetic retinopathy, strict definition

604

1.16

0.60

1.5

1.4

0.43

0.42

g/l

0.05

395

Hyperplasia of prostate

150

766

1.11

0.60

1.3

1.4

0.43

0.45

g/l

0.13

105

528

0.00

0.60

0.0

1.1

—

0.31

—

Nontoxic single thyroid nodule

236

1.27

0.59

2.1

1.3

0.31

0.42

g/l

1.25

168

Intrahepatic Cholestasis of Pregnancy (ICP)

290

1.24

0.59

1.1

1.4

0.34

0.37

g/l

0.18

204

Malignant neoplasm of urinary organs

272

1.25

0.59

1.0

1.4

0.39

0.41

g/l

0.20

198

Traction detachment of retina

0.00

0.58

0.0

1.2

—

0.33

—

HSIL lesion of the cervix uteri

853

0.87

0.58

1.4

0.40

0.37

g/l

0.22

603

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

327

1.23

0.58

1.4

0.33

0.36

g/l

0.29

226

Vascular dementia

160

1.33

0.58

1.4

1.2

0.33

0.52

g/l

1.59

117

Other mental disorders due to brain damage and dysfunction and to physical disease

327

1.23

0.58

1.4

0.44

0.41

g/l

0.18

228

Periodontitis

527

3341

1.05

0.58

1.4

0.42

0.40

g/l

0.36

376

2306

Puerperal sepsis

503

1.17

0.56

1.7

1.4

0.38

0.40

g/l

0.15

348

Pedal cyclist injured in noncollision transport accidents

473

0.82

0.56

1.4

1.3

0.39

g/l

0.02

328

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

293

1.23

0.55

1.1

1.4

0.34

0.37

g/l

0.20

202

Leiomyoma of uterus

323

1712

1.07

0.55

1.4

0.39

g/l

0.08

223

1230

Other and unspecified nonorganic psychotic disorders

880

0.87

0.55

1.2

1.4

0.39

0.38

g/l

0.13

590

Postpartum haemorrhage due to retained placenta

547

0.84

0.54

1.2

1.3

0.41

0.38

g/l

0.26

383

Maternal care for known or suspected fetal abnormality and damage

646

0.86

0.54

1.3

1.4

0.36

g/l

0.02

461

Viral hepatitis

276

1.23

0.54

1.1

1.3

0.45

0.37

g/l

0.61

189

Malignant neoplasm of bladder

151

1.33

0.53

1.5

1.2

0.34

0.46

g/l

0.67

115

Calculus of lower urinary tract

134

1.35

0.53

1.7

1.3

0.38

0.43

g/l

—

Left ventricular outflow tract obstruction, narrow definition

187

1.29

0.52

1.4

1.3

0.30

0.38

g/l

0.86

131

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.61

0.52

1.3

1.4

0.35

0.38

g/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.60

0.52

1.3

1.4

0.35

0.39

g/l

—

Transient global amnesia

293

0.78

0.52

2.4

1.4

0.57

0.43

g/l

0.20

204

Pedestrian injured in collision with pedal cycle

1.45

0.52

1.2

1.3

0.35

0.36

g/l

—

Wide developmental disorders

161

1.31

0.51

1.3

1.4

0.27

0.39

g/l

2.48

122

Malignant neoplasm of rectum

280

0.78

0.50

1.4

0.34

0.41

g/l

0.59

203

Other blood glucose lowering drugs, excl. Insulins

547

1.15

0.50

1.2

1.4

0.45

0.40

g/l

0.36

378

Pedal cyclist injured in transport accident

977

0.89

0.49

1.5

1.3

0.38

0.40

g/l

0.18

675

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

0.48

0.40

g/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.53

0.48

1.1

1.3

0.44

0.31

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

998

0.90

0.48

1.3

1.4

0.45

0.35

g/l

2.05

716

Foreign body in alimentary tract

172

1.28

0.48

1.2

1.3

0.39

0.41

g/l

0.06

124

Ill-defined and unknown causes of mortality

199

1.26

0.47

1.2

0.52

0.46

g/l

0.35

138

Pregnancy examination and test

474

1.13

0.47

1.6

1.4

0.31

0.35

g/l

0.72

345

Generalized epilepsy, mode (most common among epilepsy diagnosis)

111

1.36

0.46

1.4

1.3

0.32

0.36

g/l

—

Malignant neoplasm of head and neck

236

1.23

0.46

1.2

1.3

0.35

0.40

g/l

0.49

169

Other disorders of iris and ciliary body

1.43

0.45

1.2

1.3

0.37

0.44

g/l

—

Scissor bite

140

0.70

0.45

1.4

1.5

0.31

0.37

g/l

—

112

Type 1 diabetes, strict (exclude DM2)

448

1.16

0.45

1.2

1.4

0.42

0.37

g/l

0.43

327

HSIL lesion of the cervix uteri, vagina or vulva

928

0.89

0.45

1.4

0.38

g/l

0.04

660

Antenatal screening

101

629

0.90

0.45

1.2

1.4

0.33

0.37

g/l

0.91

457

Generalized epilepsy

156

1.29

0.45

1.4

1.3

0.35

0.40

g/l

0.36

111

Polyhydramnios

183

1.26

0.45

1.4

0.42

0.36

g/l

0.23

125

Other abnormal products of conception

171

1046

1.08

0.44

1.4

1.3

0.42

0.36

g/l

1.75

118

758

Carcinoma in situ of cervix uteri

384

0.83

0.44

1.5

1.4

0.40

0.37

g/l

0.12

265

Type 1 diabetes, definitions combined

449

1.16

0.44

1.2

1.3

0.42

0.37

g/l

0.42

329

Benign leiomyoma with endometriosis

583

1.13

0.43

1.2

1.4

0.38

0.39

g/l

0.06

396

Focal epilepsy, mode (most common among epilepsy diagnosis)

744

1.12

0.42

1.3

0.40

g/l

0.03

527

Macular hole

151

0.73

0.42

1.1

1.5

0.33

0.40

g/l

—

111

Complications following abortion and ectopic and molar pregnancy

113

1.33

0.42

1.1

1.6

0.37

g/l

—

Medical treatment for female infertility

108

977

1.10

0.42

1.3

1.4

0.32

0.37

g/l

1.56

687

Clear cell adenocarcinoma of kidney

122

1.31

0.42

1.0

1.4

0.40

g/l

—

Polycystic ovarian syndrome, broad definition

462

1.15

0.42

1.5

1.4

0.33

0.37

g/l

0.86

332

Postpartum haemorrhage due to anatomy

446

0.85

0.42

1.1

1.3

0.40

0.38

g/l

0.19

311

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

0.38

—

Alcoholic cardiomyopathy

0.00

0.41

0.0

1.4

—

0.46

—

Open bite

240

1.21

0.41

1.2

1.4

0.39

0.38

g/l

0.06

170

Other viral hepatitis

240

1.21

0.41

1.1

1.3

0.48

0.36

g/l

0.85

164

Assault by bodily force

323

1.18

0.41

1.2

1.3

0.48

0.34

g/l

1.79

219

Cardiomyopathies, Secondary/extrinsic

0.00

0.41

0.0

1.5

—

0.41

—

Focal epilepsy

870

1.10

0.41

1.3

0.39

0.40

g/l

0.09

612

Manic episode

1.40

0.40

1.4

1.3

0.23

0.35

g/l

—

Prominent ears

1.48

0.40

1.4

1.2

0.49

0.40

g/l

—

Frostbite

1.48

0.40

1.4

0.34

0.35

g/l

—

Malignant neoplasm of brain, including Hilmo

150

1.27

0.40

1.3

1.4

0.37

0.36

g/l

0.06

111

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.40

0.0

1.4

—

0.35

—

Deep bite

456

1.14

0.40

1.3

1.4

0.33

0.38

g/l

1.06

331

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.40

0.0

1.2

—

0.44

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

270

0.81

0.39

1.4

0.29

0.41

g/l

1.41

195

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.39

0.0

1.1

—

0.39

—

Colorectal adenocarcinoma

600

0.88

0.38

1.3

1.4

0.38

0.43

g/l

0.54

428

Single delivery by forceps and vacuum extractor

459

0.89

0.38

1.2

1.4

0.38

0.34

g/l

0.46

346

Malignant melanoma of skin

366

0.85

0.38

1.4

0.82

0.40

g/l

0.43

261

Other disorders of amniotic fluid and membranes

616

0.89

0.37

1.8

1.4

0.38

0.36

g/l

0.32

438

Malignant neoplasm of corpus uteri, including Hilmo

271

1.18

0.37

1.1

1.5

0.50

0.38

g/l

0.43

185

Bulimia nervosa (incl. atypical)

125

1.28

0.37

1.3

1.4

0.29

0.36

g/l

—

Pre-eclampsia

887

1.09

0.36

1.5

1.4

0.42

0.38

g/l

0.48

614

Lesion of plantar nerve

189

1.22

0.36

2.1

1.4

0.41

0.39

g/l

0.12

132

Congenital malformations of aortic and mitral valves

153

1.24

0.35

1.4

1.3

0.32

0.39

g/l

0.56

107

Postpartum care and examination

419

0.89

0.35

1.3

1.4

0.35

0.34

g/l

0.09

300

Noise effects on inner ear

126

1.27

0.35

1.2

1.3

0.35

0.41

g/l

0.41

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.37

0.34

1.0

1.4

0.23

0.31

g/l

—

Unspecified lump in breast

604

1.11

0.34

1.6

1.4

0.33

0.40

g/l

1.31

415

Kela-code for severe mental illness

159

1696

0.94

0.34

1.2

1.4

0.40

0.39

g/l

0.17

107

1157

Otosclerosis

246

1.18

0.34

1.0

1.5

0.49

0.39

g/l

1.06

173

Postpartum haemorrhage

112

1017

0.93

0.33

1.2

1.4

0.41

0.35

g/l

1.26

730

Postpartum hemorraghe, all women as controls

112

1185

0.93

0.31

1.2

1.4

0.41

0.37

g/l

0.73

845

Polycystic ovarian syndrome

202

1.19

0.31

1.4

0.34

0.40

g/l

0.57

133

Malignant melanoma of skin, including Hilmo

495

0.89

0.30

1.4

0.69

0.41

g/l

0.39

354

Contact with other sharp object(s)

272

0.84

0.30

1.3

0.29

0.37

g/l

0.99

189

Other specified disorders of external ear

102

1.28

0.30

1.8

1.3

0.28

0.45

g/l

—

Retinal breaks without detachment

620

1.10

0.29

1.7

1.4

0.33

0.41

g/l

1.07

441

Convergent concomitant strabismus

242

1.16

0.28

1.5

1.4

0.43

0.37

g/l

0.35

172

Focal epilepsy, strict definition

796

1.08

0.27

1.3

0.40

g/l

0.00

562

Nontraumatic intracranial haemmorrhage

652

1.09

0.27

1.3

1.4

0.46

0.42

g/l

0.32

450

Burn and corrosion of head and neck

1.21

0.26

1.3

0.46

0.37

g/l

—

Abnormal spermatozoa

395

1.11

0.26

1.2

1.3

0.42

0.47

g/l

0.37

278

Acute and transient psychotic disorders

489

0.90

0.26

1.1

1.4

0.34

0.38

g/l

0.77

334

Multiple gestation

405

1.11

0.26

1.4

0.40

0.34

g/l

0.71

282

Benign neoplasm of breast

457

0.90

0.26

1.3

1.4

0.30

0.40

g/l

1.94

321

Other sexually transmitted chlamydial diseases

415

0.89

0.26

1.3

1.4

0.44

0.39

g/l

0.36

274

Malignant neoplasm of ovary, including Hilmo

203

0.84

0.25

1.2

1.5

0.52

0.37

g/l

—

141

Maternal care related to the fetus and amniotic cavity and possible delivery problems

233

1308

1.05

0.25

1.4

0.37

0.39

g/l

0.38

174

945

Poor fetal growth

579

1.09

0.25

1.2

1.4

0.39

0.36

g/l

0.48

413

Other and/or unspecified nontoxic goitre

266

0.86

0.24

3.3

1.3

0.31

0.40

g/l

1.14

182

Labour and delivery complicated by fetal stress [distress]

124

765

1.06

0.24

1.3

1.4

0.38

0.35

g/l

0.84

550

malignant neoplasm of female genital organs

494

0.90

0.24

1.2

1.5

0.52

0.40

g/l

0.52

343

Fracture of forearm

276

2434

1.04

0.24

1.3

1.4

0.40

g/l

0.02

194

1699

Type 1 diabetes, strict definition, subgroup 1

340

1.12

0.23

1.3

0.34

0.36

g/l

0.19

256

Twin gestation

389

1.11

0.23

1.4

0.39

0.34

g/l

0.69

268

Hydrocephalus

190

1.16

0.23

2.0

1.3

0.39

0.42

g/l

0.13

139

Pre-eclampsia or eclampsia

102

960

1.06

0.23

1.5

1.4

0.40

0.38

g/l

0.30

669

Sulfonylureas

110

928

0.94

0.23

1.1

1.4

0.41

0.43

g/l

0.26

633

Gestational diabetes (for exclusion)

176

1281

0.96

0.22

1.2

1.4

0.38

0.37

g/l

0.15

130

923

Other and unspecified injuries of head

228

1.14

0.22

1.2

1.3

0.36

0.42

g/l

0.67

153

Ependymoma

0.00

0.21

0.0

1.2

—

0.30

—

Chronic viral hepatitis

199

0.85

0.21

1.1

1.3

0.54

0.37

g/l

0.73

133

Malignant neoplasm of larynx, including Hilmo

1.19

0.21

1.0

1.2

0.34

0.40

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

536

1.08

0.21

1.2

1.3

0.38

0.41

g/l

0.30

380

Syndactyly

0.00

0.21

0.0

1.2

—

0.30

—

Benign neoplasm of other and unspecified female genital organs

126

1.19

0.21

1.5

1.6

0.28

0.36

g/l

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.20

0.0

1.1

—

0.59

—

Helminthiases

1.25

0.20

1.7

1.2

0.22

0.34

g/l

—

Ectopic pregnancy

761

1.07

0.20

1.4

0.40

0.36

g/l

0.29

539

Malignant neoplasm of testis, including Hilmo

1.23

0.20

1.2

1.3

0.31

0.39

g/l

—

Malignant neoplasm of corpus uteri

221

1.13

0.20

1.1

1.5

0.58

0.37

g/l

0.65

154

Supervision of high-risk pregnancy

106

604

1.06

0.19

1.4

0.35

0.37

g/l

0.30

439

Burn and corrosion of trunk

1.22

0.19

1.3

0.35

0.39

g/l

—

Colorectal cancer

730

0.94

0.19

1.2

1.4

0.45

0.43

g/l

0.14

507

424

1.09

0.18

1.2

1.4

0.37

g/l

0.05

290

Abnormalities of forces of labour

467

0.92

0.18

1.3

1.4

0.32

0.34

g/l

0.27

329

Placenta praevia

194

1.14

0.18

1.3

1.4

0.37

0.36

g/l

0.05

131

Abnormal findings on antenatal screening of mother

363

0.91

0.18

1.5

0.36

0.38

g/l

0.17

260

Bicuspidal aortic valve syndrome

119

1.18

0.17

1.4

1.3

0.37

0.39

g/l

—

Complications of labour and delivery

319

1725

1.03

0.17

1.3

1.4

0.41

0.37

g/l

1.23

221

1220

Alcohol withdrawal state with delirium

233

1.12

0.17

1.1

1.3

0.45

0.41

g/l

0.21

164

Use of levodopa decarboxylase inhibitor

372

0.91

0.17

1.3

0.27

0.45

g/l

2.90

258

Renal cell carcinoma of kidney

0.73

0.17

1.0

1.2

0.42

0.40

g/l

—

Struck by thrown, projected or falling objec

178

1.12

0.15

1.3

0.38

g/l

0.01

119

Periapical abscess

222

2158

1.03

0.15

1.4

0.39

0.40

g/l

0.12

156

1519

Burns and corrosions

593

0.94

0.14

1.5

1.3

0.41

0.39

g/l

0.22

408

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.82

0.14

1.4

1.3

0.25

0.37

g/l

—

Memory loss

247

1.09

0.13

1.2

1.4

0.57

0.43

g/l

0.28

171

Antepartum haemorrhage, not elsewhere classified

397

0.93

0.13

1.3

1.4

0.36

0.35

g/l

0.17

283

Other disorders of penis

355

1.07

0.12

1.6

1.3

0.39

0.45

g/l

0.48

257

Colon adenocarcinoma

334

0.93

0.12

1.2

1.4

0.45

0.43

g/l

0.13

239

Diabetes mellitus in pregnancy

163

1013

1.03

0.12

1.2

1.4

0.35

0.38

g/l

0.58

118

733

Contact with sharp glass

133

1.13

0.12

1.2

1.3

0.38

0.37

g/l

—

Uterine polyps

346

1.07

0.12

1.4

0.29

0.39

g/l

1.48

247

Malignant neoplasm of colon, including Hilmo

590

1.05

0.12

1.5

1.4

0.48

0.42

g/l

0.39

418

Use of disulfiram, acamprosate or naltrexone

356

1.07

0.12

1.4

1.3

0.31

0.37

g/l

1.10

240

Type1 diabetes, definitions combined, early onset

308

1.07

0.10

1.3

0.37

g/l

0.02

224

Acute appendicitis, with complications

779

0.96

0.10

1.4

1.3

0.57

0.41

g/l

0.37

553

Malignant neoplasm of testis

1.11

0.10

1.2

1.4

0.34

0.37

g/l

—

Chronic periodontitis, complicated

252

2453

1.02

0.09

1.4

0.42

0.40

g/l

0.16

175

1702

Unspecified mental disorder

197

1932

1.02

0.08

1.2

1.4

0.38

0.39

g/l

0.17

137

1330

severe traumatic brain injury, does not include concussion

765

1.03

0.08

1.5

1.3

0.47

0.43

g/l

0.31

534

Injury of nerves at wrist and hand level

117

1.11

0.08

1.3

0.24

0.37

g/l

—

Combinations of oral blood glucose lowering drugs

107

1098

0.97

0.08

1.3

1.4

0.42

g/l

0.03

759

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.03

0.08

1.1

1.2

0.24

0.37

g/l

—

Other disorders of prostate

1.03

0.08

1.6

1.3

0.38

0.50

g/l

—

Postpartum hemorraghe, parous women as controls

112

977

0.98

0.07

1.2

1.3

0.41

0.38

g/l

0.47

689

Gonococcal infection

108

1.11

0.07

1.4

1.5

0.54

0.37

g/l

—

Myocardial infarction, unclassifiable

563

0.97

0.07

1.3

0.45

0.46

g/l

0.08

395

Schizophrenia or delusion, excluding more controls

124

1201

1.02

0.07

1.2

1.4

0.39

0.40

g/l

0.11

810

Maternal care for known or suspected abnormality of pelvic organs

122

812

1.02

0.07

1.2

1.4

0.37

0.36

g/l

0.13

584

Pedal cyclist injured in collision with motor vehicle

1.12

0.07

2.0

1.3

0.33

0.38

g/l

—

Other obstructed labour

305

1.05

0.06

1.2

1.4

0.30

0.35

g/l

0.72

211

Other complications of labour and delivery, not elsewhere classified

489

1.03

0.05

1.1

1.4

0.44

0.35

g/l

1.22

349

Subarachnoid haemorrhage

304

0.95

0.05

1.4

0.50

0.39

g/l

0.42

211

Use of rivastigmine

325

1.04

0.05

1.4

1.3

0.43

0.46

g/l

0.18

231

Dislocation, sprain and strain of joints and ligaments of elbow

248

1.05

0.05

1.9

1.4

0.46

0.37

g/l

0.60

175

Family history of certain disabilities and chronic diseases leading to disablement

181

0.94

0.05

1.1

1.3

0.42

0.37

g/l

0.25

129

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

201

0.94

0.04

1.5

1.4

0.55

0.35

g/l

—

138

Orchitis and epididymitis

309

1.04

0.03

1.3

1.4

0.44

0.45

g/l

0.11

214

Multiple delivery

369

1.03

0.03

1.4

1.3

0.39

0.35

g/l

0.46

284

Retinal detachment with retinal break

431

1.02

0.02

1.6

1.3

0.33

0.41

g/l

1.00

305

Fall on and from ladder

242

1.03

0.02

1.4

1.2

0.48

0.40

g/l

0.49

172

Thyrotoxicosis with toxic multinodular goitre

177

0.96

0.01

1.9

1.6

0.37

0.40

g/l

—

127

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

828

0.99

0.01

1.2

1.4

0.45

0.42

g/l

0.18

582

Failed induction of labour

243

1.03

0.01

1.3

1.4

0.31

0.36

g/l

0.38

170

Spermatocele

234

1.03

0.00

1.5

1.3

0.43

0.49

g/l

0.36

157

Divergent concomitant strabismus

284

1.02

0.00

1.7

1.4

0.43

0.37

g/l

0.24

195

Pedal cyclist injured in other and unspecified transport accidents

436

0.99

0.00

1.4

0.36

0.39

g/l

0.23

302

Family history of malignant neoplasm

444

1.01

0.00

1.2

1.4

0.27

0.39

g/l

2.89

324

Retained placenta and membranes, without haemorrhage

504

1.01

0.00

1.3

0.32

0.35

g/l

0.34

347

Single delivery by caesarean section

553

1.01

0.00

1.4

1.5

0.39

0.35

g/l

0.50

423

Burns and corrosions of external body surface, specified by site

442

1.00

0.00

1.6

1.3

0.43

0.39

g/l

0.35

308

Rubella [German measles]

122

0.98

0.00

2.5

1.4

0.29

0.37

g/l

—

Maternal care for cervical incompetence

121

0.99

0.00

1.3

1.5

0.41

0.35

g/l

—

Type 1 diabetes, strict definition

387

1.01

0.00

1.3

0.36

0.37

g/l

0.06

285

Malignant neoplasm of colon

435

1.01

0.00

1.1

1.4

0.54

0.42

g/l

0.65

306

Crowding of teeth, including avohilmo

354

1.00

0.00

1.3

1.4

0.43

0.35

g/l

0.92

254

Traumatic amputation of wrist and hand

123

0.98

0.00

1.4

1.3

0.22

0.45

g/l

—

Other sexually transmitted chlamydial diseases

257

1.01

0.00

1.3

1.4

0.46

0.39

g/l

0.49

167

Acne varioliformis

0.00

0.0

1.0

—

0.49

—

Congenital malposition of the kidney

0.00

0.0

1.0

—

0.37

—

Cholera

0.00

-0.00

0.0

1.2

—

0.33

—

Exposure to other and unspecified man-made environmental factors

0.96

-0.00

1.0

1.3

0.37

0.32

g/l

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

0.54

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.4

—

0.24

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.3

—

0.42

—

Liveborn infants according to place of birth

0.91

-0.00

1.0

1.2

0.27

0.33

g/l

—

Birth injury to skeleton

0.00

-0.00

0.0

1.5

—

0.31

—

Chondrosarcoma

0.00

-0.00

0.0

1.1

—

0.31

—

Hirsprung

0.00

-0.00

0.0

1.0

—

0.48

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.2

—

0.31

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.0

—

0.46

—

Burns and corrosions of multiple and unspecified body regions

0.91

-0.00

1.0

1.3

0.47

0.35

g/l

—

Injury of urinary and pelvic organs

0.94

-0.00

1.0

1.2

0.41

0.34

g/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 3 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS